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Zusammenfassung 
Essenzielle zelluläre Prozesse wie Zellwachstum, Teilung und Transport von Cargo sind auf 
intrazellulären Transport angewiesen. Die dafür verantwortliche Transportmaschinerie 
besteht aus molekularen Motoren, die sich direktional auf Aktinfilamenten und 
Mikrotubuli, die als ‚zelluläre Straßen‘ fungieren, bewegen. Myosin Motoren laufen auf 
Aktinfilamenten, während Mikrotubuli den entgegengesetzt gerichteten Kinesin und 
Dynein Motoren als Straßen dienen. Interessanterweise sind in vielen Fällen die 
koordinierten (oder konkurrierenden) Aktivitäten der entsprechenden Aktin- und 
Mikrotubuli-basierten Transportsysteme für Cargotransport in vivo erforderlich. Trotz dem 
detaillierten Wissen über jedes einzelne Transportsystem sind nur sehr spärliche 
Informationen über die funktionelle Verbindung zwischen dem Aktin/Myosin- und dem 
Mikrotubuli/Kinesin/Dynein-System erhältlich. Um diese Lücke zu schließen konzentriert 
sich diese Arbeit auf die Frage: Wie kommunizieren die Aktin- und Mikrotubuli-basierten 
Transportsysteme um die richtige Zustellung von Cargo zu gewährleisten? Um Einblicke in 
die Mechanismen zu erhalten, die die Aktin- und Mikrotubuli-basierten Transportsysteme 
verbinden, habe ich Pigmentzellen (Melanophoren) von der Amphibie Xenopus laevis und 
Melanozyten von der Maus als zwei gut etablierte Modellsysteme verwendet. In 
Melanophoren werden Pigmentgranulen (Melanosomen) durch die vereinten Kräfte der 
Mikrotubuli-basierten Dynein-1 und Kinesin-2 Motoren und dem Aktin-basierten Myosin 
Va Motor transportiert. Dieser Transport findet durch extrazelluläre Signale statt, die die 
Direktionalität des Melanosomentransports in vivo definieren. Es ist lange bekannt, das die 
Proteinkinase A (PKA) den nach innen gerichteten (Aggregation, niedrige PKA-Aktivität) und 
nach außen gerichteten (Dispersion, erhöhte PKA-Aktivität) Melanosomentransport 
dirigiert. Trotzdem blieben die molekularen Mechanismen, die eine solche direktionale 
Verteilung regulieren, die letzten zwei Jahrzehnte unbekannt. 
Vorangegangene Arbeit enthüllte zahlreiche Details der Mikrotubuli-basierten 
Transportmaschinerie, wohingegen nur wenig über das Aktin-basierte Transportsystem 
bekannt ist, das essenziell für den Dispersionsprozess ist. Um mechanistische Einblicke in 
die Aktin-basierte Transportmaschinerie des Melanosomentransportes zu geben, habe ich 
die Aktin-basierte Motilität von aufgereinigten Melanosomen in vitro rekonstituiert. 
Außerdem habe ich die Komponenten der Aktin-basierten Transportmaschinerie (der 
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dreiteilige Myosin Va Transportkomplex, der aus Rab27a, Melanophilin und Myosin Va 
besteht) von Xenopus laevis und Maus rekombinant exprimiert um eine umfangreiche in 
vitro Charakterisierung durchzuführen. 
Die Rekonstitution des Aktin-basierten Melanosomentransportes in vitro zeigte, dass 
Melanosomen von Zellen mit hoher PKA-Aktivität (dispergierter Zellstatus) einen 
signifikant erhöhten Myosin Va-abhängigen Transport aufweisen verglichen mit 
Melanosomen von Zellen mit niedriger PKA-Aktivität (aggregierter Zellstatus). Die 
Charakterisierung der Transportparameter des rekonstituierten Melanosomentransportes 
in vitro zeigte, dass PKA-Aktivität keinen Einfluss auf Geschwindigkeit oder Lauflänge der 
Melanosomen hatte. Ich habe die PKA als molekularen Schalter identifiziert, der direkt den 
Transport zwischen den entsprechenden Zellstatus auf der Melanosomenoberfläche 
reguliert. In vitro Phosphorylierungsexperimente mit den rekombinant exprimierten 
Komponenten Rab27a, Melanophilin und Myosin Va, die den dreiteiligen Myosin Va 
Transportkomplex in vivo bilden, demonstrieren, dass das Adaptorprotein Melanophilin 
das spezifische Phosphorylierungsziel der PKA in Xenopus und Maus ist. Besonders 
Melanophilin’s C-terminale Aktinbindedomäne ist ausgeprägtes Ziel der Phosphorylierung. 
Es ist beachtenswert, dass die in vitro Phosphorylierung von Melanophilin’s 
Aktinbindedomäne dem bereits beschriebenen in vivo Phosphorylierungsmuster sehr 
ähnlich ist. 
In meiner Arbeit stelle ich eine effiziente Strategie zur Assemblierung des dreiteiligen 
Myosin Va Transportkomplex in vitro vor, die es mir ermöglichte die funktionalen 
Konsequenzen der Melanophilin-Phosphorylierung in vitro zu testen. 
Dekorationsexperimente mit Aktin und dem Rab27a/Melanophilin-Komplex und 
Einzelmolekül-TIRF (interne Totalreflexionsfluoreszenz)-Mikroskopie-Experimente mit 
dem dreiteiligen Rab27a/Melanophilin/Myosin Va-Komplex auf Aktinfilamenten deckten 
unerwartet auf, dass die Phosphorylierung von Melanophilin’s Aktinbindedomäne nicht in 
Aktin-abhängige Prozesse, wie Melanophilin’s Bindung zu Aktin oder der Bewegung des 
Myosin Va-Transportkomplex auf Aktinfilamenten, eingreift. Stattdessen regulierte 
Melanophilin’s Phosphorylierungsstatus überraschend Melanophilin‘s Assoziation mit 
Mikrotubuli. Dephosphoryliertes Melanophilin zog die Bindung zu Mikrotubuli sogar in 
Gegenwart von Aktinfilamenten vor, währenddessen phosphoryliertes Melanophilin 
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hauptsächlich mit Aktinfilamenten assoziierte auch wenn Mikrotubuli gegenwärtig waren. 
Tatsächlich gibt Melanophilin’s Phosphorylierungsstatus vor, welches Filament der 
Rab27a/Melanophilin/Myosin Va-Komplex wählt, wenn Mikrotubuli und Aktinfilamente 
gleichzeitig vorhanden sind. Genauer gesagt zeigte der dreiteilige Myosin Va-
Transportkomplex mit phosphorylierten Melanophilin hauptsächlich direktionale 
Bewegung auf Aktinfilamenten in vitro, wie es von einem Aktin-basierten Motorprotein 
erwartet wird. Im Gegensatz dazu verstärkte die Dephosphorylierung von Melanophilin die 
Interaktion des dreiteiligen Myosin Va-Transportkomplexes mit Mikrotubuli und eine 
signifikante Anzahl an Komplexen zeigte Diffusion auf Mikrotubuli. Diese Ergebnisse decken 
die überraschende regulatorische Dominanz des Adaptorproteins Melanophilin über sein 
assoziertes Motorprotein Myosin Va auf und bieten einen Mechanismus an, wie 
Kommunikation zwischen dem Aktin- und Mikrotubuli-Transportsystemen in vivo 
bewerkstelligt werden könnte, und zwar durch das Adaptorprotein Melanophilin, das 
imstande ist mit Aktinfilamenten als auch mit Mikrotubuli zu interagieren. Die 
Bindungspreferenz des gesamten dreiteiligen Myosin Va- Transportkomplexes zu 
Aktinfilamenten oder Mikrotubuli wird durch den Phosphorylierungsstatus von 
Melanophilin reguliert. Zusammengenommen bieten die Beobachtungen dieser Arbeit 
erste Einblicke in das funktionelle Zusammenspiel zwischen den zwei zytoskelettalen 
Transportsystemen und stellen eine mechanistische Erklärung bereit, wie Zellen den 
Transport auf dem einen oder anderen zytoskelletalen Filament verschieben könnten.  
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Summary 
Essential cellular processes such as cell growth, division, migration, and cargo delivery rely 
on intracellular transport. The transport machinery responsible for such processes consists 
of molecular motors that move directionally on actin filaments or microtubules, which 
serve as ‘cellular roads’. Myosin motors walk on actin filaments, whereas microtubules 
serve as tracks for the oppositely directed kinesin and dynein motors. Interestingly, in many 
cases, the coordinated (or competing) activities of the respective actin- and microtubule-
based systems are required for cargo transport in vivo. Despite the detailed knowledge on 
each individual transport system, only very sparse information is available on the functional 
interface between the actin/myosin- and the microtubule/kinesin/dynein-systems. To 
close this gap, this thesis is focused on the question: how is crosstalk between the actin- 
and microtubule-based transport systems achieved to bring about correct cargo delivery? 
To gain insights into the mechanisms that link the actin- and microtubule-based transport 
systems, I used pigment cells (melanophores) from the amphibian Xenopus laevis and 
melanocytes from mouse as two well-established model systems. In melanophores, 
pigment granules (melanosomes) are transported by the concerted action of the 
microtubule-based dynein-1 and kinesin-2 motors and the actin-based myosin Va motor 
upon external cues that in turn define the overall directionality of transport in vivo. It is 
long known that protein kinase A (PKA) orchestrates the inward (aggregation, decreased 
PKA activity) and the outward (dispersion, increased PKA activity) of movement of 
melanosomes. However, molecular mechanism(s) of how such directional distribution is 
regulated remained elusive over the past two decades. 
Previous work illuminated numerous details of the microtubule-based transport machinery 
that move the melanosome, whereas only little is known about the actin-based transport 
system that is essential for the dispersion process. To provide mechanistic insights into the 
actin-based machinery of melanosome transport, I reconstituted the actin-based motility 
of purified melanosomes in vitro. Furthermore, I recombinantly expressed the components 
of the actin-based transport machinery (the tripartite myosin Va transport complex 
consisting of Rab27a, melanophilin, and myosin Va) from Xenopus laevis and mouse to 
perform an extensive in vitro characterization. 
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Reconstituting the actin-based transport of melanosomes in vitro revealed that 
melanosomes from cells with high PKA activity (i.e. dispersed cell state) exhibit significantly 
increased myosin Va-dependent transport compared to melanosomes derived from cells 
with low PKA activity (i.e. aggregated cell state). Characterizing the transport parameters 
of the reconstituted melanosome transport in vitro showed that PKA activity did not 
influence velocity or run length of melanosomes. I identified PKA as the molecular switch 
that directly regulates this transport between the respective cell states on the melanosome 
surface. In vitro phosphorylation assays with the recombinantly expressed components 
Rab27a, melanophilin, and myosin Va that form the myosin Va tripartite transport complex 
in vivo demonstrate that the adaptor protein melanophilin is the specific phosphorylation 
target of PKA in Xenopus and mouse. Particularly melanophilin’s C-terminal actin-binding 
domain is a pronounced phosphorylation target. Of note, in vitro phosphorylation of 
melanophilin’s actin-binding domain closely resembled the previously described in vivo 
phosphorylation pattern. 
In my work, I present an efficient strategy to assemble the tripartite myosin Va transport 
complex in vitro that enabled me to test the functional consequences of melanophilin 
phosphorylation in vitro. Filament decoration assays with actin and the 
Rab27a/melanophilin complex and single-molecule total internal reflection fluorescence 
(TIRF) microscopy assays with the tripartite Rab27a/melanophilin/myosin Va complex on 
actin filaments revealed unexpectedly that phosphorylation of melanophilin’s actin-binding 
domain did not interfere with actin-dependent processes such as binding of melanophilin 
to actin filaments or movement of the tripartite complex along actin filaments. Surprisingly 
instead, melanophilin’s phosphorylation state regulated its association with microtubules 
in vitro. Dephosphorylated melanophilin preferred to bind to microtubules even in the 
presence of actin filaments, whereas phosphorylated melanophilin predominantly 
associated with actin filaments when microtubules were also present. In fact, 
melanophilin’s phosphorylation state enforced track selection of the tripartite 
Rab27a/melanophilin/myosin Va complex when microtubules and actin filaments were 
present simultaneously. More precisely, the tripartite complex assembled with 
phosphorylated melanophilin mostly exhibited directional movement on actin filaments in 
vitro, as expected of an actin-based motor protein. In contrast, dephosphorylation of 
melanophilin enhanced the interaction between the tripartite complex and microtubules 
Summary   8 
 
 
and a signification number of complexes showed diffusional movement on microtubules. 
These results reveal the surprising regulatory dominance of the adaptor protein 
melanophilin over its associated motor protein myosin Va and provide a mechanism of how 
crosstalk between the actin- and microtubule-transport systems might be achieved in vivo; 
namely through the adaptor protein melanophilin that is capable of interacting with both 
actin filaments and microtubules. The binding preference of the entire tripartite complex 
for actin or microtubules is regulated via the phosphorylation state of melanophilin. Taken 
together, the observations presented in this thesis offer first insights into the functional 
interface between the two cytoskeletal transport systems and provide a mechanistic 
explanation how cells might bias cargo transport on one or the other cytoskeletal filament. 
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1. Introduction 
1.1 Melanosome transport in general and as model system to study intracellular 
transport 
Directed intracellular transport is central to the survival of all eukaryotic cells and pivotal 
processes such as cell division (1-3), neuronal signaling (4), organization of 
endomembranes (5), secretion (6), and transport of organelles (7, 8) depend on it. Three 
super families of molecular motors – dyneins, kinesins and myosins – move on the two 
cytoskeletal tracks – actin and microtubule (MT) filaments – to transport cargo to its 
destined place in the cell. Especially, the correct delivery of the vast majority of cargo 
utilizes the coordinated action of both cytoskeletal systems in the cell. Based on the work 
of many groups during the last decades, we now have a detailed knowledge on how each 
transport system works individually, whereas only very limited information is available on 
how the two cytoskeletal systems are coordinated and crosstalk is brought about to ensure 
proper intracellular transport of, e.g. organelles. One excellent and well-established model 
system to study the coordinated action of both cytoskeletal transport systems is the 
melanosome transport in pigment cells from amphibians or mammals. 
Melanosomes are membrane-bound organelles specialized for the synthesis, storage, and 
transport of the brown-black pigment melanin that reside in epithelial cells termed 
melanophores in amphibians or melanocytes in mammals, respectively. Melanophores and 
melanocytes are flat cells that possess protrusions radiating out from the cell body. 
Pigment cells exist in different colors like brown-black, yellow-red, yellow, red, and white-
metal (9). Brown-black pigment cells (melanophores/melanocytes) are the most 
widespread type of pigment cell and are responsible for most of the dorsal pigmentation 
in vertebrates. They enable organisms to change the color of their skin and thus serve 
diverse biological functions including camouflage, sexual display and protection from UV 
radiation, amongst others. Additionally, it is speculated that melanosomes are involved in 
the innate immune system in a yet unknown way (10). In order to fulfill these versatile 
functions, melanosomes need to be synchronously moved intra- (e.g. amphibians and fish) 
or intercellularly (mouse and human) in response to environmental cues. The process of 
transporting melanosomes toward the cell periphery to distribute them evenly throughout 
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the cytoplasm is called dispersion (Figure 1 A). By enlarging the cellular area occupied by 
dark melanosomes, the organism (i.e. amphibians and fish) appears darker. 
 
Figure 1: Dispersed and partially aggregated melanophore from the immortalized Xenopus laevis 
cell line. (A) Melanosomes were stimulated to undergo dispersion by adding 100 nM α-MSH (upper 
panel). Schematic illustration depicting the dispersion process and its net transport direction to the 
cell periphery (lower panel). (B) Identical cell as in (A) was stimulated to aggregate the 
melanosomes in the cell center with 50 nM melatonin (upper panel). Melanosomes are gathered 
in the cell center during aggregation (lower panel). Scale bar: 50 µm. 
The opposite-directed transport of melanosomes towards the cell center is termed 
aggregation (Figure 1 B). Thereby, the dark melanosomes are concentrated in the 
perinuclear region of the cell, the occupied area by black pigment is minimized and the skin 
of the organism appears brighter. Thus, melanosome transport in amphibians and fish is a 
dynamic and reversible process that enables the animal to adapt to its fast-changing 
environment. 
In contrast, melanosomes in mammals are mainly transported toward the cell periphery to 
be transferred to neighboring keratinocytes that are located in the skin epidermis. In 
keratinocytes, the melanosomes cluster around the nucleus to protect the DNA from 
harmful UV radiation. This transport process occurs upon exposure to sun light and is much 
slower than dispersion in amphibians or fish. Moreover, the main transport direction in the 
mammalian system is toward the cell membrane to hand melanosomes over to adjacent 
keratinocytes. 
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The establishment of an immortalized cell line of melanophores from Xenopus laevis by 
Lerner and coworkers in 1990 (11) paved the way for using these cells as a model system 
to explore intracellular transport. Melanophores are easily and in high quantities 
maintained in tissue culture and melanosome transport can be stimulated by the addition 
of hormones to the growth medium. Furthermore, their size (ca. 500 nm in diameter) and 
black color make them extremely suitable for microscopy and easily distinguishable from 
other organelles. In the late 90s, Gelfand and coworkers developed a method to isolate 
functional melanosomes and reconstitute melanosome transport in vitro (12), opening new 
perspectives on investigating and manipulating melanosome transport in vitro. In this 
study, it was made use of the immortalized Xenopus laevis melanophore cell line and the 
previously developed method to isolate pigment granules for subsequent in vitro dissection 
of pigment granule transport. 
1.2 Cytoskeletal components involved in melanosome transport 
The transport of melanosomes is achieved by the movement of three distinct motor 
proteins from all known super families: dyneins, kinesins, and myosins. They are attached 
to the organelle surface and walk unidirectionally on polar cytoskeletal filaments by 
converting the chemical energy of ATP hydrolysis into steps along the filament. The motor 
proteins involved in melanosome transport are the two MT-based molecular motors 
kinesin-2, which is plus-end directed, and cytoplasmic dynein, which walks toward the 
minus-end of MTs (12-14). 
 
Additionally, the actin-based motor protein myosin Va (MyoVa) is responsible for transport 
of melanosomes on actin filaments (8, 15). Therefore, melanosomes are transported on 
Figure 2: The three molecular motors dynein, kinesin-
2 and MyoVa are attached to the melanosome and 
work together to achieve its proper transport within 
the cell. The MT-based motor protein cytoplasmic 
dynein is colored in green, MT-based heterodimeric 
kinesin-2 is depicted in dark blue and red, and the 
actin-based molecular motor MyoVa is illustrated in 
light blue. 
Introduction   18 
 
 
both cytoskeletal tracks used for cargo transport inside cells: microtubule and actin 
filaments. Orientation and localization of these ‘cellular roads’ within pigment cells 
significantly impact the transport of melanosomes. Using immunocytochemistry with 
fluorescently labeled antibodies, fluorescence microscopy revealed the distribution of each 
filament type in melanophores (Figure 3). 
 
Figure 3: Distribution of cytoskeletal filaments in Xenopus laevis melanophores in the aggregated 
cell state. (A) MTs are arranged in a radial array in melanophores. MTs were labeled in fixed cells 
with α-tubulin primary antibody and fluorescein-linked secondary antibody. (B) Actin filaments are 
randomly oriented and more abundant at the cell margins and were labeled using rhodamine 
phalloidin. Figure 3 is taken and adapted from (16). 
MTs are unipolarly distributed within melanophores with their minus-ends located at the 
microtubule organization center (MTOC) close to the nucleus and their plus-ends pointing 
toward the cell membrane (Figure 3 A) (17). Early studies on frog and fish melanophores 
with microtubule-disrupting drugs like nocodazole or colchicine demonstrated that 
melanosome transport was MT-dependent, because the treatment resulted in both 
inhibited aggregation and dispersion of pigment granules (18-20). Nevertheless, little 
motion of melanosomes was still observable after nocodazole treatment, suggesting the 
existence of yet another transport mechanism (21). 
In contrast to MT distribution, actin filaments are randomly distributed throughout the 
cytoplasm with their polar ends pointing in every direction, showing a higher concentration 
close to the membrane (Figure 3 B). Disruption of the actin cytoskeleton with the drugs 
cytochalasin or latrunculin exhibits distinct effects in frog and fish melanophores. The 
absence of the actin-system in frog melanophores leads to melanosome accumulation in 
the cell center (15), whereas melanosomes in fish melanophores are transported to the cell 
margins; a process referred to as hyperdispersion (22). Mammalian melanocytes behave 
similar to frog melanophores to disruption of the actin cytoskeleton, as melanosomes are 
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clustered in the cell center and dispersion cannot be achieved anymore (23). These 
differential behaviors of frog and fish melanophores point to a distinct contribution of the 
MT- and actin-systems to the overall transport of melanosomes in frog and fish. The MT-
system seems to be more dominant in fish melanophores because it is able to transport 
melanosomes all the way to the plus-ends in the absence of actin filaments. Conversely, 
the actin-system appears to play a stronger role in frog cells and mammalian melanocytes, 
as the MT-system alone is not capable of accomplishing melanosome dispersion when actin 
filaments are disrupted. 
1.2.1 MT-based transport of melanosomes 
MTs are tubular polymers (ca. 25 nm in diameter) comprised of α- and β-tubulin dimers 
and possess distinct polarity. The fast growing end is termed the plus-end, whereas the 
slower growing end that often nucleates from a MTOC or centrosome is called the minus-
end. Two motor protein super families – kinesins and dyneins – use microtubule filaments 
as their tracks and follow the polarity of the roads in distinct directions. Most members of 
the kinesin superfamily move toward the plus-end of MT, while all known dynein motors 
walk toward the minus-end of MT. The unipolar microtubule organization enables the 
transport of organelles to the plus-ends of MT, thus to the cell periphery, by kinesin-2 and 
the transport toward the minus-ends of MT and the cell center by cytoplasmic dynein. Thus, 
aggregation of melanosomes in the cell center is mainly achieved by the molecular motor 
cytoplasmic dynein that transports melanosomes all the way to the minus-ends of MTs, 
which are all located close to the cell nucleus. Vice versa, kinesin-2 is responsible for 
delivering melanosomes closer to the cell margins. If kinesin-2 was the only molecular 
motor involved in the dispersion process, melanosomes would all cluster at the cell 
membrane. As melanosomes are evenly distributed throughout the entire cytoplasm 
during the dispersion process, another transporter is needed: the actin-based motor 
protein MyoVa that moves on actin filaments is involved in melanosome distribution as 
well (for a detailed description see section 1.2.2). To ensure complete dispersion, kinesin-
2 delivers melanosomes to the dense actin network in the cell cortex followed by MyoVa-
mediated transport on actin to achieve an even distribution within the entire cell. Vice 
versa, melanosomes need to be brought in close proximity to MTs by MyoVa where they 
are further transported toward the cell center by dynein for aggregation. 
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The attachment of cytoplasmic dynein to its cargos is well characterized (24-27). The 
multimeric protein complex dynactin, specifically the subunit p150Glued, binds to the 
intermediate chain of dynein, linking the dynein motor to the cargo surface. Furthermore, 
dynactin has been shown to increase dynein’s activity and processivity (28). Surprisingly, 
blocking p150Glued function in extruded squid axoplasm led to the inhibition of both minus- 
and plus-end directed transport of organelles along MTs (29). Based on that observation, 
Deacon et al. investigated whether there was an interaction between kinesin-2 and the 
dynactin complex. Indeed, they showed that the dynactin complex directly binds to kinesin-
2, implicating the anchorage of kinesin-2 to the melanosome membrane in Xenopus laevis 
melanophores via dynactin (30). More precisely, the non-motor subunit of kinesin-2, 
kinesin-associated protein (KAP), was shown to bind to the identical domain of p150Glued as 
the dynein intermediate chain does. 
1.2.2 Actin-based transport of melanosomes 
Actin is a very abundant, globular protein that is either present in the cell as a monomer 
(i.e. G-actin) or polymerized into linear, polar actin filaments (or filamentous actin, F-actin). 
The polarity derives from the identical orientation of the subunit G-actin and leads to one 
barbed end (or plus-end) and one pointed end (or minus-end) of the actin filament. Actin 
filaments are randomly distributed in the cytoplasm of melanophores with a higher 
concentration close to the cell membrane. Transport of melanosomes by the actin-based 
motor protein MyoVa that moves toward the barbed end of F-actin thus results in a rather 
even distribution of melanosomes in the cytoplasm with a higher tendency in close 
proximity to the cell membrane. MyoVa is the best characterized non-muscle myosin 
(unconventional myosin) that is involved in a wide range of transport processes (31). Two 
Figure 4: The dynactin complex links cytoplasmic dynein to 
the melanosome membrane and is also implicated to 
anchor kinesin-2 to the organelle via the identical domain 
in p150Glued. The dynein intermediate chain binds to a N-
terminal coiled-coil region in p150Glued, dynactin’s largest 
subunit. Immunoprecipitation assays with kinesin-2 and 
p150Glued suggested an interaction that inhibited 
simultaneous binding of dynein (30). 
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identical polypeptide chains homodimerize to assemble a double-headed motor protein 
that walks in a hand-over-hand fashion on the actin filament toward the barbed end (32). 
 
Three domains are typical for the myosin family: (i) the usually N-terminally located head 
domain containing the ATP- and actin-binding sites, (ii) the so-called neck domain or lever 
arm that links the head domain to the stalk and contains a variable number of IQ motifs, 
and (iii) the tail domain or stalk that is comprised of a coiled-coil region for 
homodimerization followed by a globular tail domain (GTD) consisting only of α-helices and 
loops that is proposed to be involved in cargo binding. The coiled-coil region of MyoVa’s 
tail in addition contains six alternatively spliced exons A-F (33, 34), determining MyoVa’s 
cargo specificity in combination with the GTD (35). By alternately binding and releasing of 
the two head domains and a conformational change upon ATP hydrolysis, MyoVa is able to 
move processively along actin filaments (36). The melanocyte-specific isoform of MyoVa 
contains the alternatively spliced exons ACDEF (37). 
Genetic studies of three coat color mutants in mouse led to a detailed understanding of 
MyoVa’s attachment to the melanosome (34, 38, 39). These three mutations share a similar 
phenotype where melanosomes are clustered in the perinuclear region and melanosome 
dispersion is not correctly accomplished. A similar effect of perinuclear clustering is 
provoked by disrupted actin filaments (see section 1.2, page 17), suggesting that the 
mutations affect the actin-based transport of melanosomes. Analysis of these mutations 
revealed the tripartite MyoVa transport complex that is required for actin-based 
melanosome motility to achieve dispersion in mouse melanocytes (40-42) (Figure 6). The 
two proteins involved in linking MyoVa to the melanosome are Rab27a and melanophilin 
Figure 5: Domain structure of MyoVa. (A, B) MyoVa possesses 
an N-terminal catalytic head domain with ATP- and actin-
binding sites, followed by a neck domain that binds calmodulins 
and the C-terminal tail domain for dimerization and cargo 
binding. The head domain binds to actin and by a 
conformational change of the neck domain MyoVa is able to 
take consecutive steps along an actin filament (i.e. MyoVa walks 
processively on actin). 
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(Mlph). The complex formed by these three proteins is referred to as the tripartite complex 
or MyoVa transport complex (41-43). 
 
Figure 6: The tripartite MyoVa transport complex on the melanosome surface in mouse 
melanocytes. The actin-based motor protein MyoVa is recruited to the melanosome via Rab27a 
and Mlph in mouse melanocytes. (A) Rab27a resides in the melanosome membrane and binds to 
the adaptor protein Mlph in a GTP-dependent manner. Mlph in turn binds to MyoVa, linking the 
motor protein to the melanosome surface. (B) Domain structures of Rab27a (top) and Mlph 
(bottom). Mlph binds to Rab27a’s effector-binding domain (Mlph-BD) with its N-terminal Rab27a-
BD. MyoVa in turn associates with Mlph’s middle domain (MyoVa-BD) with exon F and the GTD 
domain. Additionally, Mlph contains a C-terminal actin-binding domain (ABD). 
Rab27a is a member of the Rab family belonging to the Ras superfamily of small guanosine 
triphosphatases (GTPases) and resides in the membrane of the melanosome. It inserts into 
the hydrophobic membrane with two posttranslationally attached C20 geranylgeranyl 
groups bound to cysteines near the C-terminus. Rab27a is able to bind and hydrolyze GTP 
with the help of guanine nucleotide exchange factors (GEFs) and guanine nucleotide 
activating proteins (GAPs), respectively, and exists in two conformational states: the active 
GTP-bound state that is able to bind to effector proteins, and the inactive GDP-bound state. 
One effector protein that binds to Rab27a in its active, GTP-bound state is Mlph (or Slac2-
a), a member of the synaptotagmin-like protein (Slp) family. The Slp family possesses two 
conserved domains – SHD1 and SHD2 - at the N-terminus, sometimes interrupted by two 
zinc-finger motifs. Mlph’s SHD (termed Rab27a binding domain, Rab27a-BD in this thesis) 
directly interacts with the GTP-bound form of Rab27a in vitro and in vivo (44-46). The 
middle domain of Mlph (MyoVa binding domain, MyoVa-BD) specifically binds to MyoVa’s 
GTD and exon F, with exon F being essential for this interaction (47). Additionally, Mlph 
contains a previously described actin-binding domain (ABD) at its C-terminus that was 
previously reported to interact with F-actin and EB1 (37, 48-50). Therefore, MyoVa is 
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recruited to the melanosome by the membrane-bound GTPase Rab27a and the adaptor 
protein Mlph in mouse melanocytes. It remains to be shown whether MyoVa recruitment 
is accomplished similarly in other organisms like fish or frog. 
1.3 Signals governing melanosome transport 
The synchronous transport of hundreds of melanosomes by the three motor proteins 
dynein-1, kinesin-2, and MyoVa to the cell center or the cell periphery requires a tight and 
fast responsive signal transduction and regulation. Most information on the signaling 
cascade controlling melanosome transport has been collected in frog or fish melanophores. 
Previous studies elucidated the involvement of intracellular cyclic adenosine 
monophosphate (cAMP) levels, protein kinase A or cAMP-dependent kinase (PKA) activity, 
and phosphorylation and dephosphorylation events in regulation of melanosome transport 
(8, 9). It is well established that changes in the intracellular cAMP concentration and 
subsequent activation or inactivation of PKA are the major key players in regulating the 
melanosome transport direction in frog melanophores. High levels of cAMP accompanied 
by active PKA induce dispersion, whereas low levels of cAMP and inactive PKA result in 
aggregation. PKA was shown to be recruited to the melanosome surface in Xenopus laevis 
melanophores by Rab32 (51), implying a role for motor regulation by the key player PKA. 
Additionally, PKA was found to form complexes with dynein or kinesin-2 and MyoVa (52). 
1.3.1 Dispersion 
The peptide hormone α-melanocyte-stimulating hormone (α-MSH) produced in the 
pituitary gland and the hypothalamus stimulates dispersion of melanosomes in frog 
melanophores. Binding of α-MSH to the Mc1r receptor in the melanophore membrane (53) 
leads to increased intracellular cAMP levels (54-56), which in turn activate PKA (57, 58). It 
has been suggested that Ca2+ is necessary for the interaction between α-MSH and the 
receptor (59, 60). Furthermore, PMA, an activator of protein kinase C or calcium-
dependent protein kinase (PKC), can partially induce dispersion via a distinct pathway, 
without elevating intracellular cAMP levels (57). Additionally, an increased activity of the 
mitogen-activated protein kinase (MAPK) signaling pathway during dispersion in Xenopus 
laevis melanophores was reported (61). The authors speculated it to be a possible 
indication for the involvement of MAP kinases in coordination of bidirectional melanosome 
transport (61). Finally, dispersion of melanosomes can be induced by light in Xenopus 
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melanophores. An increase in intracellular IP3 and Ca2+ is involved in light-induced 
dispersion (62). 
In this study it will be focused on the α-MSH-induced dispersion via the classical and best 
studied PKA pathway. This pathway requires phosphorylation events, but also 
dephosphorylation events occur (57). Taking together all available data so far, the signaling 
cascade for dispersion involves a high intracellular cAMP concentration and high activity of 
PKA. In other words, increased PKA activity leads to the transport of melanosomes to the 
cell periphery achieved by kinesin-2 and MyoVa. Switching from MT filaments to the actin 
cytoskeleton is an absolute necessity to complete melanosome dispersion. Nevertheless, 
the target(s) of PKA remain(s) unidentified and it is not known how the signal is further 
passed on to the motor proteins on the melanosome surface. 
In mouse melanocytes, it has been demonstrated that α-MSH induces the rapid transport 
of melanosomes to the dendrite tips of melanocytes through stimulation of the cAMP 
pathway (63). The authors suggested involvement of small GTP-binding proteins belonging 
to the p21Rho family and the effector protein p160 Rho-associated kinase and not PKA to 
play a key role in redistribution of melanosomes. Further, they postulated that cAMP 
stimulated the expression of Rab27a and rapidly enhanced the interaction of Mlph with 
actin filaments. Besides that, no further data is available on signaling cascades governing 
melanosome transport in mouse melanocytes. 
1.3.2 Aggregation 
Aggregation in frog melanophores can be induced by the addition of the pineal gland 
hormone melatonin (64). Melatonin binds the specific high-affinity receptor mel1c (65) and 
subsequently Gi/o proteins are activated, inhibiting adenylyl cyclase and PKA (66). As a 
consequence, intracellular cAMP levels are decreased in the melanophores (54). An 
additional melatonin-induced pathway involves mel1c receptor, Gβγ protein-dependent 
activation of phosphoinositide-3-kinase (PI3-K) and subsequently activation of 
phosphodiesterase 4 (PDE4), resulting in lowered cAMP levels (67). How the signal is 
further transduced to the motor proteins on the melanosome to accomplish melanosome 
aggregation in the cell center is not yet elucidated. 
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Again as for dispersion, dephosphorylation and phosphorylation events are required for 
transducing the aggregation signal (57). Using specific phosphatase inhibitors, a role for 
protein phosphatase 2A (PP2A) in aggregation in Xenopus melanophores was discovered 
(57). Tyrosine-phosphorylation of a 280 kDa protein during aggregation was also 
demonstrated (68), whose identity is still unknown, but was speculated to be spectrin (68, 
69). Moreover, involvement of MEK and MAP kinases is also likely (70). In summary, 
lowered cAMP levels and subsequent dephosphorylation of unknown targets by PP2A and 
maybe other phosphatases result in dynein-mediated melanosome transport toward the 
cell center. Importantly, melanosomes have to be transferred from the actin cytoskeleton 
back to MTs to allow dynein-mediated transport. 
1.4 Regulation of the individual motor proteins to achieve proper melanosome 
distribution 
In vivo, melanosomes show discontinuous, bidirectional movements even when induced to 
disperse or aggregate. Furthermore, melanosomes often stall and pause before continuing 
or switching direction on a microtubule (71). Consequently, more than one type of 
molecular motor on the organelle is active during dispersing or aggregating melanosomes. 
Therefore, the outcome of the net transport direction is dictated by the motor protein(s) 
that travels the farthest total distance compared the others (transport toward the cell 
center versus transport toward the cell margins). 
Investigations on motor regulation can be performed using two distinct experimental 
approaches, amongst others: i) Isolation of melanosomes and performance of in vitro 
motility assays, possibly in the presence of potential regulating substances. ii) Manipulation 
of one cytoskeletal system (actin filaments or microtubules) or inhibition of one type of 
motor protein (dynein, kinesin, or myosin) in living cells and observing the effects on 
transport with in vivo tracking of melanosomes. In 1997, Gelfand and coworkers showed 
that isolated pigment granules retained their regulated states in vitro (12), as a first insight 
into MT-based motor regulation that seems to occur on the melanosome surface. The 
majority of melanosomes purified from dispersed melanophores moved to the plus-ends 
of MTs in motility assays in vitro (12). Vice versa, melanosomes isolated from aggregated 
melanophores mostly exhibited minus-end directed movement on MTs in vitro (12). The 
use of dominant negative tail constructs to selectively block either kinesin-2 or MyoVa 
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activity in Xenopus melanophores impaired the cells’ ability to properly disperse their 
pigment granules, demonstrating that the activity of both kinesin-2 and MyoVa is required 
for pigment dispersion (13, 72). A combination of motor manipulation with dominant 
negative tail constructs and biophysical characterization of melanosome transport in vivo 
contributed extensively to today’s understanding of motor regulation in Xenopus 
melanophores (73). Gross et al. revealed that dynein activity is upregulated during 
aggregation and downregulated when melanosomes disperse (73). Conversely, MyoVa is 
downregulated by about 50% during aggregation compared to pigment dispersion, 
whereas kinesin-2-mediated transport is not changed during aggregation or dispersion 
(73). Thus, competition between the dynein/MT-and MyoVa/actin-system seems to occur, 
whose winner determines the transport direction of the organelles. Quantitative 
immunoblotting indicated identical amounts of cargo-bound kinesin-2 and dynein between 
dispersed melanosomes versus aggregated melanosomes (73). However, MyoVa showed a 
ca. 35% decrease on aggregated melanosomes compared to dispersed pigment granules 
(65 ± 10 per aggregated melanosome on average and 88 ± 7 MyoVa molecules per 
dispersed melanosome on average) (73). The authors speculated that the observed 
downregulation of the actin-based motor MyoVa during aggregation is achieved by 
decreasing the organelle-bound motor number (73). From their observation that dynein 
velocity is not altered in a kinesin-2-blocked background, they further concluded that there 
likely is coordination between the two MT-based motors, but a continuous tug-of-war 
between the actin- and MT-systems that determines the transport direction (73). By 
downregulating MyoVa and upregulating dynein, pigment granule aggregation is favored. 
Vice versa, upregulating MyoVa activity and lowering dynein activity set the course for 
pigment dispersion. Lastly, they hypothesized that switching from MT onto actin filaments 
primarily occurs during minus-end runs, because minus-end runs are predominantly 
decreased during dispersion (73). Another in vivo tracking study using a novel algorithm by 
Rodionov and colleagues suggested that, in addition to upregulation of MyoVa, MT-based 
transport toward the MT plus-ends by kinesin-2 is increased during early dispersion and 
gradually declines again as dispersion advances (correlating with high cAMP levels at the 
beginning of dispersion that continuously decline again to reach basal levels at late 
dispersion) (71). Gelfand and coworkers continued investigating how the MT-based motors 
on the melanosome are regulated with the means of a novel fast-tracking method in vivo 
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(74). By comparing the velocity distribution of MT-mediated transport during the 
aggregation and dispersion process, they postulated that only the number of active dyneins 
changes (74). In contrast, they found the number of active kinesin molecules to be similar 
between aggregation and dispersion. Therefore, the number of active dynein motors 
determines the transport direction of a single melanosome on MTs. According to their 
model, one to three active dynein copies move a pigment granule toward the MT minus-
end, whereas one to two kinesin-2 molecules are responsible for the plus-end-directed 
transport (74). 
One candidate for coordinating the MT-based motor proteins kinesin-2 and dynein is the 
dynactin complex, in particular the largest subunit p150Glued. p150Glued is long known as the 
adaptor that establishes the direct link between dynein and various cargos via the dynactin 
complex. Moreover, p150Glued was also demonstrated to interact with kinesin-2 on Xenopus 
melanosomes via the same binding domain on p150Glued utilized by dynein (30). Thus, 
binding of kinesin-2 and dynein is mutually exclusive. Inhibition of one MT-based motor or 
the dynactin complex also affects the other MT-based motor in other systems, implying 
that MT-based transport is likely to be coordinated as observed in several other transport 
processes (29, 75, 76). In addition, dynein needs the dynactin complex to processively move 
on MTs (77) and dynactin was also shown to increase the activity of kinesin-2 (78). Dynactin 
as a shared organelle adaptor for both MT-motors that is additionally capable of 
modulating both motor’s processivities is a promising candidate in coordinating 
melanosome transport on MT. How this is achieved mechanistically in the cell remains an 
object of investigation. 
During the last 20 years, many advances have been achieved in elucidating regulation of 
the three motor proteins that power melanosome transport. The common consensus is 
that dynein activity is higher during aggregation and decreased during dispersion. 
Furthermore, MyoVa transport is regulated in the opposite manner: higher activity during 
pigment granule dispersion and lower activity during aggregation. The decision which way 
to go (aggregation or dispersion) seems to be determined by a tug-of-war between the 
dynein/MT- and MyoVa/actin-system. Kinesin-2 transport is reported to be relatively 
constant and might only be temporarily upregulated during early dispersion. Importantly, 
correct dispersion cannot be accomplished in all organisms if MyoVa activity is impaired 
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(Xenopus and mammals: perinuclear clustering; fish: hyperdispersion); indicating that 
switching from MTs onto actin filaments is an absolute necessity for the dispersion process. 
Vice versa, for aggregation of melanosomes, it is absolutely essential that melanosomes 
are handed from the actin cytoskeleton back to the microtubule system.  
1.5 Crosstalk between the actin-based and the MT-based transport systems in 
melanosome transport 
Extensive work on the model system for intracellular transport, transport of melanosomes, 
established that switching between actin filaments and MTs is an absolute prerequisite for 
proper intracellular melanosome distribution. This necessitates regulatory mechanisms 
controlling the switching of melanosomes from one cytoskeletal system to the other. 
However, information on how crosstalk is achieved mechanistically between the two 
cytoskeletal systems to bring about the precisely regulated melanosome transport is still 
very sparse. 
Disruption of the actin cytoskeletal system was already sufficient to impair proper 
dispersion in all pigment cell types, implying that both transport machineries work closely 
and coordinately together. Several experimental observations point to a coordination 
between the two MT-based motor proteins without providing a molecular mechanism. A 
tug-of-war seems to occur between the dynein/MT- and MyoVa/actin-system, where 
downregulation of one motor helps the other to determine the transport direction. 
However, only sparse information on the crosstalk between the two cytoskeletal systems 
is available to date and mechanistic details remain elusive. 
Previous in vitro work with dynein-dynactin and myosin-V-coated beads showed that the 
force produced by dynein and myosin-V controls motor switching at actin-MT junctions 
(79). The force produced by each motor type correlated to the motor number on the beads. 
By varying the ratio of dynein and myosin-V on the beads, switching of motor-coated beads 
could be biased to either MTs (if the force produced by dynein was higher) or actin 
filaments (if the force produced by myosin-V was higher), independent of the entry 
filament. The authors concluded that a simple mechanical tug-of-war could explain many 
of the observations. Experiments with kinesin-2- and myosin-V-coated beads suggested 
that switching frequencies between actin filaments and MTs were dependent on the 
starting track (80). Twice as many kinesin-2 compared to myosin-V molecules were 
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required for equal switching probabilities when the starting track was a MT. Identical 
numbers of kinesin-2 and myosin-V molecules yielded in an equal switching probability 
when the starting track was an actin filament. The authors propose that, in addition to 
relative force, the switching probability of kinesin-2- and myosin-V-coated beads at actin-
MT intersections is determined by the dynamics of the motor-filament interaction. Higher 
number of kinesin-2 molecules are needed due to the quick detachment of kinesin-2 under 
load. Collectively, these two studies provide first valuable information that regulation of 
cargo switching between MTs and actin filaments is influenced by the number of active 
motors, however, it is very likely that cells employ additional mechanisms to link the two 
cytoskeletal transport systems. 
Work on fish melanophores by Rodionov and coworkers demonstrated that switching from 
MTs onto actin filaments is tightly controlled by the intracellular concentration of cAMP 
(81), implicating that coordination of both cytoskeletal systems is accomplished at least in 
part by signaling events. The underlying mechanism, however, remains still completely 
unclear. Employing a combination of in vivo particle tracking and computational modeling 
suggested that switching of filaments is solely determined by changing the switching rate 
from actin filaments onto MTs in fish melanophores (82). The authors hypothesized that 
the switching rate from actin filaments to MTs is controlled by modulating motor protein 
activities (decreasing MyoVa activity and increasing dynein activity) and additionally 
changing the affinity for one or both cytoskeletal track(s) or a yet unknown mechanism. So 
far, no experimental evidence has been put forward to explain the molecular mechanism 
governing this switching rate.  
Another study in fish melanophores, specifically on the zebrafish mutant j120 put forward 
the adaptor protein Mlph as a potential coordinator between MT- and actin-dependent 
transport. The mutant j120 displays defects in dispersion that are caused by a mutation in 
the Mlph gene (i.e. one of the adaptor proteins linking MyoVa to the melanosome), 
resulting in a premature stop codon and thus a shortened, nonfunctional Mlph protein (83). 
The authors further observed that this dispersion defect arises from exceptionally long 
minus-end runs on MTs and provided evidence that an additional function of Mlph, besides 
linking MyoVa to the melanosome, is to suppress dynein runs during dispersion. 
Mechanistic details on this additional function of Mlph implied by this study remain to be 
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demonstrated. This is the first indication of a direct crosstalk between the two cytoskeletal 
systems through the adaptor protein Mlph.  
It is very likely that the actin- and MT-systems employ further mechanisms for coordination 
and crosstalk. This thesis was focused on elucidating further details on how the cytoskeletal 
systems are intertwined to achieve transport of melanosomes to the proper destination 
within the cell at the correct time.  
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2. Aims of this thesis 
2.1 Reconstitution of the actin-based melanosome transport in vitro 
Transport of melanosomes in Xenopus laevis melanophores served as a model system to 
study intracellular transport for more than 30 years. Despite the detailed knowledge about 
the microtubule-based transport system involved in melanosome transport, little is known 
about the actin-based transport of melanosomes. It was previously shown that MyoVa is 
the motor responsible for actin-based melanosome transport in Xenopus laevis 
melanophores (15), however, the components of the putative MyoVa receptor complex 
remain unidentified. Previous reconstitution of actin-based melanosome transport on 
Nitella actin cables in vitro exhibited an atypically slow velocity of 40 nm s-1 (15). 
Even though the involvement of cAMP and PKA in signal transduction in amphibian 
melanophores is well established, the underlying molecular mechanisms of how PKA 
activity modulates the transport direction of melanosomes are not yet known. 
One major goal of this thesis was to gain insights into the regulation of the actin-based 
transport of melanosomes in Xenopus laevis melanophores. To this end, I aimed to 
reconstitute melanosome transport on actin filaments instead of Nitella actin cables in vitro 
and characterize MyoVa-dependent transport dependent on the respective cell states (i.e. 
dispersed and aggregated cell state). Additionally, this experimental setup enabled me to 
directly test the effects of the ‘master regulator’ (i.e. PKA) on MyoVa-driven transport 
under defined experimental conditions. Results will shed light onto the mechanisms 
underlying MyoVa-mediated transport of melanosomes in amphibians. 
2.2 Formation of the MyoVa transport complex in the amphibian Xenopus laevis 
The second aim of this study was to elucidate details on the formation of the MyoVa 
transport complex on Xenopus laevis melanosomes. Despite its essential role in 
melanosome transport, it is not known how MyoVa is linked to melanosomes in Xenopus 
laevis melanophores. Genetic studies in mouse melanocytes identified the two adaptor 
proteins Rab27a and Mlph that link MyoVa to the melanosome surface. By recombinant 
expression of the respective proteins from Mus musculus and Xenopus laevis/tropicalis and 
subsequent coexpression, I aimed to assemble the MyoVa transport complex in vitro. 
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Reconstituting the MyoVa transport complex in vitro will enable an in-depth mechanistic 
dissection of MyoVa-driven transport in vitro. 
2.3 Regulation of the MyoVa transport complex from Mus musculus in vitro 
Phosphorylation events appear to be a common signal for melanosome transport toward 
the cell periphery. However, it is not yet known how the signal(s) is/are passed to the motor 
proteins conducting this transport. The third aim of this thesis was to identify (a) 
downstream target(s) of phosphorylation by, for example, the prevalent kinase PKA using 
the recombinantly expressed proteins from Xenopus and mouse. 
How is the MyoVa transport complex regulated to switch from the MT network to the actin 
network to enable efficient dispersion of melanosomes? As previously demonstrated, 
MyoVa is capable of interacting with MTs and exhibits bidirectional diffusional movement 
on MTs in vitro (84, 85). Does this special property of MyoVa help to switch melanosomes 
from actin onto MTs in cells? To provide first insights into how cells bias the transport 
direction of melanosomes, TIRF microscopy assays were employed in this work. I 
performed filament decoration assays with different complexes on actin and MTs and 
mixed networks of both filaments to observe the individual and combined binding 
preferences. Single-molecule TIRF assays with the reconstituted MyoVa transport complex 
on actin, MTs, and mixed networks will reveal potential mechanisms by which cells regulate 
the binding preferences toward actin or MTs. 
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3. Materials 
3.1 Cell culture accessories 
Name of item Company, location 
Fetal Bovine Serum (FBS) USA origin, sterile-
filtered, cell culture- and hybridoma-tested 
Sigma-Aldrich, Taufkirchen 
Cellfectin® II reagent  Life Technologies, Darmstadt 
Insulin from bovine pancreas Sigma-Aldrich, Taufkirchen 
Trypsin/EDTA PAA, Cölbe 
Melatonin Sigma-Aldrich, Taufkirchen 
α-melanocyte stimulating hormone (α-MSH) Sigma-Aldrich, Taufkirchen 
Leibovitz’s L-15 medium Life Technologies, Darmstadt 
Penicillin/streptomycin Life Technologies, Darmstadt 
Gentamicin Bio&Sell, Feucht bei Nürnberg 
Sf-900 II SFM medium Life Technologies, Darmstadt 
 
3.2 Buffers and solutions 
All buffers and solutions used in this study were prepared with reagents from Sigma-Aldrich 
(Taufkirchen) and Carl Roth (Karlsruhe). Compositions are listed in the respective method section. 
3.3 Antibodies 
 Antibody name Isotype/host Company, location 
 α-GAPDH IgG1/mouse Millipore, Temecula (U.S.A.) 
P
ri
m
ar
y 
α-Mlph IgG/goat Everest Biotech, Upper 
Heyford (UK) 
α-MyoVa (clone LF-18), polyclonal IgG/rabbit Sigma-Aldrich, Taufkirchen 
α- protein kinase A (PKA) catalytic 
subunit α/β/ 
IgG/rabbit Santa Cruz, Heidelberg 
α-Rab27a IgG/mouse Benson Dickinson, Heidelberg, 
Germany 
Se
co
n
d
ar
y 
Anti-Mouse IgM (µ-chain specific) 
peroxidase conjugate 
IgM/goat Sigma-Aldrich, Taufkirchen 
Anti-Goat (whole molecule) peroxidase 
conjugate 
IgG/rabbit Sigma-Aldrich, Taufkirchen 
Anti-Rabbit IgG (whole molecule) 
peroxidase conjugate 
IgG/goat Sigma-Aldrich, Taufkirchen 
Anti-Mouse IgG (Fc-specific) Peroxidase 
Conjugate 
IgG/ goat Sigma-Aldrich, Taufkirchen 
 
3.4 Chemicals and ready-to-use solutions 
Name Company, location 
Casein from bovine milk, technical grade Sigma-Aldrich, Taufkirchen 
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cOmplete Protease Inhibitor cocktail, EDTA-
free 
Roche, Penzberg 
PhosSTOP Phosphatase Inhibitor cocktail Roche, Penzberg 
H-89 dihydrochloride hydrate  Sigma-Aldrich, Taufkirchen 
peqGOLD prestained Protein Marker IV PeqLab, Erlangen 
peqGOLD Protein Marker II PeqLab, Erlangen 
 
3.5 Media 
For cell culture media composition refer to respective section in 4. Methods. 
3.6 Plasmids and vectors 
Description Distributor, Location 
pFastBacTM Dual Life Technologies, Darmstadt 
pFastBacTM 1 Life Technologies, Darmstadt 
 
3.7 Oligonucleotides 
3.7.1 Cloning primers 
Primer name Primer sequence Restriction 
site 
XlRab27a_Fw 5’-aggctcgagatgtcggatgg-3’ XhoI 
XlRab27a_6XHis_Rv 5’-ggcaaatgcggctgtggcgcgccacaccaccatcaccatcattaaggta 
ccata-3’ 
KpnI 
XtMlph-NFLAG-
SalI_Fw 
5’-acggaagtcgacatggactacaaggacgacgatgacaagggcgcacct 
gggaagaagctggactt-3’ 
SalI 
XtMlph-SalI_Fw 5’-acggaagtcgacatggggaagaagctggactt-3’ SalI 
XtMlph-NotI_Rv 5’-cccattgtgaatcagagatgagcggccgcttccgt-3’ NotI 
XtMlph_ABD_del1_Rv 5’-gccagcaacatcagtgacaaaggaggatgagcggccgcttccgt-3’ NotI 
XtMlph_ABD_del2_Rv 5’-ggagcatgcccgtcagagcggttgagcggccgcttccgt-3’ NotI 
XlMyoVa_NheI_Fw2 5’-gcgctagcatggaaaacaatttagattttgc-3’ NheI 
NheI-FLAG-
XlMyoVa_Fw 
5’-atagctagcatggactacaaggacgatgacgacaagggcggcgaaaa 
caatttagattttgc-3’ 
NheI 
XlMyoVa_1110_NheI_
FLAG_Fw 
5’-atagctagcatggactacaaggacgatgacgacaagggcggcccagga 
cacaagcgc-3’ 
NheI 
XlMyoVa_m1247_ 
SphI_Rv 
5’-gcgcaaggcaatcactgagaaagcttccccatgagcatgcata-3’ SphI 
XlMyoVa_SphI_Rv 5’-ggttcctcacacgcgtctgagcatgcaac-3’ SphI 
MmMlph_BamHI_Xho
I_FLAG_Fw 
5’-aggggatccctcgagatggactacaaagatgacgacgataaaggcgg 
tggaaaaagattggacc-3’ 
BamHI 
MmMlph_ABD_del1_
Rv 
5’-gcctggaggaattgacatccaacatcagcggaagttcgacgtaaggta 
ccaagcttata-3’ 
HindIII 
MmMlph_ABD_del2_
Rv 
5’-cgcaaccctcgttcacccggaaacccagctaggccgacaaagtaaggt 
accaagcttata-3’ 
HindIII 
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MmMyoVa_HMM_Ba
mHI_XhoI_FLAG_Fw 
5’-aggggatccctcgagatggattacaaagacgatgatgataaaggc 
ggagcggcttcgg-3’ 
BamHI 
XhoI 
MmMyoVa_HMM_11
19G_HindIII_KpnI_Rv 
5’-ggaaatgaccttgatgctgaacgtgcctaagcccggctaaggt 
accaagcttata-3’ 
KpnI 
HindIII 
 
3.7.2 Sequencing primers 
Primer name Primer sequence 
PH 5’-cctataaatattccggattattcataccg-3’ 
P10 5’-cggacctttaattcaaccc-3’ 
XtMlph_Seq1_Fw 5’-agtggacaggttggtgaagg-3’ 
XtMlph_Seq2_Fw ttcaagagcaagggcagaat 
XtMlph_Seq3_Fw 5’-cggtaccactgactccgaat-3’ 
XlMyoVa_Fw13 5’-gccacctgaagcaagaattg-3’ 
XlMyoVa_Fw16 5’-ttgttcatgtgtttgcgtca-3’ 
XlMyoVa_Fw17 5’-gccattaattcaggctgctc-3’ 
MmMlph_Seq1 5’-gccgagcatgtctgggccgtggtccagaggg-3’ 
MmMlph_Seq2 5’-gccgtcgggcgaggacgcacatgcgg-3’ 
MmMlph_Seq3 5’-gggcggatctcccaaggtctgcacagacacgggcc-3’ 
MmMyoVa_Seq0 5’-cggtgtctggttcagcaagtgaagcg-3’ 
MmMyoVa_Seq1 5’-gggcaacgctgactcgttccattacactaagcaggg-3’ 
MmMyoVa_Seq1_1 5’-gccgtgcatcaacctgattgagagtaagttggg-3’ 
MmMyoVa_Seq2 5’-ccccgaattgttccaggacgatgagaaggctatctcgcctac-3’ 
MmMyoVa_Seq3 5’-cgcgtgcgtggatggctcgctcgc-3’ 
MmMyoVa_Seq4 5’-cgcccctcgcacggaggaaccc-3’ 
 
3.8 Microorganisms 
Cell strain Company 
MAX Efficiency® DH10BacTM Competent E. coli Life Technologies, Darmstadt 
XL1-Blue Subcloning-Grade Competent Cell Stratagene, La Jolla (U.S.A.) 
 
3.9 Media and agars for microorganisms 
For bacteria media composition refer to respective sections in 4. Methods. 
 
3.10 Enzymes and kits for biochemistry and molecular biology 
Name of item Company, location 
Antarctic Phosphatase (Kit) New England Biolabs, Frankfurt a. Main 
Bac-to-Bac® Baculovirus Expression System Life Technologies, Darmstadt 
Platinum® Pfx Polymerase (Kit) Life Technologies, Darmstadt 
T4 Ligase (Kit) New England Biolabs, Frankfurt a. Main 
QiaPrep® Miniprep Kit Qiagen, Hilden 
Restriction enzymes New England Biolabs, Frankfurt a. Main 
Materials   36 
 
 
Protein Kinase A Catalytic Subunit from 
bovine heart (PKA) 
Sigma-Aldrich, Taufkirchen 
cAMP-dependent Protein Kinase A (PKA), 
catalytic subunit 
New England Biolabs, Frankfurt a. Main 
Protein Phosphatase 2A C subunit (human 
recombinant; L309 deletion) 
Cayman Chemical, Ann Arbor (U.S.A.) 
SNAP-Surface® Alexa Fluor® 488 New England Biolabs, Frankfurt a. Main 
SNAP-Surface® Alexa Fluor® 647 New England Biolabs, Frankfurt a. Main 
 
 
3.11 Software for data acquisition and analysis 
Software Company, location 
Igor Pro Version 6.12 WaveMetrics Inc., Portland (U.S.A.) 
ImageJ Versions 1.44p and 1.50i NIH, Bethesda (U.S.A.) 
ImageJ plugin ParticleTracker 2D/3D NIH, Bethesda (U.S.A.) 
ImageJ macro MultipleKymograph NIH, Bethesda (U.S.A.) 
MATLAB R2016b The MathWorks, Natick (U.S.A.) 
OriginPro 9.1G 64-bit OriginLab, Northampton (U.S.A.) 
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4. Methods 
4.1 Cell culture 
4.1.1 Cell culture of immortalized Xenopus laevis melanophores 
Immortalized Xenopus laevis melanophores (gift of Vladmimir I. Gelfand, Northwestern University, 
Chicago, U.S.A.) were cultured at 28 °C in melanophore medium as previously described (11). 
Depending on the amount of melanosomes needed, cells were grown in 25 cm2, 75 cm2, or 175 cm2 
sterile tissue culture-treated flasks. Usually cells were grown to confluency and split by 
trypsinization once a week. 
Cells were transferred into serum-free medium 24 hours prior to hormone stimulation. One hour 
prior purification, aggregation or dispersion of pigment granules was stimulated by adding 50 nM 
Melatonin or 100 nM α-melanocyte stimulating hormone to the serum-free culture medium, 
respectively. 
For long-term storage and subsequent thawing, freeze cultures of melanophores were prepared. 
To this end, a confluently grown 75 cm2 culture flask was trypsinized and melanophores were 
resuspended in 30 ml 0.7X L-15 medium. Cell suspension was transferred into two sterile 50 ml 
Falcon tubes and centrifuged at room temperature for 15 minutes at 150X g. After discarding the 
supernatant, cells were gently resuspended in 3 ml melanophore freeze medium I and incubated 
on ice for five minutes. 3 ml of melanophore freeze medium II were added dropwise under constant 
shaking to the chilled cell suspension. The mixture was cooled on ice for 15 minutes before 
transferring 1 ml each into sterile cryo vials. Vials were placed into a box with absorbent cotton and 
frozen for three to four hours at -80 °C. Finally, cryo vials were placed in a liquid nitrogen tank for 
long-term storage. 
To start a new melanophore culture, one vial was taken out of the liquid nitrogen tank and quickly 
thawed in a 37 °C water bath. Cell suspension was transferred into a sterile 15 ml Falcon tube and 
5 ml of warm melanophore medium was slowly added. After centrifuging at room temperature for 
five minutes at 500X g, cells were gently resuspended in 10 ml warm melanophore medium and 
seeded in a 25 cm2 tissue culture flask. To remove melanophores that did not survive freezing and 
thawing procedure, melanophore medium was exchanged after two to three days after incubation 
at 28 °C. 
Melanophore medium: 0.7X L-15 medium, 10% fetal bovine serum, 5 µg/ml insulin, 100 U/ml 
penicillin and streptomycin 
Trypsin in 0.7X PBS: 0.05% Trypsin/EDTA, 0.7X PBS 
Melanophore freeze medium I: 0.7X L-15 medium, 40% FBS 
Melanophore freeze medium II: 0.7X L-15 medium, 50% FBS, 20% DMSO 
4.1.2 Cell culture of Sf9 insect cells 
The Sf9 insect cell line (Life Technologies) was used to recombinantly express proteins with the 
baculovirus system (Life Technologies). This cell line is a clonal isolate derived from the parental 
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Spodoptera frugiperda (fall armyworm) cell line IPLB-Sf-21-AE (86-88), which originated from a 
population of cells that was isolated from S. frugiperda ovarian tissue. 
Sf9 cells were suspension-cultured in Sf-900 II SFM medium supplemented with 10% FBS and 0.5 
mg/ml Gentamicin at 28 °C and 110 rpm in Erlenmeyer flasks. The cultures typically had a volume 
from 50 to 500 ml and a cell density of 0.5 to 8X106 cells/ml. Cells were diluted every other day with 
fresh supplemented medium. For protein expression, cells were diluted to a density of 2X106 
cells/ml before adding virus(es), whereas cells were brought to a density of 0.5X106 for the purpose 
of amplifying a virus generation. 
In general, cells were propagated up to 30 passages. To start a new round of Sf9 propagation, liquid 
nitrogen-stored cell stocks were thawed and expanded according to the manufacturer’s protocol. 
Aliquots of cells to be stored in liquid nitrogen were prepared and handled as described by the 
manufacturer. 
Sf-900 II SFM medium (supplemented): Sf-900 II SFM medium, 10% FBS, 0.5 mg/ml Gentamicin 
4.2 Molecular biological methods 
Standard molecular biological methods were mainly performed as described in (89). 
4.2.1 DNA 
4.2.1.1 Constructs generated by PCR or by restriction enzyme-mediated cloning 
All constructs were placed inside the appropriate vector by restriction enzyme-mediated cloning. 
All restriction sites employed in this work are summarized for each construct in Table I. 
Table I: Used restriction sites for cloning of constructs into pfastBac1. 
Construct name 5’ restriction site 3’ restriction site 
XlRab27a constructs XhoI KpnI 
XtMlph constructs SalI NotI 
XlMyoVa constructs NheI NotI 
MmRab27a constructs XhoI KpnI 
MmMlph constructs XhoI KpnI 
MmMyoVa constructs XhoI KpnI 
 
C-terminally 6XHis-tagged (6XHistidin-tag, Qiagen) XlRab27a was generated by PCR with the 
primers XlRab27a_Fw and XlRab27a_6XHis_Rv (for sequences refer to section 3.7.1 Cloning 
primers).The C-terminal SNAP-tag (New England Biolabs) was introduced into the constitutively 
active XlRab27a-Q78L using the restriction sites AscI and KpnI.  
Mlph DNA from Xenopus tropicalis (accession number NM_001126722.1) was a kind gift of Vladimir 
I. Gelfand (Northwestern University, Chicago, U.S.A.). An N-terminal FLAG-tag (Sigma-Aldrich) was 
introduced into the Mlph gene using the PCR primers XtMlph_NFLAG-SalI_Fw and XtMlph-NotI-Rv. 
An untagged Mlph was cloned using the primers XtMlph-SalI_Fw and XtMlph-NotI_Rv. PCR of 
untagged and N-terminally FLAG-tagged XtMlph was performed by Dennis Zimmermann. C-
terminally truncated Mlph constructs with an N-terminal FLAG-tag were generated using the 
primers XtMlph_NFLAG-SalI_Fw and XtMlph_ABD_del1_Rv or XtMlph_ABD_del2_Rv, respectively. 
Methods   39 
 
 
X. laevis MyoVa sequence was cloned from cDNA from immortalized X. laevis melanophores 
(accession number JX494698.1) via RACE-PCR by Dennis Zimmermann (90). The N-terminally FLAG-
tagged XlMyoVa construct was generated using the primer pair NheI_FLAG_XlMyoVa_Fw and 
XlMyoVa_SphI_Rv (90). The untagged XlMyoVa construct was obtained by PCR with the primers 
XlMyoVa_NheI_Fw2 and XlMyoVa_SphI_Rv (90). The XlMyoVa-HMM construct (1-1237) was 
generated using the primers NheI-FLAG_XlMyoVa_Fw and XlMyoVa_m1247_SphI_Rv, whereas the 
C-terminal truncation construct XlMyoVa C-tail (1110-1852) was obtained by PCR with the primer 
pair XlMyoVa_1110_NheI_FLAG_Fw and XlMyoVa_SphI_Rv. Drosophila melanogaster calmodulin 
(gift of James A. Spudich, Stanford University, Stanford, U.S.A.) was always coexpressed with MyoVa 
constructs for motor functionality. 
The C-terminally truncated MmMlph constructs with an N-terminal FLAG-tag were obtained by PCR 
with the primer pairs MmMlph_BamHI_XhoI_FLAG_Fw and MmMlph_ABD_del1_Rv or 
MmMlph_ABD_del2_Rv, respectively. 
The N-terminal truncation construct of MmMyoVa (1-1109) was generated with the primers 
MmMyoVa_HMM_BamHI_XhoI_FLAG_Fw and MmMyoVa_HMM_1119G_HindIII_KpnI_Rv. 
4.2.1.2 Polymerase chain reaction (PCR) 
To generate truncated or modified constructs, PCRs were performed with specifically designed 
oligonucleotides (primers) to amplify the template DNA. The respective DNA template was mixed 
with the forward and reverse primer, DNA polymerase, deoxyribose nucleoside triphosphates 
(dNTPs), and the appropriate reaction buffer and objected to a thermal cycle to amplify the desired 
DNA part. The PCR cycle starts with heat-denaturation of the double-stranded DNA, is followed by 
hybridization of the single strands and added primers, and is completed by the eventual synthesis 
of the complementary strand via DNA polymerase. Repeating this cycle 35 times yields in a large 
amount of the specific DNA fragment. 
Reactions were performed as outlined in Table II using Pfx DNA Polymerase, together with the 
desired combination of forward and reverse primer and previously purified template DNA. The 
applied PCR program is shown in Table III. 
Table II: PCR setup for reactions with Pfx Polymerase. 
Component (concentration) Final concentration Applied volume (µl) 
Reaction buffer 10X 1X 5 
Template DNA (200-300 ng) - 1 
dNTP-mix (10 mM) 0.4 mM 2 
Forward primer (10 µM) 0.5 µM 2.5 
Reverse primer (10 µM) 0.5 µM 2.5 
Platinum Pfx Pol (250 U) 2.5 U 1 
Sterile H2O - ∆ 50 
Total reaction volume  50 
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Table III: Thermal cycle for PCR with Pfx Polymerase. 
 Temperature (°C) Cycle Time (s) Cycles 
Denaturation 94 120  
 94 15 35 
Annealing 55 45 35 
Elongation 68 180 35 
 68 420  
4.2.1.3 DNA fragment analysis by agarose gel electrophoresis 
The expected size of the amplified DNA fragments was verified by agarose gel electrophoresis. To 
this end, agarose (1%) and ethidium bromide (1%) were dissolved in TAE buffer. Ethidium bromide 
intercalates into DNA and makes the fragments visible under ultraviolet light. Samples were mixed 
with 6X DNA loading buffer prior to applying them on the gel. Gels were usually run at 50 to 90 volts 
for 30 to 60 minutes. 1 kb DNA ladder was used to determine the sizes of the amplified DNA 
fragments. DNA bands were detected by a UV light source. 
TAE buffer (50X): 24.2% (w/v) Tris Base, 5.7% (v/v) Glacial acetic acid, 50 mM EDTA pH 7.0 
DNA loading buffer: 20% Glycerol, 0.1 M EDTA, 1% SDS, 0.25% Bromophenol Blue 
4.2.1.4 Gel extraction of DNA fragments 
Subsequent to electrophoresis, restriction-digested DNA fragments were excised with a clean 
scalpel and DNA was purified using the Qiaquick® Gel Extraction Kit (Qiagen) to remove enzyme, 
template and dNTPs. Typically, purified DNA was eluted in 30 to 50 µl elution buffer. Samples were 
then stored at -20 °C until further usage. 
Elution buffer: 10 mM Tris Base pH 8.0, 1 mM EDTA 
4.2.1.5 Purification of PCR products and plasmids 
PCR products and amplified plasmids were purified using the Qiaquick® PCR Purification Kit (Qiagen) 
according to the manufacturer’s instruction. Purified DNA was eluted from the column with 30 µl 
elution buffer and samples were stored at -20 °C. 
Elution buffer: 10 mM Tris Base pH 8.0, 1 mM EDTA 
4.2.1.6 DNA sequencing 
All plasmids and PCR products were purified before sequencing at the Sequencing Service Unit of 
the Ludwig-Maximilians-Universität (München). 50 to 200 ng of PCR product or 150 to 300 ng 
plasmid DNA was mixed with 3.3 pmol sequencing primer in elution buffer. Sequencing at the 
service unit was performed with the “Cycle, Clean & Run” program using BigDye v3.1. 
Sequencing was partly performed by MWG Eurofins (Ebersberg). 50 to 100 ng/µl purified DNA were 
mixed with 15 pmol sequencing primer in a total volume of 15 µl H2O. Sequencing at the company 
was performed using the Single Read Service. 
Elution buffer: 10 mM Tris Base pH 8.0, 1 mM EDTA 
Methods   41 
 
 
4.2.1.7 Determination of DNA concentration 
The concentration of purified DNA was measured spectroscopically by determining the optical 
density at 260 nm. DNA was diluted 1:100 or 1:200 in H2O and measured against H2O. DNA 
concentration of the sample was calculated using the following equations: 
1:100 dilution: (OD260 nm x 10)/2 = µg DNA/µl 
1:200 dilution: OD260 nm/2 = µg DNA/µl 
4.2.1.8 DNA sequence synthesis of Rab27a, Mlph, and MyoVa constructs 
The majority of constructs used in this study was synthesized by GenScript (Piscataway, U.S.A.) 
employing the OptimumGeneTMcodon optimization technology to increase protein yields in insect 
cells. To this end, the OptimumGeneTM algorithm was used that alters the bases in the DNA 
sequence without changing the amino acid sequence. 
XlRab27a DNA was synthesized using the GenBank sequence NM_001092394.1 with a C-terminal 
FLAG-tag. Constitutively inactive and active forms of FLAG-tagged XlRab27a were created by 
substituting the threonine at position 23 with an asparagine (XlRab27a-T23N) and exchanging the 
glutamine at position 78 with a leucine (XlRab27a-Q78L), respectively (46). Furthermore, XlMyoVa 
GTD (1445-1852) was synthesized with an N-terminal FLAG-tag and the molecular leucine zipper 
GCN4 to ensure dimerization. 
MmRab27a (accession number NM_023635.4) and MmRab27a-Q78L with a C-terminal SNAP-tag 
followed by a 6XHis-tag, MmMlph (accession number NM_053015.2) with N-terminal FLAG-tag, 
and MmMyoVa (accession number NM_010864.1) with N-terminal FLAG-tag were synthesized as 
well. Four point mutated and N-terminally FLAG-tagged MmMlph constructs, mimicking the 
dephosphorylated state by substituting serine or threonine with alanine residues, were prepared 
by GenScript. Following point mutants were generated: MmMlph T443A/S445A/T446A, MmMlph 
S491/498A, MmMlph S544/546/547A, and MmMlph Dephos control mutant 
T392A/S393/396/398/399A/T400A/S401A. 
4.2.2 Cloning techniques 
4.2.2.1 Restriction enzyme-mediated DNA digest 
All constructs have been cloned using two different restriction sites engineered at their 5’ and 3’ 
ends and digested with the respective restriction enzymes according to the manufacturer’s 
guidelines. Double digests were performed whenever possible, sequential digest was carried out 
when no buffer suitable for both enzymes was available. 5 µg DNA were employed for digesting 
vectors. 
4.2.2.2 Dephosphorylation of linearized DNA 
Religation was prevented by dephosphorylation of the digested 5’ vector end. For this, the vector 
was incubated with Antarctic Phosphatase for 1 hour at 37 °C following the manufacturer’s 
recommendation. After dephosphorylation, the phosphatase was heat inactivated for 5 minutes at 
70 °C. 
4.2.2.3 Ligation of DNA fragments into linearized vector 
T4 DNA Ligase was employed to fuse the insert with the respective vector. Ligation reaction was 
carried out for 16 to 72 hours at 16 °C in the provided T4 Ligase buffer. 
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4.2.2.4 Transformation of chemically competent E. coli XL1-Blue cells 
Ligated vector and insert were gently mixed with 200 µl slowly thawed E. coli XL1-Blue cells and 
incubated on ice for 5 minutes. Cells were heat shocked for 1 minute at 42 °C, immediately put back 
on ice and incubated for 2 minutes. 200 µl S.O.C. medium was added to the transformed cells and 
incubated in a thermo mixer at 37 °C and 900 rpm for one hour. Cells were plated onto a LB agar 
plate supplemented with selection antibiotic and incubated at 37 °C for approximately 18 hours.  
S.O.C. medium: 2% (w/v) Tryptone, 0.5% (w/v) Yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM 
MgCl2, 10 mM MgSO4, 2% (v/v) 1 M Glucose 
LB-Ampicillin agar: 1.5% (w/v) Agar, 1% (w/v) Tryptone, 0.5% (w/v) Yeast extract, 1% (w/v) NaCl, 
0.1% (v/v) Ampicillin solution (100 mg/ml) 
4.2.2.5 Selection and expansion of transformed E. coli 
Growth on LB agar plates with ampicillin only allows growth of those cells that incorporated the 
plasmid-DNA containing the ampicillin-resistance cassette (pFastBac1 and pFastBacDual vectors). 
Transformed E. coli were incubated overnight at 37 °C in an incubator. Four to six colonies were 
picked and two to four ml LB-Ampicillin medium were inoculated with a single colony each for Mini-
plasmid preparation (Mini-Prep). Shaking cultures were incubated overnight at 37 °C and 210 rpm 
in a shaking incubator device. 
LB-Ampicillin medium: 1% (w/v) Tryptone, 0.5% (w/v) Yeast extract, 1% (w/v) NaCl, 0.1% (v/v) 
Ampicillin solution (100 mg/ml) 
4.2.2.6 Plasmid-DNA extraction from transformed bacteria 
Overnight shaking cultures were transferred into 2 ml reaction tubes and cells were pelleted by 
centrifugation at 14.000 rpm for one minute in a tabletop centrifuge. Supernatant was discarded 
and DNA was extracted using the QIAprep Spin Miniprep Kit (Qiagen) and corresponding buffers. 
DNA was eluted with typically 50 µl pre-warmed elution buffer. 
Elution buffer: 10 mM Tris Base pH 8.0, 1 mM EDTA 
4.3 Protein biochemistry 
4.3.1 Analytical methods 
4.3.1.1 Protein analysis by SDS-polyacryl amide gel electrophoresis (SDS-PAGE) 
This technique is employed to separate proteins according to their mass. SDS is an anionic detergent 
which denatures secondary and non-disulfide-linked tertiary structures, and applies a negative 
charge to each protein in proportion to its mass. In an electric field, the negatively charged proteins 
move to the positive charged electrode. 
In this thesis, gels containing 10% or 12% acrylamide were used. First the resolving gel mixture was 
prepared and filled in the gel chamber (Bio-Rad). About 1.5 cm of the gel chamber were left for the 
stacking gel. To get a straight etch of the resolving gel, isopropyl alcohol was layered on top of the 
liquid resolving gel. After polymerization, the isopropyl alcohol was discarded and the stacking gel 
mixture was filled into the chamber. The protein samples, usually 5 to 30 µl, were mixed with 1 to 
6 µl SDS loading buffer (6X) and incubated at 95 °C for five minutes. The samples, along with protein 
marker, were carefully loaded into the pockets of the gel. To analyze the size of the respective 
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proteins, electrophoresis was performed at about 20 to 80 mA for 40 to 60 minutes. The gel was 
either stained with Coomassie Brilliant Blue or used for immunoblotting. 
The gels were put in Coomassie Brilliant Blue solution and heated for 15 seconds in a microwave. 
Staining occurred for 20 to 60 minutes under constant shaking at 60 rpm. Coomassie Brilliant Blue 
solution was exchanged with destain buffer and heated for 15 seconds in a microwave. After 20 
minutes of shaking at 60 rpm, the destain buffer was replaced with fresh destain buffer and 
incubated for another 20 minutes. Destained gels were stored in H2O and digitalized. 
Separating gel (10%, 10 ml): 3.3 ml Rotiphorese Gel 30, 2.5 ml Separating gel buffer, 4.2 ml H2O, 10 
µl Temed, 100 µl APS 
Separating gel buffer (10X): 0.5 M Tris Base pH 6.8, 0.4% (w/v) SDS 
APS solution (100X): 10% (w/v) APS in H2O 
Stacking gel (10%, 10 ml): 1.3 ml Rotiphorese Gel 30, 2.5 ml Stacking gel buffer, 6.2 ml H2O, 10 µl 
Temed, 100 µl APS 
Stacking gel buffer (10X): 1.5 M Tris Base pH 8.8, 0.4% (w/v) SDS 
Electrophoresis buffer (10X, pH 8.8): 3% (w/v) Tris Base, 1% (w/v) SDS, 14% (w/v) Glycine 
SDS protein sample buffer (6X): 300 mM Tris Base pH 6.8, 15 mM EDTA, 12% (w/v) SDS, 30% (v/v) 
Glycerol, 0.06% (v/v) Bromphenol Blue, 15% (v/v) β-Mercaptoethanol 
Coomassie Brilliant Blue solution: 0.25% (w/v) Brilliant Blue R-250, 50% (v/v) Methanol, 10% (v/v) 
Glacial acetic acid 
Destain solution: 10% Glacial acetic acid, 25% Isopropyl alcohol 
4.3.1.2 Determination of protein concentration 
To determine the protein concentration of purified proteins Bovine Serum Albumin (BSA) standards 
were run on the SDS-PAGE with the protein(s) of interest. Four different concentrations of BSA (0.1; 
0.2; 0.3, and 0.4 mg/ml) were used to generate a calibration curve. To this end, the Coomassie-
stained gel was digitalized and the band intensities were measured using the ImageJ software (91). 
The protein concentrations were calculated by measuring the respective band intensity and 
employing the BSA calibration curve.  
4.3.1.3 Western blot analysis 
Following gel electrophoresis, proteins were transferred onto a nitrocellulose membrane (Protran-
Whatman, Dassel, Germany) using a semi-dry transfer apparatus (PeqLab, Erlangen, Germany). 
Blots were blocked for 3 hours with milk powder (5%, in TBST buffer). Incubation with primary and 
secondary antibodies was performed overnight at 4 C and at room temperature for 1 h, 
respectively.  
Primary antibodies used were as follows: anti-GAPDH, anti-protein kinase A (PKA) catalytic subunit 
α/β/, anti-MyoVa, anti-Mlph, α-Rab27a. Secondary antibodies (all horseradish-peroxidase-
conjugated) used were the following: anti-mouse polyclonal IgG (fc-specific), anti-rabbit polyclonal 
IgG (whole molecule), anti-goat IgG (whole molecule). 
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Blotting buffer: 24 mM Tris, 192 mM Glycin, 0.02% SDS, 20% Methanol 
TBS buffer: 20 mM Tris pH 7.4, 150 mM NaCl 
TBST buffer: 20 mM Tris pH 7.4, 150 mM NaCl, 0.05% (v/v) Tween-20 
Solution A (ECL) (200 ml): 100 mM Tris-HCl pH 8.6, 50 mg Luminol 
Solution B (ECL) (10 ml): 11 mg Coumaric acid in DMSO 
ECL solution (4.4 ml): 4 ml solution A (ECL), 0.4 ml solution B (ECL), 1.2 µl H2O2 (30%) 
4.3.2 Isolation, purification and handling of cytoskeletal proteins 
4.3.2.1 G-actin purification from rabbit muscle tissue 
Actin from rabbit skeletal muscle was extracted from an acetone powder as described (92). The 
back and upper thigh muscles of a rabbit were chilled, ground twice and, to remove myosins, 
extracted with high-salt extraction buffer for 10-15 minutes on a stirrer. The mixture was 
centrifuged (4 000X g, 4 °C, 10 minutes) and re-extracted. The pellet was then stirred in cold distilled 
water for 10 minutes and subsequently centrifuged as before with repeats until swelling of the 
sediment was observed. The pellet was incubated with cold acetone for about 30 minutes, filtered 
and dried overnight. The acetone powder was stored at -20 °C for subsequent actin preparations. 
Usually, 10 g acetone powder were extracted with 200 ml G-buffer plus 0.2 mM ATP at 4 °C for 30 
minutes, filtered through nylon nets and re-extracted for 15 minutes. The filtrate was centrifuged 
(30 000X g, 30 minutes, 4 °C), actin polymerization was promoted by the addition of 50 mM KCl, 2 
mM MgCl2 and 1 mM ATP dissolved in 100 mM NaOH and the mixture was incubated at 4 °C for 
two hours or overnight. To remove tropomyosin, solid KCl was slowly added until a final 
concentration of 0.8 M was reached. Filamentous actin was subsequently pelleted by centrifugation 
(150 000X g, 3 hours, 4 °C), the supernatant was discarded and the pellet was homogenized in G-
buffer with a douncer. For actin depolymerization, the homogenized F-actin pellet was dialyzed 
against G-buffer for 2-3 days with a total of about 6 buffer changes. 
The solution was centrifuged at 150 000X g and 4 °C for 3 hours, and about 65% from the top 
supernatant were further purified using a Sephacryl S300 gel filtration column (2.5 x 45 cm, 
Pharmacia). Fractions were collected and the actin concentrations determined by measuring the 
optical density at 290 nm (1 mg/ml pure actin: OD290nm=0.65) (93) and their quality tested in a falling 
ball viscometry assay. The prepared G-actin could be stored on ice for up to 3 weeks for most 
applications and was dialyzed against fresh G-buffer before usage. 
High-salt extraction buffer: 0.5 M KCl, 0.1 M K2HPO4 
G-buffer: 2 mM Tris HCl pH 8.0, 0.2 mM CaCl2, 0.5 mM DTT, 0.01% NaN3 
4.3.2.2 G-actin polymerization 
For the preparation of fluorescent actin filaments, 5 µM of purified G-actin (gift of Michael 
Schleicher, Ludwig-Maximilians-Universität, and Andreas Bausch, Technische Universität München) 
was polymerized in assay buffer (AB) (zero ATP) for 1 h at room temperature in the presence of 5 
µM Atto488-phalloidin. 
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AB: 25mM Imidazole pH 7.5, 25mM KCl, 1mM EGTA, 4mM MgCl2, 10 mM DTT, 1 mM ATP, protease 
inhibitor cocktail 
4.3.2.3 Tubulin purification from porcine brain tissue 
Tubulin was purified as described previously (94). Briefly, meninges, connective tissue and veins of 
at least 10 porcine brains were quickly removed in the cold room. 700 g of brain material were 
mixed with one volume of buffer A and homogenized in a mixer. The homogenate was centrifuged 
at 13 000 rpm at 4 °C for 70 minutes. The supernatant was collected in a graduated cylinder and 
the volume was measured. ¼ volume glycerol and 2 mM ATP was added to the supernatant. The 
suspension was kept at 35 °C for 30 minutes to polymerize the tubulin. Polymerized MTs were 
centrifuged at 42 000 rpm and 35 °C for 45 minutes. Afterwards, a centrifugation step at 35 000 
rpm and 32 °C for 50 minutes was performed. Pellets were resuspended in buffer C. Pellets were 
homogenized on ice and MTs were depolymerized for 25 minutes on ice. Homogenate was 
centrifuged at 36 000 rpm and 4 °C for 30 minutes. Supernatant was collected in a graduated 
cylinder and 2 mM ATP was added. For polymerization, the suspension was kept at 35 °C for 30 
minutes. MTs were sedimented by centrifugation at 35 000 rpm at 35 °C for 40 minutes. 
Supernatant was discarded and pellet was resuspended in buffer B and transferred in a 
homogenizer. Suspension was homogenized and kept on ice for 25 minutes to depolymerize MTs 
and occasionally homogenized. Tubulin was centrifuged at 36 000 rpm and 4 °C for 25 minutes. The 
volume of the supernatant was measured and 1/10 volume DMSO and 2 mM ATP was added. For 
polymerization of tubulin, the suspension was kept at 35 °C for 30 minutes. Polymerized MTs were 
pelleted at 33 000 rpm at 35 °C for 40 minutes. Supernatant was discarded and pellet was 
resuspended in buffer D and transferred into a homogenizer on ice. To depolymerize filaments, the 
suspension was homogenized on ice for 30 minutes. Precipitates were removed by centrifugation 
at 34 000 rpm at 4 °C for 30 minutes. Supernatant was transferred onto an equilibrated 
phosphocellulose (P-11) column to separate tubulin from microtubule-associated proteins (MAPs). 
Tubulin was eluted with buffer B and main fractions were united. 0.1 M GTP was added to purified 
tubulin and aliquots were frozen in liquid nitrogen and stored at -80 °C. 
Buffer A: 100 mM Pipes pH 6.8, 2 mM EGTA, 1 mM MgSO4, 1 mM DTT, 0.1 mM ATP 
Buffer B: 500 mM Pipes pH 6.8, 2 mM EGTA, 1 mM MgSO4, 1 mM DTT, 1 mM ATP 
Buffer C: 100 mM Pipes pH 6.8, 1 mM EGTA, 1 mM MgSO4, 1 mM DTT, 1 mM ATP 
Buffer D: 100 mM Pipes pH 6.8, 1 mM EGTA, 1 mM MgSO4, 0.05 mM ATP, 0.022 mM GTP, 1 mM 
DTT 
4.3.2.4 Tubulin polymerization 
Biotinylated and Atto488-labeled tubulin was polymerized in BRB80 buffer supplemented with 1 
mM GTP. To stabilize filaments, 5 µM taxol were added after 30 minutes of incubation at 35 °C. 
Polymerization was continued overnight at 35 °C. Prior to use, MTs were diluted with BRB80/TX 
and stored at 35 °C at all times. 
BRB80/TX: 80 mM Pipes pH 6.9, 2 mM MgCl2, 1 mM EGTA, 5 mM DTT, 5 µM taxol 
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4.3.3 Isolation of melanosomes 
Melanosome purification from aggregated or dispersed melanophores was performed as described 
previously (12, 52) in AB, supplemented with cOmplete EDTA-free protease inhibitor. Aggregation 
or dispersion of hormone-stimulated melanophores was checked and flasks were flushed with 5 ml 
0.7X PBS (per 175 cm2 flask), followed by 5 ml 1X AB without ATP, DTT, and protease inhibitors. 
Cells were scraped into 2 ml supplemented AB and transferred into 2 ml reaction tubes. 
Melanophores were lyzed in AB with the so-called Balch-Homogenizer using a tungsten ball with 6 
µm clearance and 20 passages. Lysate was transferred into a 15 ml falcon tube and cell debris was 
pelleted at 750X g for 7 minutes at 4 °C. The supernatant was centrifuged at 2 500X g for 7 minutes 
at 4 °C to pellet melanosomes. Supernatant was discarded and pigment granules were then 
resuspended in 50 to 100 µl of AB with supplements. 
In experiments with the PKA catalytic subunit from bovine heart and/or H-89 dihydrochloride 
hydrate, PKA and H-89 was present during the purification at 74 nM and 40 µM, respectively. AB 
was additionally supplemented with PhosSTOP phosphatase inhibitor cocktail when PKA was 
present. 
In experiments with the cytoplasmic extract from either dispersed or aggregated cells, the 
respective supernatant after the second centrifugation step was added to the purified 
melanosomes. Prior to mixing the cytoplasmic extract with purified melanosomes, deprivation of 
storage buffer was performed by pelleting the pigment granules for 3 minutes at 1 500X g and 4 °C. 
Melanosomes were then gently resuspended in cytoplasmic extract from the respective cell state. 
For immunoblotting, melanosomes were purified as described above, resuspended in a suitable 
volume of AB and run on a 10% SDS-PAGE. 
PBS buffer (1X): 137 mM NaCl, 7.9 mM Na2HPO4 X 2 H2O, 2.7 mM KCl, 1.5 mM KH2PO4 
AB: 25mM Imidazole pH 7.5, 25mM KCl, 1mM EGTA, 4mM MgCl2, 10 mM DTT, 1 mM ATP, protease 
inhibitor cocktail 
4.3.4 Protein expression using the baculovirus expression system 
The baculovirus expression system was used for protein expression in this thesis. Examination of 
proteins relies on the quality of expressed proteins. Especially for motor proteins, proper folding 
and posttranslational modifications are essential for functionality. Furthermore, the baculovirus 
system provides high expression levels and mostly soluble proteins that can be easily purified from 
insect cells. Lastly, the system is safe to work with because only a small range of invertebrates serve 
as hosts.  
4.3.4.1 Generation of the recombinant transfer vector for protein expression 
As described in section 4.2.2 Cloning techniques, the gene of interest was cloned into a pFastBacTM 
donor plasmid (in this study: pFastBacTM1 and pFastBacTM Dual). This donor plasmid was 
transformed into Escherichia coli MAX Efficiency®DH10BacTM cells to produce the baculovirus 
shuttle vector (bacmid) used for transfection of insect cells, virus generation and subsequent 
protein expression. The E. coli DH10 BacTM cells contain a helper plasmid that encodes a transposase 
and has a tetracycline-resistance. The mini-Tn7 element from the pFastBacTM donor plasmid is site-
specifically transposed to the mini-attTn7 attachment site on the bacmid, introducing the gene of 
interest into the viral genome and disrupting the lacZα gene. Cells with successfully transposed 
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bacmids will be white, in contrast to non-transposed cells that grow blue on blue-white-selection 
agar plates. 
DH10BacTM competent cells were thawed on ice. Approximately 500 ng of recombinant donor 
plasmid was added to the thawed cells and gently mixed. The mixture was kept on ice for 20 
minutes followed by a heat shock for one minute at 42 °C. Afterwards, cells were cooled on ice for 
two minutes. 800 µl S.O.C.-medium was gently added to cell suspension and cells were allowed to 
grow at 37 °C for four hours at 225 rpm. Different amounts of cell suspension (50, 15, and 1.5 µl) 
were plated on freshly prepared blue-white plates and incubated at 37 °C for two to three days. 
White colonies were restriked onto new blue-white plates and again grown for two to three days 
to confirm colony color.  
To isolate bacmid DNA, a single white colony was picked, added to 6 ml blue-white medium and 
grown overnight at 37 °C with medium agitation. Cells were pelleted and DNA was isolated with 
QIAprep Spin Miniprep Kit (Qiagen). Isolated DNA was finally solved in 50-100 µl sterile H2O or TE 
buffer. 
Blue-white agar: 1.5% (w/v) Agar, 1% (w/v) Tryptone, 0.5% (w/v) Yeast extract, 1% (w/v) NaCl, 0.1 
mg/ml Bluo-gal, 0.04 mg/ml IPTG, 0.05 mg/ml Kanamycin, 7 µg/ml Gentamicin, 0.02 mg/ml 
Tetracycline 
Blue-white medium: 1% (w/v) Tryptone, 0.5% (w/v) Yeast extract, 1% (w/v) NaCl, 0.05 mg/ml 
Kanamycin, 7 µg/ml Gentamicin, 0.02 mg/ml Tetracycline 
Tetracycline solution (100 ml): 50 mg Tetracycline in 100 ml H2O 
Kanamycin (100 ml): 50 mg Kanamycin monosulfate in 100 ml H2O 
Gentamicin solution (100 ml): 50 mg Gentamicin sulfate in 100 ml H2O 
TE buffer: 10 mM Tris pH 8.0, 1 mM EDTA 
4.3.4.2 Transfection of Sf9 insect cells with recombinant bacmid 
5 to 15 µl of isolated bacmid DNA were used to transfect Sf9 insect cells. For each construct, 2 ml 
of Sf9 cells at 0.5X 106 c/ml were plated into one 35-mm well of a 6-well plate. Bacmid DNA was 
mixed with 10 µl Cellfectin® II reagent and 200 µl Sf-900 II SFM medium and incubated at room 
temperature for 30 minutes. This allowed the lipid to cover the DNA for better uptake by the insect 
cells. Seeded cells were washed twice with unsupplemented Sf-900 II SFM medium. 800 µl 
unsupplemented Sf-900 II SFM medium was added to the DNA-Cellfectin mixture and the mixture 
was carefully applied onto the cells for 5 hours at 28 °C. After incubation time, DNA-Cellfectin 
mixture was aspired from the cells and 2 ml Sf-900 II SFM medium supplemented with Gentamicin 
and FBS was gently added. Cells were allowed to grow for three to four days at 28 °C in sealed 6-
well plates. Successful transfection of insect cells led to swelling of cells and finally cell death and 
was checked by light microscopy. The first virus generation P0 was harvested with a sterile 2 ml 
syringe and filtered through a filter with 0.22 µm pore size prior to storage at 4 °C in the dark. 
4.3.4.3 Amplification of baculovirus P0 generation 
Due to the low virus titer of P0, the second baculovirus generation P1 was amplified. P1 was then 
used for later virus amplification and for protein test expression. For this purpose, 30 ml Sf9 cells at 
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a density of 0.5X 106 c/ml were seeded in a sterile 26-cm tissue culture dish and 1 ml of P0 was 
applied to transfect the cells. One dish with Sf9 cells at 0.5X 106 c/ml without addition of virus was 
always incubated as a negative control for later comparison. Transfected cells were incubated for 
five to seven days at 28 °C protected from light. Transfection was checked by light microscopy and 
virus was harvested when holes in the cell lawn and many dead cells that detached from the surface 
could be observed. Cell suspension was transferred into a fresh 50 ml falcon tube and centrifuged 
for 15 minutes at 3 500 rpm and room temperature. Thus virus particles remained in the 
supernatant, whereas cells and debris were pelleted. Supernatant was stored at 4 °C in the dark in 
a sterile 50 ml falcon tube and used for amplification of the third virus generation P2 and once for 
protein test expression. P2 was obtained following the identical procedure as for P1. 
4.3.4.4 Protein expression in Sf9 insect cells 
Protein expression in Sf9 insect cells was carried out in suspension culture at 28 °C and 110 rpm in 
an Innova 43 shaker (Eppendorf, Hamburg). The desired amount of Sf9 cells at a density of 2X 106 
c/ml was prepared in a sterile Erlenmeyer flask. Sf9 cells were infected with 1-6% (v/v, of prepared 
cell suspension) of virus and grown for 48 to 72 hours at 28 °C and 110 rpm. Cells were harvested 
by centrifugation at 1 500 rpm and room temperature for 15 minutes. Medium was discarded and 
cell pellets were either used for immediate protein purification or stored at -20 °C for later protein 
purification. Whenever MyoVa was expressed, cell pellets were shock-frozen in liquid nitrogen and 
used for protein purification or stored at -80 °C. 
4.3.5 Affinity protein purification procedures 
Protein tags introduced at the N- or C-terminus of the protein sequence enable easy protein 
purification and mostly yield in reasonably clean protein preparations. Either a FLAG® or a 6XHis-
tag was used for protein purification in this study. 
4.3.5.1 His-tag affinity purification 
Cell pellet was resuspended in His lysis buffer. Cell debris was separated by centrifuging the 
suspension at 30 000 rpm and 4 °C for 10 minutes. The supernatant containing the target protein 
was incubated with about 0.5% (v/v) of washed Ni-NTA agarose beads (Qiagen) for 1.5 hours rolling 
in a Falcon tube at 4 °C. Agarose beads were spun down at 500 rpm and 4 °C for 15 minutes and 
supernatant was discarded. Beads were transferred into a 1.5 ml Eppendorf tube and agarose was 
washed six times with 1 ml His wash buffer. His-tagged protein was eluted twice with elution buffer 
for 30 minutes at 4 °C. Protein was either aliquoted, shock-frozen in liquid nitrogen and stored at   
-80 °C or subjected to subsequent FLAG-tag affinity purification. Protein purification was verified 
and protein concentration was determined by SDS-PAGE. 
His lysis buffer: 20 mM Tris pH 8.0, 300 mM NaCl, 10 mM Imidazole, 1 mM DTT, 0.5% Triton X-100, 
protease inhibitor cocktail 
His wash buffer: 50 mM Tris pH 8.0, 500 mM NaCl, 40 mM Imidazole, 1 mM MgCl2, 1 mM EGTA, 1 
mM DTT, 0.05% Tween-20 
His elution buffer: 50 mM Tris pH 7.5, 150 mM NaCl, 300-500 mM Imidazole, 1 mM MgCl2, 1 mM 
EGTA, 1mM DTT, 0.05% Tween-20 
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4.3.5.2 FLAG-tag affinity purification 
FLAG®-tagged proteins were purified with the following procedure: Cells were lyzed in FLAG lysis 
buffer. Lysate was centrifuged at 30,000 rpm and 4 °C for 10 to 15 minutes to pellet cell debris. 
Supernatant was transferred into a fresh Falcon tube and 0.1% (v/v) FLAG® Resin (Sigma-Aldrich) 
was added and incubated for 1.5 hours at 4 °C on a rolling device. Suspension was centrifuged at 
500 rpm and 4 °C for 15 minutes to pellet agarose beads. Supernatant was discarded and beads 
were transferred into a fresh 1.5 ml Eppendorf tube. To remove unspecifically bound proteins from 
FLAG® resin, beads were washed three times with 1 ml FLAG wash buffer I followed by three times 
1 ml of FLAG wash buffer II. Protein was eluted twice by applying 0.2% (v/v) elution buffer to FLAG® 
resin and incubating it for 30 minutes at 4 °C on a rolling device. Elution was aliquoted, shock-frozen 
in liquid nitrogen and stored at -80 °C. Protein concentration was determined on a SDS gel. 
FLAG lysis buffer: 20 mM Tris pH 7.5, 300 mM NaCl, 1 mM MgCl2, 1 mM DTT, 0.5% Triton X-100, 
protease inhibitor cocktail 
FLAG wash buffer I: 50 mM Tris pH 7.5, 500 mM NaCl, 1 mM MgCl2, 1 mM EGTA, 1 mM DTT, 0.1% 
Tween-20 
FLAG wash buffer II: 50 mM Tris pH 7.5, 150 mM NaCl, 1 mM MgCl2, 1 mM EGTA, 1 mM DTT, 0.05% 
Tween-20 
FLAG elution buffer: 50 mM Tris pH 7.5, 150 mM NaCl, 1 mM MgCl2, 1 mM EGTA, 1 mM DTT, 0.05% 
Tween-20, 0.2 mg/ml FLAG® peptides 
4.3.5.3 Optimized FLAG-tag affinity purification for XlMyoVa and MmMyoVa 
Purification of FLAG®-tagged MyoVa was performed as described in (95) with minor changes. After 
72 hours of growth, virus-infected cells were harvested. Supernatant was discarded and cell pellet 
was frozen in liquid nitrogen. Pellet was resuspended in MyoVa lysis buffer and homogenized in a 
glass homogenizer for five minutes on ice. Homogenate was transferred into a fresh Falcon tube 
and incubated on a rolling device at 4 °C for 20 minutes. Suspension was cleared by centrifugation 
for 15 minutes at 4 °C and 35 000 rpm. Supernatant was incubated with FLAG®-Resin for 1.5 hours. 
Beads were washed on a PolyPrep column (Bio-Rad) with 2 ml each of MyoVa wash buffer I, MyoVa 
wash buffer II, MyoVa wash buffer I, MyoVa wash buffer III, MyoVa wash buffer IV, MyoVa wash 
buffer III and MyoVa wash buffer I. MyoVa was eluted with MyoVa elution buffer, aliquoted, frozen 
in liquid nitrogen and stored at -80 °C. 
MyoVa lysis buffer: 10 mM MOPS pH 7.0, 200 mM NaCl, 10 mM MgCl2, 1 mM EGTA, 2 mM ATP, 0.1 
mM PMSF, 1 mM DTT, protease inhibitor cocktail 
MyoVa wash buffer I: 10 mM MOPS pH 7.0, 500 mM NaCl, 0.1 mM EGTA, 1 mM DTT, 0.1 mM PMSF 
MyoVa wash buffer II: 10 mM MOPS pH 7.0, 500 mM NaCl, 0.1 mM EGTA, 1 mM DTT, 0.1 mM 
PMSF, 1 mM ATP, 5 mM MgCl2 
MyoVa wash buffer III: 10 mM MOPS pH 7.0, 0.1 mM EGTA, 1 mM DTT, 0.1 mM PMSF, 1 mM EDTA 
MyoVa wash buffer IV: 10 mM MOPS pH 7.0, 500 mM NaCl, 0.1 mM EGTA, 1 mM DTT, 0.1 mM 
PMSF, 1 mM EDTA 
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MyoVa elution buffer: 10 mM MOPS pH 7.0, 200 mM KCl, 0.1 mM EGTA, 1 mM DTT, 0.1 mM PMSF, 
0.3 mg/ml FLAG® peptides 
4.3.6 Reconstitution of the tripartite MyoVa receptor complex in vitro 
Previously tandem purified Rab/Mlph complex was again bound to NiNTA agarose beads for 1.5 
hours at 4 °C and washed with His wash buffer to remove unbound proteins. Rab27a/Mlph-loaded 
NiNTA beads were incubated with separately purified MyoVa diluted in His dilution buffer for 1.5 
hours rolling at 4 °C. Beads were washed six times with His wash buffer before eluting the tripartite 
complex twice for 30 minutes with His elution buffer. 
His dilution buffer: 50 mM Tris pH 7.5, 150 mM NaCl, 1 mM MgCl2, 1 mM EGTA, 1mM DTT 
His wash buffer: 50 mM Tris pH 8.0, 500 mM NaCl, 40 mM Imidazole, 1 mM MgCl2, 1 mM EGTA, 1 
mM DTT, 0.05% Tween-20 
His elution buffer: 50 mM Tris pH 7.5, 150 mM NaCl, 300-500 mM Imidazole, 1 mM MgCl2, 1 mM 
EGTA, 1mM DTT 
4.3.7 Fluorescent labeling of proteins 
Recombinantly expressed proteins in this study were fluorescently labeled employing the SNAP-tag 
method (New England BioLabs, Frankfurt a. Main).  
For this purpose, the protein of interest (here: Rab27a) was N- or C-terminally tagged with a SNAP-
tag. The SNAP-tag is derived from mammalian O6-alkylguanine-DNA-alkyltransferase and has a size 
of about 30 kDa (96, 97). Fluorescent dyes (in this study: SNAP-Surface® Alexa Fluor® 488 or 647) 
are coupled to derivatives of benzylguanines and benzylchloropyrimidines that are employed as 
SNAP substrates. During the labeling reaction, the substituted benzyl group of the substrate with 
the dye is covalently bound to the SNAP-tag carrying protein of interest. The respective protein was 
purified using the standard protein purification protocol and prior to elution it was labeled with 10 
µM SNAP-tag substrate in the wash buffer for one hour at room temperature and in the dark on a 
rotator. The beads were extensively washed with wash buffer to remove excess dye prior to elution. 
4.3.8 Dephosphorylation and phosphorylation of Mlph 
XtMlph or MmMlph was dephosphorylated or phosphorylated during the purification procedure to 
reveal direct effects of Mlph phosphorylation. Therefore, protein was bound to agarose beads and 
unspecifically bound proteins were washed off. To phosphorylate Mlph, 200 to 900 nM PKA 
catalytic subunit (Sigma-Aldrich) and 10 000 U PKA (catalytic subunit, New England Biolabs) in 
kinase buffer with 0.25 mM ATP were incubated with Mlph-coated beads for one hour at room 
temperature on a rotator. To protect phosphorylated protein, phosphatase inhibitor cocktatil 
PhosSTOP was included in all wash buffers. For dephosphorylation, 30 to 60 units of antarctic 
phosphatase and 30 units of human protein phosphatase 2A in dephosphorylation buffer were 
applied onto the protein-bound beads for one hour at room temperature on a rotator. Kinase and 
phosphatases were removed by washing the beads at least four times with wash buffer. 
Kinase buffer: 25 mM Imidazole pH 7.5, 25 mM KCl, 10 mM MgCl2, 10 mM DTT 
Dephosphorylation buffer: 25 mM Imidazole pH 7.5, 25 mM KCl, 11 mM MgCl2, 10 mM DTT, 50mM 
Bis-Tris-Propane-HCl, 0.1 mM ZnCl2 
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4.3.9 Protein purification by chromatography 
4.3.9.1 Ion exchange chromatography 
To purify (especially) His-tagged proteins further, ion exchange chromatography was applied. This 
separation technique relies on electrostatic interactions between charged molecules and a charged 
bead matrix. Each protein possesses a characteristic isoelectric point where the net electrical 
charge is zero. Due to this property, every molecule is released from the bead matrix at a different 
salt concentration when the pH value remains constant. In this thesis, the strong anion exchanger 
column Mono Q HR 5/5 (GE Healthcare Life Sciences) was employed. It is packed with 10 µm beads 
that are positively charged with the group -CH2-N+(CH3)3 allowing high performance 
chromatography and sharp peaks. In order to separate the protein of interest from contaminating 
proteins that were also eluted, previously dialyzed protein mixture was loaded onto a Mono Q HR 
5/5 column that was equilibrated in Mono Q buffer A with 30 mM NaCl (3% Mono Q buffer B) using 
a FPLC system (Amersham Biosciences). All buffers were sterile-filtered through a 0.22 µm pore size 
membrane and degassed prior to usage. A salt gradient over 20 column volumes (CV) from 30 mM 
to 500 mM NaCl was run at a flow rate of 0.75 to 1 ml per minute (ml/min) depending on the back 
pressure of the column. Peak fractions were collected in 0.5 ml fraction size and analyzed on a SDS 
gel. Mono Q column was cleaned with five CVs of 100% Mono Q buffer B followed by at least 20 
CVs of 3% Mono Q buffer B. Buffer was washed out with minimum 20 CVs of H2O and column was 
slowly rinsed with 20% EtOH for long-term storage. 
Dialysis buffer: 20 mM Tris pH 8.0, 30 mM NaCl, 1 mM MgCl2, 1 mM EGTA, 1 mM DTT 
Mono Q buffer A: 20 mM Tris pH 8.0, 1 mM MgCl2, 1 mM EGTA, 1 mM DTT 
Mono Q buffer B: 20 mM Tris pH 8.0, 1 M NaCl, 1 mM MgCl2, 1 mM EGTA, 1 mM DTT 
4.3.10 Methods for functional protein analysis 
4.3.10.1 In vitro motility assay with melanosomes on F-actin 
 
Figure 7: Schematic overview of motility assay setup with isolated melanosomes on surface-
adhered F-actin in vitro. 
For motility assays, 15 µl flow cells covered by a nitrocellulose coverslip were used (Figure 7). Actin-
adherence to the glass coverslip was performed as previously described (98). For this purpose, 0.2 
mg/ml N-ethylmaleimide-modified heavy meromyosin (NEM-HMM) (gift of Matthias Rief, 
Technische Universität München) was infused into the flow cell and incubated for 5 minutes. 
Remaining NEM-HMM was removed by washing with AB. Then, 0.5 to 1 µM fluorescently labeled 
F-actin was infused and incubated for 5 minutes, followed by a wash step with AB. To prevent 
unspecific binding to the glass surface, an additional wash step with casein (15 mg/ml in AB) was 
included. Finally, purified pigment granules diluted in AB (plus 2 mM ATP) were perfused into the 
flow cell and incubated for an additional two minutes. 
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In vitro motility was observed at room temperature by video-enhanced differential interference 
contrast (DIC) microscopy using a Zeiss Axiophot (Oberkochen) equipped with a plan-apochromatic 
oil immersion objective lens (63X; NA 1.4), DIC prisms, and an oil-immersion condenser (for NA 1.4). 
Images were captured with a C2400 Newicon camera (Hamamatsu Photonics, Herrsching), while 
contrast enhancement was performed using a DVS1000 video processor (Hamamatsu Photonics). 
Image data was digitally recorded and saved as TIFF image sequences with a frame interval of one 
second. By taking eight image sequences of approximately one minute, the average acquisition time 
of one flow chamber typically was ten minutes. 
Quality and density of actin filaments in flow cells was monitored for every flow cell using an 
Axiophot (Zeiss) equipped with plan-apochromatic oil immersion objective lens (63X; NA 1.4), and 
filter No. 10 (Zeiss; excitation: BP 450-490 nm, FT 510 nm, emission: BP 515-565 nm). For excitation, 
a HBO 100 light source was used (Zeiss). Fluorescent images of flow cell-adhered F-actin were 
acquired using an inverted Axiovert 200M microscope (Zeiss) equipped with a plan-apochromatic 
oil immersion objective lens (100X; NA 1.4). For excitation, a HBO 103 light source was used and 
emission was collected using a Zeiss filter set 38HE. 
NEM buffer: 25 mM Imidazole pH 7.5, 4.4 mM MgCl2, 1 mM EGTA, 300 mM KCl, 10 mM DTT 
Collodion solution: 0.1% collodion in isoamyl alcohol 
Casein: 15 mg/ml Casein (30 mg/ml in Tris-Cl) in AB buffer 
AB: 25 mM Imidazole pH 7.5, 25 mM KCl, 4 mM MgCl2, 1 mM EGTA, 10 mM DTT 
ATP solution (0.1 M pH 7.0): 100 mM Na2ATP in H2O 
4.3.10.2 Coimmunoprecipitation 
To test the interaction of two proteins, Sf9 cells were coinfected with two baculoviruses. It was 
important to always use differently tagged protein combinations. A FLAG-tagged protein was 
coexpressed with either an untagged protein or a His-tagged protein. Standard protein purification 
was carried out (section 4.3.5.2 FLAG-tag affinity purification) and coimmunoprecipitation was 
analyzed with SDS-PAGE. 
4.3.10.3 Negative-staining transmission electron microscopy 
Samples were adsorbed on glow-discharged formvar-supported carbon-coated Cu400 TEM grids 
(Science Services, Munich) and stained using a 2% aqueous uranyl formate solution containing 25 
mM sodium hydroxide. Imaging was performed using a Philips CM100 EM operated at 100 kV. 
Images were acquired using an AMT 4 Megapixel CCD camera. Micrograph scale bars were 
calibrated by imaging 2D catalase crystals and using the lattice constants as length reference. 
Imaging was performed at 28 500X magnification. Single particle micrographs were created by 
manual particle picking using the Xmipp 3.1 boxing routine (99). 
4.3.10.4 In vitro phosphorylation assay with isotope-labeled ATP 
The use of radiolabeled ATP (Adenosine 5’-triphosphate [γ-32P]) enables to identify targets of 
protein kinases. Kinase and presumptive target are incubated in the presence of isotope-labeled 
ATP. The mixture is separated by SDS-PAGE and the gel is placed against a phosphor storage screen. 
The screen is then scanned with a phosphorimager and appearing bands represent phosphorylated 
proteins. 
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200 nM of freshly dissolved PKA catalytic subunit was mixed with 1.2 µM of substrate in kinase 
buffer in a constant sample volume of 30 µl. 1 µM isotope-labeled ATP (diluted 1:30 with cold ATP) 
was added to start the reaction and incubated at 30 °C in a thermo mixer for 15 minutes. Reaction 
was stopped by adding 10 µl of SDS sample buffer. Time course experiments were performed using 
a master mix of kinase-substrate mixture. At desired time points, 30 µl were taken out and pipetted 
into previously prepared Eppendorf tubes with 10 µl SDS sample buffer. For determining the 
stoichiometry of ABD phosphorylation, 0.5 µM of substrate was mixed with 200 nM PKA and 
incubated at 30 °C for 20 minutes. 15 µl of each reaction were applied onto a 12.5% SDS gel and 
electrophoresis was run for 1 hour at 300 V and 35 mA per gel. The gel apparatus was carefully 
disassembled and the gel was sealed with plastic wrap before placing it against the phosphor 
storage screen overnight. The screen was scanned with a phosphorimager (Typhoon 9200, 
Molecular Dynamics) and digital images were used for analysis. 
Kinase buffer: 25 mM Imidazole pH 7.5, 25 mM KCl, 10 mM MgCl2, 10 mM DTT 
4.3.10.5 In vitro filament decoration assay with Mlph proteins and F-actin 
0.25 µM biotinylated G-actin and 4.75 µM G-actin were polymerized with 5 µM Atto488-phalloidin 
in AB for 30 minutes at room temperature. 0.5 mg/ml biotinylated BSA was flowed into a 10 µl flow 
chamber and incubated for three minutes. Glass surface was blocked with 8 mg/ml BSA in AB. 0.5 
mg/ml streptavidin was bound to biotinylated BSA for three minutes followed by a wash step with 
8 mg/ml BSA in AB. Biotinylated actin filaments were attached to the biotin-streptavidin layer and 
unbound filaments were washed out with 8 mg/ml BSA in AB. Alexa Fluor 647-labeled Rab27a/Mlph 
complex diluted in AB was infused into the flow chamber. The chamber was washed with AB 
supplemented with 0.4% Glucose, 0.18 mg/ml glucose-oxidase, and 0.06 mg/ml catalase and image 
acquisition of the sealed chamber was performed at room temperature using a commercially built 
TIRF microscope (Leica AF6000 Modular Systems, Leica, Wetzlar, Germany) equipped with a HCX 
PL Apo 100X/1.47 TIRF objective. Images were acquired with an iXon Ultra X-9360 EMCCD camera 
(Andor, Belfast, U.K.) controlled by the Leica Application Suite Advanced Fluorescence. Acquired 
images were further processed using the ImageJ software. 
AB: 25 mM Imidazole pH 7.5, 25 mM KCl, 4 mM MgCl2, 1 mM EGTA, 10 mM DTT 
4.3.10.6 Single-molecule TIRF assay with tripartite complex on F-actin 
The tripartite MyoVa transport complex Rab27a/Mlph/MyoVa was reconstituted and labeled with 
Alexa Fluor 488 or 647 on the SNAP-tagged Rab27a subunit as described in section 4.3.7. 0.25 µM 
biotinylated G-actin and 4.75 µM G-actin were polymerized with 5 µM Atto488- or Atto647N-
phalloidin in AB for 90 to 120 minutes at room temperature and then stored on ice. Actin filaments 
were attached to the glass surface via biotin-streptavidin (see 4.3.10.5) and wash steps were carried 
out with AB supplemented with 1 mg/ml BSA. The glass surface was blocked with 8 mg/ml BSA in 
AB after incubation with actin filaments. Reconstituted tripartite complex diluted in AB 
supplemented with 0.4% Glucose, 0.18 mg/ml glucose-oxidase, 0.06 mg/ml catalase, 2 mM ATP, 
and 0.06 mg/ml bovine calmodulin (Calbiochem, San Diego, U. S. A.) was flowed into the chamber. 
Sealed chambers were imaged at room temperature using the TIRF microscope setup described 
before. Acquired images and movies were further processed using the ImageJ software. 
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4.3.10.7 Photobleaching assay 
All tripartite complexes used for single-molecule TIRF assays were also subjected to photobleaching 
assays to ensure that transport parameters were mainly obtained from single tripartite complexes 
and not oligomeric complexes. For this purpose, Rab27a/Mlph/MyoVa complexes were diluted in 
AB and unspecifically bound to the glass surface of a flow chamber. The time-lapse recordings were 
performed at 80% laser power and 200 ms exposure time. Spots for analysis were chosen for all 
constructs by intensity over mean intensity and the intensity values for a 3X3 pixel window were 
summarized. Observation of the spot intensities over time resulted in bleaching curves. Performing 
a gliding-t-value test with a corresponding threshold identified the bleaching steps (100). 
4.3.10.8 In vitro filament decoration assay with Mlph proteins and MTs 
Tubulin was prepared from porcine brain and polymerized as described previously (4.3.2.3 and 
4.3.2.4). Biotinylated BSA was flowed into a 10 µl flow chamber and incubated for three minutes. 
Glass surface was blocked with 8 mg/ml BSA in BRB80 buffer. Streptavidin was bound to 
biotinylated BSA for three minutes followed by a wash step with 8 mg/ml BSA in BRB80 buffer. 
Biotinylated and Atto488-labeled MTs were attached to the biotin-streptavidin layer and unbound 
filaments were washed out with 8 mg/ml BSA in BRB80 buffer. Alexa Fluor 647-labeled 
Rab27a/Mlph complexes diluted in BRB80 buffer were flowed into the flow chamber. Excess protein 
was removed by washing with BRB80 supplemented with 0.4% Glucose, 0.18 mg/ml glucose-
oxidase, and 0.06 mg/ml catalase. Sealed chambers were imaged at room temperature as described 
above (see 4.3.10.5). 
BRB80 buffer: 80 mM Pipes pH 6.9, 2 mM MgCl2, 1 mM EGTA, 5 mM DTT 
4.3.10.9 MT cosedimentation assay with Mlph proteins 
Tubulin was polymerized at 35 °C in BRB80 buffer supplemented with 1 mM GTP. 5 µM taxol was 
added after incubation for 30 minutes at 35 °C and polymerized MTs were kept at 35 °C overnight. 
MTs were centrifuged through a sucrose cushion (40% sucrose in BRB80) and resuspended in BRB80 
buffer supplemented with 5 µM taxol. Cosedimentation assays were carried out in BRB80 buffer 
with 2 µM MTs and 5 µM of the respective MmMlph protein. Reactions were mixed thoroughly and 
incubated at room temperature for 15 minutes. MT-Mlph mixes were carefully pipetted onto a 
sucrose cushion and centrifuged at 80 000 rpm for 15 minutes at 22 °C. Supernatant was gently 
removed and sucrose cushion was washed with BRB80. Sucrose cushion was taken off and pellet 
was washed twice with BRB80. Pellet was resuspended in BRB80 and samples of total reaction, 
supernatant, and pellet were prepared and analyzed with SDS-PAGE. 
BRB80 buffer: 80 mM Pipes pH 6.9, 2 mM MgCl2, 1 mM EGTA, 5 mM DTT 
4.3.10.10 In vitro filament decoration assay with Mlph proteins on networks built with F-actin 
and MTs 
Competition experiments with mixed networks (MTs and actin filaments) were performed with 
biotinylated, Atto488-labeled MTs and biotinylated, Atto565-labeled actin filaments. Surface-
attachment of filaments was performed via the biotin-streptavidin layer in BRB80 buffer (see 
4.3.10.8). Actin filaments were flowed into the prepared flow chamber first, followed by MTs. After 
removing unbound filaments with a wash step with 8 mg/ml BSA in BRB80 buffer, Alexa Fluor 647-
labeled, dephosphorylated or phosphorylated Rab27a/Mlph protein was infused into the flow 
chamber and image acquisition was performed as described above (see 4.3.10.5). 
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BRB80 buffer: 80 mM Pipes pH 6.9, 2 mM MgCl2, 1 mM EGTA, 5 mM DTT 
4.3.10.11 Single-molecule TIRF assay with tripartite complex on F-actin and MTs 
MTs and actin filaments were prepared as described previously. Briefly, Atto488-labeled MTs and 
Atto565-labeled actin filaments, both biotinylated, were employed in this experiment. MTs were 
first attached to the surface of a flow chamber, followed by actin filaments. Wash steps were 
performed using BRB80 buffer. After perfusing the actin filaments into the flow chamber, surface 
was blocked with 10 mg/ml BSA in AB. Alexa Fluor 647-labeled dephosphorylated or 
phosphorylated Rab27a/Mlph/MyoVa complex was diluted in AB supplemented with 0.4% Glucose, 
0.18 mg/ml glucose-oxidase, 0.06 mg/ml catalase, 2 mM ATP, and 0.06 mg/ml bovine calmodulin 
and flowed into the chamber. Time-lapse movies with a cycle time of 223 ms were acquired using 
the previously described TIRF microscope. To analyze the switching behavior of the MyoVa 
transport complex on mixed networks, only complexes in close proximity to a MT-actin intersection 
were taken into account. The number of complexes that switched filament at an intersection or 
passed the intersection without changing filament was manually counted. The percentage of 
switching complexes or passing complexes was calculated for dephosphorylated or phosphorylated 
Rab27a/Mlph/MyoVa complexes with and without Mlph’s ABD. 
BRB80 buffer: 80 mM Pipes pH 6.9, 2 mM MgCl2, 1 mM EGTA, 5 mM DTT 
AB: 25 mM Imidazole pH 7.5, 25 mM KCl, 4 mM MgCl2, 1 mM EGTA, 10 mM DTT 
4.3.10.12 Sequence alignment 
XlMyoVa sequence (JX494698.1) was aligned with MmMyoVa (NP_034994.2) and MmMyoVb 
(NP_963894.1) using ClustalX 2.1 (101). Following Mlph ABD sequences were aligned: MmMlph 
(NP_443748.2), HsMlph (NP_077006.1), FdMlph (XP_010624436.1), ClMlph (NP_001096689.2), 
OaMlph (NP_001139743.1), and XtMlph (NP_001120194.1). Alignment figures were prepared with 
the means of BioEdit Sequence Alignment Editor (102). 
4.3.10.13 Mass spectrometry (LC-MS/MS) analysis 
Wild type MmMlph was FLAG-affinity purified and dephosphorylated or phosphorylated while 
bound to FLAG-affinity resin. Purified protein was analyzed by the Mass Spectrometry Service of 
the Max Planck Institute of Biochemistry (Martinsried) using the following procedure: Protein 
samples were denatured adding 4 M guanidium hydrochloride solution (final concentration). The 
proteins were reduced and alkylated using 10 mM Tris(2-carboxyethyl)phosphine hydrochloride 
(TCEP) and 40 mM Chloroacetamide (CAA), respectively. Samples were then diluted to a final 
concentration of 0.4 M guanidium hydrochloride using 50 mM ammonium bicarbonate solution. 
These reduced and alkylated protein samples were digested overnight with trypsin (1 µg trypsin for 
50 µg protein). After overnight digestion, peptides were desalted using a C18 StageTip (103) and 
used for LC-MS/MS analysis. Peptides were loaded on a 15 cm long 75 µm inner diameter reversed 
phase C18 column packed with 1.9 µm beads via autosampler in the Thermo Easy LC 1000. The 
peptides were separated over a 120 minute linear gradient with 0.1% formic acid (buffer A) as the 
loading buffer and 0.1% formic acid and 80% acetonitrile as the eluting buffer (buffer B). Separated 
peptides were directly electrosprayed into Q Exactive HF benchtop Orbitrap mass spectrometer 
(104). The mass spectrometer was operated in data dependent mode, with up to top 15 precursors 
selected for fragmentation. The full scans were acquired at 120 000 resolution (m/z=200) with up 
to 3E6 charges accumulated in the C-trap and the HCD fragmentation spectra were recorded at 15 
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000 resolution with up to 1E5 charges of the precursor ions. The raw data were processed with 
MaxQuant computation platform (105) version 1.5.2.22 using the Andromeda (106) search engine. 
Precursor and fragment ions were searched with 4.5 and 20 ppm mass tolerance, respectively, with 
FDR set to 1% both at the protein and peptide level. Carbamidomethylation of cysteine was set as 
fixed modification and oxidation of methionine, protein N-terminal acetylation and 
phosphorylation on serine, threonine and tyrosine were used as variation modifications in the 
database search. 
4.4 Data analysis 
4.4.1 DIC microscopy: Melanosome tracking with Particle Tracker (ImageJ) 
Quantification of actin-based melanosome transport with granules from the aggregated or 
dispersed cell state was carried out with the data obtained from the in vitro melanosome motility 
experiments on F-actin. 
Melanosome transport events were defined as a sequence of one-directional, uninterrupted, linear 
displacement that lasted for 3 seconds and longer. The acquired image sequences were then 
analyzed by means of ImageJ software and the plugin ParticleTracker 2D/3D (107). For tracking, 
images were adjusted according to the manual and the following parameters were set prior running 
the program: Kernel radius 5 to 7 pixels (px); cutoff radius 1 to 3 px; percentile 0.1; maximum 
displacement 50 px; and link range 2 to 3 frames.  
Trajectories that met all of the criteria above were analyzed by converting the tracking-coordinates 
into travelled distances applying Pythagoras’ theorem. 
4.4.2 DIC microscopy: Velocity and run-length measurements 
For the biophysical characterization of melanosome transport under various conditions, the 
following parameters were determined: (i) run length (r) was defined as the total distance that was 
covered by an individual melanosome during one transport event on F-actin; and (ii) transport 
velocity (v) for a given melanosome was calculated from the total run length the melanosome of 
interest traveled in a given time. Single values for velocity and run length of individual transport 
events were plotted as a histogram. In the case of v, a single Gaussian was fitted to the data 
according to Equation 1. 
𝒚 = 𝒂 ∗ 𝐞𝐱𝐩[−(
𝒙−𝒙𝟎
𝒃)𝟐
] Equation 1 
 
Based on the obtained Gaussian fit curve for the obtained velocity histogram, the mean velocity 
was determined. As previously described (108), mean values for r were obtained from a single-
exponential fit to the histogram plots that derived from the respective measured single values. 
Kymographs of representative image-sequences from the performed in vitro motility assays on F-
actin were generated with the MultipleKymograph macro for ImageJ. 
4.4.3 Statistical analysis of motile melanosomes 
To determine the fraction of motile versus non-motile melanosomes, according to the criteria 
described above, all surface-adhered melanosomes recorded, were checked for potential 
displacements. Subsequently, based on the total number of surface-bound melanosomes, the 
fraction of moving melanosomes was calculated. The thereby obtained values from each isolation 
of the respective condition were averaged and SD, as well as SEM was calculated.Data plotting and 
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fitting, but also the statistical analysis was performed with IgorPro software (WaveMetrics Inc., 
Portland, U.S.A.). 
4.4.4 Analysis of time course phosphorylation assays 
Digital images of scanned phosphor storage screens were analyzed using ImageJ software. The 
mean gray value of each band representing an individual time point was measured using the 
polygonal selection tool with constant area. For background subtraction, the mean gray value of 
four different parts of the gel with identical area as for the time points were averaged and 
subtracted from mean gray values of time points. Obtained values were divided by 1X 106 and 
plotted against time with means of the Origin software. The resulting curve was fitted with a single-
exponential function. 
4.4.5 Analysis of the stoichiometry of Mlph ABD phosphorylation 
Digital images of scanned phosphor storage screens were analyzed using ImageJ software. The 
mean gray value of each band representing wild type or point mutated Mlph was measured using 
the polygonal selection tool with constant area. For background subtraction, the mean gray value 
of four different parts of the gel with identical area as for the Mlph proteins were averaged and 
subtracted from mean gray values of the different Mlph proteins. The acquired values were 
corrected for applied protein amounts determined with the corresponding Coomassie-stained SDS-
PAGE. The value obtained for wild type Mlph was set to 100% and values of different Mlph point 
mutants were compared to the wild type Mlph value. 
4.4.6 Quantification of filament decoration assays with Mlph proteins and F-actin 
For quantification of the Mlph-actin interaction, 400 nM of phosphatase-treated, Alexa Fluor 488-
labeled Rab27a/Mlph complex and PKA-treated, Alexa Fluor 647-labeled Rab27a/Mlph complex (or 
complexes with swapped fluorescent dyes) were perfused into the flow chamber with surface-
attached Atto565-labeled actin filaments. The color swap on the Rab27a/Mlph protein controlled 
for inherent intensity differences of the Alexa Fluor 647 and Alexa Fluor 488 fluorophores. 
Association of dephosphorylated or phosphorylated Mlph to actin filaments was evaluated using a 
co-localization analysis script implemented in MATLAB. The filament images were binarized using a 
common threshold algorithm (109). The available binding area of actin filaments was determined 
after crossing or overlapping sections of filaments were deleted from the binary images. The 
background in each Rab27a/Mlph image was calculated as the mean of the image without the actin 
area and subtracted from the images. A normalization parameter was introduced in order to 
account for differences in the imaging parameters for the two Rab27a/Mlph channels (488 and 647 
channel). The images were normalized ignoring a percentage of pixels that was given by the 
parameter. The value was chosen by a parameter space check for the value where both original 
experiment and color swap experiment resulted in the same (inverse) ratio of decoration. This ratio 
of bound Rab27a/Mlph was calculated from the intensity observed in the actin area for the 
phosphorylated channel, divided by the intensity in the dephosphorylated channel. Data from 30 
images for the combination of dephosphorylated Alexa Fluor 488- and phosphorylated Alexa Fluor 
647-Rab27a/Mlph complexes and 44 images for the combination of phosphorylated Alexa Fluor 
488- and dephosphorylated Alexa Fluor 647-Rab27a/Mlph complexes were analyzed. Errors are 
given as SD between ratios for the single images analyzed for each experiment. 
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4.4.7 Data analysis of single-molecule TIRF assays with tripartite complex on F-actin 
Movies were recorded at a cycle time of 238 ms and analyzed using a custom routine implemented 
in the MATLAB development environment. Spots were selected automatically according to their 
brightness compared to the mean brightness in each frame. The position of the spots was 
determined with sub-pixel accuracy using a radial center approach. A list of spots for each frame 
was generated and the distances of spots between each subsequent frame was compared. The 
connection of each spot to the closest one in the next frame (with a cutoff maximal distance) 
resulted in tracking traces for each spot. The distance to the first position of each spot over time 
was fitted with a linear model. Smooth runs that resulted in a linear fit with a r2-value higher than 
97% and had a length of at least 10 frames were chosen for speed and run length measurements. 
For run length measurements an additional threshold of 1 µm was applied. The speed was 
calculated from the slope of the performed fit and the run length was calculated from the maximal 
distance of the spot from its original position. Missing run lengths were accounted for in the 
histogram fit by truncating the single exponential model. 
4.4.8 Analysis of MT cosedimentation assays with Mlph proteins 
Digital images of total, supernatant, and pellet of each reaction on Coomassie-stained SDS gels were 
analyzed with ImageJ and MATLAB, respectively. In order to calculate the relative degrees of MT-
bound protein fraction, a semi-automatic routine was implemented using MATLAB. The area 
containing the peak of interest was chosen manually from an intensity lane profile of the gel created 
with ImageJ. Binning the intensity for a histogram and using the upper limit of the heaviest 
populated bin as a threshold, the peak data was separated from the baseline. To account for a linear 
variation of the base line, a straight line was fitted to the separated baseline data. The peak area 
was calculated integrating the intensity data between the first interceptions of this line with the 
profile data before and after the peak. Resulting area values were used and percentages of MT-
bound protein to total protein were calculated. The relative degree of MT-bound MmMlph ΔABD 
fraction was not determinable because of the close proximity of protein and tubulin peaks. 
4.4.9 Quantification of filament decoration assays with Mlph proteins and MTs and F-actin 
Competitive Mlph binding to MTs and actin filaments was evaluated using a co-localization analysis 
script implemented in MATLAB as described in 4.4.6 (page 57). The available binding area for each 
filament type was determined as detailed previously. The channel for Mlph-associated fluorescence 
was also thresholded in order to avoid influence of the background intensity on the data. The sum 
of Mlph-associated intensity in the area of filaments detected before was normalized to the total 
binding area of this filament type, yielding a binding parameter B_filament. The binding proportion 
for each filament was then calculated as B_filament1/(B_filament1 + B_filament2). Data from 17 
images for the dephosphorylated Rab27a/Mlph complex and 29 images for the phosphorylated 
Rab27a/Mlph complex were analyzed. The ratio of the binding area (actin : MTs) for the 
competition experiments with the dephosphorylated Rab27a/Mlph complex was 4.87 ± 1.58. The 
ratio of the binding area (actin : MTs) for the competition experiments with the phosphorylated 
Rab27a/Mlph complex was 2.78 ± 1.46. Error bars were calculated from the SD occurring when 
averaging over data from all images. 
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5. Results 
5.1 PKA directly regulates the MyoVa-mediated melanosome transport on F-actin in vitro 
To date, the MyoVa-dependent transport has been reconstituted on actin cables from 
Nitella with melanosomes that were purified from uninduced melanophores (15) and with 
melanosomes purified from mouse melanocytes on bundled F-actin (110). Xenopus laevis 
melanosomes displayed an atypically slow velocity of 0.036 µm s-1, whereas melanosomes 
derived from mouse cells moved between 0.1 and 0.3 µm s-1. Given the in vitro velocities 
of purified MyoVa motors were reported to be around 0.3 µm s-1 (36), the slow velocity 
displayed by melanosomes from Xenopus laevis is surprising. 
The cloning of the full length MyoVa motor involved in melanosome transport 
demonstrated that this motor is indeed capable of supporting movement at 0.13 µm s-1 in 
vitro (90). Is the atypically slow MyoVa-dependent movement of melanosomes from 
Xenopus laevis a result of regulation of the MyoVa on the melanosome surface? If so, do 
melanosomes isolated from dispersed and aggregated cell states behave differently in 
vitro? And lastly, does PKA directly affect the reconstituted melanosome transport in vitro? 
I sought answers to these questions by reconstituting the MyoVa-dependent transport of 
melanosomes isolated from the distinct cell states on F-actin. 
5.1.1 Reconstitution of melanosome motility on F-actin in vitro 
I achieved to isolate functional pigment granules and reconstitute the transport process on 
surface-adhered F-actin in vitro. To this end, I made use of the previously described 
melanosome purification method by Gelfand and coworkers (12) and optimized it for 
motility assays on F-actin. The isolated pigment granules were flowed in flow chambers 
with previously surface-attached F-actin and motility was acquired using a DIC microscope 
(Figure 8). All motility assays were performed using the DIC microscope with which 
fluorescent actin was observable by eye only, but that was not equipped to record 
corresponding fluorescent images. 
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To ensure that observed motility was a melanosome moving on an actin filament, a 
representative motility assay was additionally performed with a fluorescence microscope 
and Atto488-labeled actin filaments (Figure 9). These fluorescent images were merged with 
the corresponding phase-contrast images to visualize that the moving pigment organelle 
indeed used F-actin as a track. Figure 9 clearly illustrates that the movement occurs on the 
filament, but also that melanosomes appear as blurry black dots in bright field or phase-
contrast microscopy. Hence, phase-contrast microscopy is unsuitable for imaging motility 
of melanosomes and DIC microscopy was employed for high quality acquisition of moving 
melanosomes. 
 
Figure 9: In vitro reconstitution of MyoVa-mediated melanosome transport on fluorescently 
labeled F-actin. (A) Phase contrast images of a moving melanosome derived from the dispersed 
state merged with corresponding fluorescent images of surface-attached F-actin labeled with 
Atto488-phalloidin. The black arrowhead depicts the position of the moving melanosome. The 
white arrowhead indicates the starting point of the trajectory. (B) The trajectory of the melanosome 
(white line) follows the path of the curved actin filament. Scale bar: 2 µm. 
Figure 8: Trajectory of a melanosome from a dispersed cell moving 
on surface-adhered F-actin in vitro. (A) Selected DIC images taken at 
10 s intervals. Scale bar: 2 µm. (B) Corresponding trajectory visualized 
using Particle Tracker 2D/3D. Scale bar: 1 µm. (C) Corresponding 
kymograph of sequential frames depicting the trajectory of a 
unidirectionally moving melanosome on F-actin in vitro. 
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The first obvious step to gain insights into the regulation of MyoVa-dependent transport 
was to isolate melanosomes from the two different cell states and compare the observed 
motility. The hormone α-MSH was used to fully disperse the melanosomes within the 
melanophores prior to cell lysis and granule isolation. These melanosomes are referred to 
as dispersed melanosomes. Aggregation was induced by addition of melatonin to the 
melanophore medium. After completion of the aggregation process, melanosomes were 
purified and are called aggregated melanosomes. 
Isolated melanosomes from dispersed and aggregated cells both exhibited unidirectional 
transport on surface-attached F-actin in vitro. The large number of moving melanosomes 
allowed a statistical analysis of the biophysical parameters of reconstituted melanosome 
transport (Figure 10, Video 1). 
 
Figure 10: Purified melanosomes display consistent kinetic transport parameters in vitro. Motile 
(A) or dormant melanosomes (B) were purified from the dispersed (dark blue) and aggregated cell 
states (orange), respectively. Velocities (v) and run lengths (r) are mean values ± SD deduced from 
the Gaussian (velocities) and single-exponential (run lengths) fit curves (solid lines) to the histogram 
data, except for (B) for which the mean velocity was calculated. 
Table IV: Biophysical parameters of melanosome transport in vitro. Melanosomes were purified 
from the distinct cell states (i.e. active melanosomes from dispersed cells, inactive melanosomes 
from aggregated cells, respectively). Mean values ± SD were obtained as described in Figure 10. 
 
Velocity [µm/s] 
± S.D. 
Run length [µm] 
± S.D. 
Analyzed 
runs 
Independent 
isolations 
Disp. 0.19 ± 0.07 1.5 ± 0.1 137 2 
Aggr. 0.22 ± 0.1 1.6 ± 0.1 90 9 
 
The biophysical parameters of melanosome transport from the distinct cell states do not 
show considerable differences between the dispersed and aggregated cell states. 
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Importantly, the observed velocities of melanosomes closely match the in vitro velocities 
of purified MyoVa from Xenopus laevis (90) and therefore validate my reconstitution assays 
with purified melanosomes. 
Furthermore, the here obtained run lengths for melanosomes from dispersed and 
aggregated cell states agree well with the previously published run length for single MyoVa 
molecules from chicken (85). 
5.1.2 Regulation of melanosome transport during dispersion and aggregation 
To quantify the efficiency of initiated transport events by melanosomes derived from 
dispersed and aggregated cell states, only unidirectional melanosome movements that 
lasted three seconds or longer, covering a distance greater than 0.5 µm were taken into 
account for later analysis. Due to the sticky surface of isolated melanosomes, numerous 
melanosomes bound unspecifically to the glass surface. To compare the motility of 
melanosomes isolated from the distinct cell states, idle and motile melanosomes were 
counted and the percentage of transport events for each condition was calculated. The 
percentage of transport events was used as a standard to compare melanosome motility 
from different cell states. 
Acquisition of over 1,300 melanosomes purified from dispersed melanophores yielded in 
an average motile fraction of 18.3% (Figure 11, Table V, Video 1). In contrast, over 2,000 
melanosomes isolated from the aggregated cell state displayed an average percentage of 
transport events of 4.8% (Figure 11, Table V). 
 
 
Figure 11: Cell state-dependent in vitro 
reconstitution of melanosome transport on F-
actin. Melanosomes purified from the 
aggregated cell state (Aggr.; orange) display a 
pronounced decrease in MyoVa-dependent 
transport events compared to melanosomes 
purified from the dispersed cell state (Disp.; 
dark blue). Addition of cytoplasmic extract 
from dispersed cells (CEDisp.; yellow), but not 
from aggregated cells (CEAggr.; light blue), 
reactivates dormant melanosomes purified 
from aggregated cells. Melanosomes derived 
from the dispersed cell state are rendered 
dormant by addition of cytoplasmic extract 
from aggregated cells (red). Error bars show 
the SEM. 
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These results show that MyoVa is more active during dispersion and in a rather idle state 
while melanosomes aggregate. Furthermore, the difference in transport events from 
dispersed and aggregated melanophores clearly demonstrates that this experimental setup 
enables the observation of regulated melanosome transport in vitro. 
The observed differences in MyoVa-dependent transport between dispersion and 
aggregation raise the question what factor accounts for this effect. Is this activating factor 
present in the cytoplasm of dispersed cells? To test this hypothesis, melanosomes from 
aggregated cells were incubated with cytoplasmic extract from dispersed melanophores 
and vice versa (i.e. supernatant after second centrifugation step of purification, for details 
see section 4.3.3, page 46). Strikingly, melanosomes from the aggregated cell state that 
were incubated with dispersed cytoplasmic extract exhibited a significantly increased 
number of transport events of 21.5% (Figure 11, yellow bar, Table V, Video 2). In contrast, 
incubation of dispersed melanosomes with aggregated cytoplasmic extract reduced the 
mean transport events from 18.3% to 7.9% (Figure 11, red bar, Table V). Aggregated 
melanosomes were incubated with aggregated cytoplasmic extract to exclude any effects 
by the centrifugation and incubation procedure. As expected, the number of transport 
events remained unchanged at 5% (Figure 11, Table V).  
Table V: Transport events from the dispersed and aggregated cell state incubated with aggregated 
or dispersed cytoplasmic extract. Transport event numbers represent the average of all isolations 
under identical conditions ± SD. 
 
Transport events 
± S.D. 
Independent 
isolations 
Number of moving 
melanosomes 
Total 
melanosomes 
Disp. 18.3 ± 7.2% 11 257 1385 
Aggr. 4.8 ± 1.5% 11 97 2023 
Disp. + aggr. CE 7.9 ± 0.7% 3 24 292 
Aggr. + aggr. CE 5.0 ± 4.2% 3 14 321 
Aggr. + disp. CE 21.5 ± 10.7% 8 140 775 
 
Thus cytoplasm from dispersed melanophores can reactivate dormant melanosomes 
derived from aggregated melanophores. The activating and inactivating factor(s) is/are 
indeed present in the cytoplasm. 
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5.1.3 PKA directly regulates MyoVa-driven melanosome transport in vitro 
It is long known that cAMP and PKA play important roles in signal transduction for 
melanosome dispersion in Xenopus laevis melanophores, as well as in other pigment cells 
(9, 11, 52, 57, 81). With my experimental setup I was able to directly test whether PKA 
accounts for the increased activity of melanosomes from the dispersed cell sate. To this 
end, I made use of the constitutively active PKA and its specific inhibitor H-89 (111-113). 
Incubation of aggregated melanosomes with dispersed cytoplasmic extract that was 
supplemented with the PKA-specific inhibitor H-89 markedly suppressed the reactivation 
of the dormant melanosomes (Figure 12, yellow vs. green bar; Table VI). 
  
Table VI: Reactivation and reinhibition of melanosomes purified from the aggregated cell state 
using exogenous PKA and its inhibitor, respectively. Transport event numbers represent the 
average of all isolations under identical conditions ± SD. 
 
Transport 
events ± SD 
Independent 
isolations 
Number of moving 
melanosomes 
Total 
 melanosomes 
Aggr. + PKA 12.3 ± 3.8% 6 109 949 
Aggr. + PKA + H-89 3.0 ± 1.5% 3 16 595 
Aggr. + disp. CE + H-89 7.2 ± 1.1% 3 52 714 
 
These results indicate the involvement of PKA in regulation of actin-based melanosome 
transport. To test whether PKA directly regulates melanosome transport, I isolated 
melanosomes from the aggregated cell state in the presence of commercially available, 
exogenous, and constitutively active PKA (catalytic subunit from bovine heart). In fact, I 
observed a significant increase in transport events from 5% (aggregated state, Figure 12, 
Figure 12: PKA reactivates dormant 
melanosomes in vitro. The reactivation of 
melanosomes from the aggregated cell state 
with dispersed cytoplasmic extract (yellow, 
replotted from Figure 11) was prevented by 
the PKA-specific inhibitor H-89 (green). 
Dormant melanosomes derived from the 
aggregated cell state (orange, replotted from 
Figure 11) were noticeably reactivated by 
purified PKA (magenta). PKA-dependent 
reactivation can be fully prevented by H-89 
(purple). Error bars show the SEM. 
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orange bar) to 12.3% in the presence of PKA (Figure 12, magenta bar; Table VI, Video 3). 
The commercially available PKA-specific inhibitor H-89 reversed this effect by PKA (Figure 
12, purple bar; Table VI).  
Taken together, I observed that the frequency of MyoVa-mediated transport events was 
higher with melanosomes from dispersed cells than with melanosomes from aggregated 
cells, pointing to a stronger involvement of MyoVa-transport in the dispersion process than 
in the aggregation process. Even more importantly, I showed that PKA is directly involved 
in regulation of MyoVa activity between more active during dispersion and lower activity 
during aggregation and this regulation occurs directly on the melanosome surface. 
In contrast, the biophysical parameters of reactivated melanosome transport with 
dispersed cytoplasmic extract and exogenous PKA were again very similar (Figure 13, Table 
VII), suggesting that the transport properties of the motor do not alter between the 
respective cell states. 
 
Figure 13: Reactivated melanosome transport exhibits similar kinetic transport parameters in 
vitro as active transport. Dormant melanosomes from aggregated cell states were purified and 
incubated with dispersed cytoplasmic extract (A, yellow) or constitutively active PKA (B, magenta), 
respectively. Velocities (v) and run lengths (r) are mean values ± SD deduced from the Gaussian 
(velocities) and single-exponential (run lengths) fit curves (solid lines) to the histogram data. 
Table VII: Biophysical parameters of reactivated melanosome transport in vitro. Melanosomes 
were purified from the aggregated cell state and incubated with dispersed cytoplasmic extract or 
constitutively active PKA, respectively. Mean values ± SD were obtained as described in Figure 13. 
 
Velocity [µm/s]  
± S.D. 
Run length [µm]  
± S.D. 
Analyzed 
runs 
Independent 
isolations 
Aggr. + disp. CE 0.16 ± 0.04 1.4 ± 0.3 101 6 
Aggr. + PKA 0.16 ± 0.04 1.2 ± 0.2 116 5 
 
Results   66 
 
 
5.2 The tripartite MyoVa receptor complex is present on purified melanosomes from 
Xenopus laevis 
The organelle receptor complex for MyoVa in mouse melanocytes has been identified more 
than 10 years ago (39-44, 114-117). The membrane-bound small GTPase Rab27a recruits 
Mlph in a GTP-dependent manner that in turns binds MyoVa. For Xenopus laevis 
melanosomes it is not known yet whether MyoVa is bound to the organelle in a similar way. 
To show that a similar complex is formed also on the melanosomes from Xenopus, I 
performed immunoblots with purified melanosomes and commercially available 
antibodies against Rab27a, Mlph, and MyoVa. Figure 14 A depicts the presence of the 
entire MyoVa tripartite transport complex, as identified in mouse melanocytes, on Xenopus 
laevis melanosomes. Further, the catalytic subunit of PKA is bound to melanosomes (Figure 
14 A), which directly regulates MyoVa-driven melanosome transport on actin in vitro 
(Figure 12). PKA was previously shown to be present on melanosomes and form complexes 
with motor proteins on Xenopus melanosomes (51, 52).  
 
Figure 14: Rab27a, Mlph, MyoVa, and the catalytic subunit β (cat. SU β) of PKA are present on 
purified melanosomes. (A) Immunoblots of a purified melanosome fraction demonstrate that 
Rab27a, Mlph, and MyoVa presumably build the tripartite complex in Xenopus as well and 
compounds stay attached during isolation procedure. Furthermore, PKA, which orchestrates actin-
based transport, is bound to melanosomes. (B) Glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) is detected in the cytoplasmic extract (CE), but not in the purified melanosome fraction 
(M). The absence of the housekeeping protein GAPDH from melanosome fraction demonstrates 
that cytosolic components are separated from melanosomes and melanosomes do not contain 
cytoplasmic contaminations. 
To test for cytosolic contaminations, melanosomes were blotted with an antibody against 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH), which is stably and constitutively 
expressed at high levels in the cytosol. GAPDH is detected in the cytoplasmic extract (i.e. 
melanophore cytoplasm), but not in purified melanosomes, indicating that cytosolic 
components are well separated from melanosomes during the purification procedure. 
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Collectively, these results indicate for the first time that in Xenopus laevis – as shown 
previously in mouse melanocytes – MyoVa is recruited to the melanosome via Rab27a and 
Mlph. 
5.3 Building the tripartite MyoVa receptor complex in vitro 
The here presented reconstitution of the MyoVa-based transport of Xenopus laevis 
melanosomes revealed that PKA directly regulates MyoVa-driven transport. So far, it is 
known that PKA orchestrates the direction of melanosome transport (57), but the 
molecular mechanism is entirely ambiguous and the downstream target(s) of PKA remain 
unidentified. As PKA directly affects transport driven by MyoVa, one possibility could be 
that MyoVa or one of the adaptor proteins (Rab27a or Mlph) is phosphorylated by PKA. To 
examine whether a member of the MyoVa receptor complex is a direct target of PKA, I 
recombinantly expressed the three proteins from Xenopus – Rab27a, Mlph, and MyoVa – 
to investigate them in vitro. Additionally, I also expressed Rab27a, Mlph, and MyoVa from 
Mus musculus to additionally check possible (PKA) phosphorylation in a distantly related 
species. Figure 15 A depicts the tripartite MyoVa receptor complex and its melanosome 
association. Domain structures of Rab27a, Mlph, and MyoVa are illustrated in Figure 15 B. 
 
Figure 15: Schematic illustration of the MyoVa receptor complex on melanosomes in mouse 
melanocytes. (A) MyoVa is attached to the melanosome via the adaptor protein Mlph, which in 
turn binds to the membrane-bound Rab27a. (B) Schematic diagram of protein domain structures of 
Rab27a, Mlph, and MyoVa. The small GTPase Rab27a, which consists of 221 aa (27 kDa), resides in 
the melanosome membrane and binds to Mlph via its N-terminal effector binding domain (Mlph-
BD). The 66 kDa large Mlph contains an N-terminal Rab27a-binding domain (Rab27a-BD), followed 
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by a MyoVa-binding domain (MyoVa-BD). The C-terminal part of Mlph (actin-binding domain: ABD) 
interacts with actin filaments and EB1 (48-50) but also with MTs as demonstrated in this work. 
MyoVa is a large 216 kDa protein that homodimerizes to build the double-headed actin-based 
motor protein. It consists of a head domain that binds to actin and hydrolyzes ATP, a neck domain 
with six IQ motifs, a proximal tail domain that forms coiled-coils for dimerization, and the C-terminal 
distal tail domain that forms the globular tail domain and is thought to mediate cargo binding. Exon 
F, which is essential for Mlph binding, is located in the distal tail domain. 
Previous work on mouse melanocytes and mouse proteins has uncovered detailed 
information about the protein interactions within the MyoVa receptor complex (43, 45, 46, 
49, 118, 119). It has been shown that Mlph binds to Rab27a’s N-terminal effector binding 
domain in a GTP-dependent manner. The Mlph-MyoVa interaction occurs between Mlph’s 
MyoVa-binding domain and the globular tail domain of MyoVa at its C-terminus. This 
interaction is dependent on exon F, a short sequence specific for the melanocyte isoform 
of MyoVa (47), which is located in the globular tail domain of MyoVa. Until now, molecular 
details of the MyoVa receptor complex in amphibians await clarification. 
5.3.1 Generation of constructs 
For individual expression and subsequent coexpression and assembly of the entire 
tripartite complex, as well as for in vitro experiments, all three subunits were expressed 
using the baculovirus system. Differently tagged constructs used in this study were either 
generated by PCR (for details see section 4.2.1.1; overview of Xenopus constructs is shown 
in Figure 16) or commercially synthesized (for details see section 4.2.1.8). All constructs 
were cloned into the baculovirus-compatible transfer vector plasmid pFastBacTM1 
downstream of the Polyhedrin promoter (PPH) via restriction enzyme-mediated cloning. 
An overview of generated constructs from Xenopus is presented in Figure 16. XlRab27a was 
used with a C-terminal FLAG-tag for purification. Furthermore, a GDP-mimic (XlRab27a-
T23N) and a GTP-mimic (XlRab27a-Q78L) of Rab27a (46) with a FLAG-tag at the C-terminus 
were employed in this study. For the purpose of assembling the tripartite complex, a C-
terminally SNAP- and 6XHis-tagged GTP-mimic Rab27a was generated. 
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Figure 16: Overview of generated constructs from Xenopus laevis/tropicalis employed in this 
study. (A) Rab27a from Xenopus laevis was C-terminally tagged with FLAG, or SNAP-6XHis. The point 
mutated Rab27a-Q78L or Rab27a-T23N constructs were used as GTP- or GDP-bound mimic, 
respectively. (B) Mlph was used untagged or N-terminally FLAG-tagged. C-terminally truncated 
Mlph constructs containing amino acids 1-388 (Mlph ΔABD) or 1-438 were generated via PCR and 
FLAG-tagged at the N-terminus. (C) Full length MyoVa was used untagged or N-terminally FLAG-
tagged. The C-terminally truncated construct MyoVa HMM (residues 1-1237), the N-terminally 
truncated constructs MyoVa C-tail (residues 1110-1852) and MyoVa GTD (residues 1445-1852) with 
a N-terminal GCN4 leucine zipper for dimerization were employed in this thesis. 
Untagged and N-terminally FLAG-tagged wild type XtMlph constructs were obtained by PCR 
with custom-made primers (for details see section 3.7.1 and 4.2.1). N-terminally FLAG-
tagged XtMlph constructs lacking the C-terminal ABD (XtMlph ΔABD (1-388) and XtMlph 1-
438) were generated by PCR with custom-made primers. XlMyoVa was used with a N-
terminal FLAG-tag. Drosophila melanogaster calmodulin was always coexpressed with 
XlMyoVa to ensure motor functionality. The N-terminally FLAG-tagged truncation 
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constructs XlMyoVa HMM (aa 1-1237) and XlMyoVa C-tail (aa 1110-1852) were generated 
by PCR with custom-made primers. N-terminally FLAG-tagged XlMyoVa GTD (aa 1445-1852) 
that only contains the globular tail domain of MyoVa without exon F was fused to the 
molecular zipper GCN4 to ensure dimerization and commercially synthesized. 
MmRab27a and MmRab27a-Q78L with a C-terminal SNAP tag followed by a 6XHis-tag, wild 
type MmMlph with a N-terminal FLAG-tag, MmMyoVa with an N-terminal FLAG-tag, and 
untagged Mus musculus calmodulin were commercially synthesized and used for 
respective experiments. The C-terminally truncated MmMlph constructs MmMlph ΔABD 
(1-400) and MmMlph 1-440 with an N-terminal FLAG-tag were obtained by performing PCR 
with custom-made primers. The C-terminally truncated construct MmMyoVa HMM (aa 1-
1109) was generated by PCR. As Xenopus and mouse Rab27a, Mlph, and MyoVa share the 
same domain organization and exhibit only minor differences in residues number please 
refer to Figure 16 as a construct overview. 
5.3.2 Purification of XlRab27a, XtMlph, and XlMyoVa 
All proteins were expressed in Sf9 cells and purified as described in section 4.3.5. XlRab27a-
Q78LS-H was further purified with ion exchange chromatography (see section 4.3.9.1). 
Eluted proteins are depicted in Figure 17. Immediately after purification, purified proteins 
were aliquoted, flash-frozen in liquid nitrogen, and stored at -80° C. For experiments, 
protein aliquots were quickly thawed, kept on ice and used within a few hours. 
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Under our laboratory conditions, XtMlph 1-583F appeared at a higher molecular weight as 
the theoretically calculated molecular weight, as noticed before for mammalian Mlph by 
others (117, 118, 120). 
5.3.3 Purification of MmRab27a, MmMlph, and MmMyoVa 
Proteins from Mus musculus were essentially purified as described for Xenopus laevis 
proteins (section 5.3.2) and representative purifications are presented in Figure 18. The 
discrepancy between the theoretical molecular weight of all Mlph constructs from mouse 
and the molecular weight apparent from SDS-PAGE was pronounced. 
Figure 17: 6XHis- and FLAG-tag affinity purified XlRab27a, XtMlph, and 
XlMyoVa constructs. (A) FLAG-affinity purified wild type Rab27a (XlRab27a-
WtF), GTP-bound mimic XlRab27a-Q78LF, GDP-bound mimic XlRab27a-T23NF 
were applied on lanes from left to right. (B) C-terminally SNAP-6XHis-tagged 
XlRab27a GTP-mimic (XlRab27a-Q78LS-H) was purified via 6XHis-affinity 
purification followed by ion exchange chromatography. (C) Wild type XtMlph 
(XtMlph 1-582F) and the two ABD deletion constructs (XtMlph 1-438F and 
XtMlph ΔABDF) were purified via FLAG-tag. (D) Full length XlMyoVaF, XlMyoVa 
HMMF lacking the tail domain, and XlMyoVa C-tailF, which only consists of the 
tail domain, were purified via FLAG-affinity purification. Irrespectively of the 
XlMyoVa construct expressed, a contaminating band at about 100 kDa was 
present in the purification, which was identified as N-terminal degradation 
product of XlMyoVa by LC-MS/MS for full length XlMyoVa. (E) Purified 
XlMyoVa GTD containing the globular tail domain without exon F and N-
terminally fused GCN4 zipper for dimerization. Images show 10% SDS-PAGE 
gels. Approximate molecular weights of the constructs are indicated on the 
right side of each gel image. 
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Figure 18: 6XHis- and FLAG-tag affinity purified Rab27a, Mlph, and MyoVa from Mus musculus. 
(A) MmRab27aS-H was purified via 6XHis-tag followed by ion exchange chromatography. (B) Wild 
type MmMlph (MmMlph 1-590F) and the two ABD deletion mutants (MmMlph 1-440F and MmMlph 
ΔABDF) were purified via FLAG-tag affinity purification. (C) Full length MmMyoVaF and the construct 
lacking the tail domain MmMyoVa HMMF were purified via the N-terminal FLAG-tag. Images show 
10% SDS-PAGE gels. Approximate molecular weights of the constructs are indicated on the right 
side of each gel image. 
MmMyoVa is purified in very high quantities compared to MyoVa from Xenopus laevis. 
5.3.4 Recombinantly expressed XlMyoVa forms a dimeric motor 
I used the full length MyoVa from Xenopus laevis that was previously cloned and 
characterized by Dennis Zimmermann (90). 
 
Figure 19: Recombinantly expressed full length XlMyoVa forms a dimeric motor. (A) Predicted 
domain organization of XlMyoVa. The N-terminal catalytic head domain containing the ATP- and 
actin-binding sites is followed by six IQ motifs. The stalk is composed of a predicted coiled-coil 
region, whereas the C-terminus forms the globular tail domain that mediates cargo binding. (B) 
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Negative-staining transmission electron micrographs of XlMyoVa motor proteins revealed the 
typical appearance of a motor protein with two motor heads and a stalk domain that appears as a 
slender rod (n=394). (C) Negative-staining electron micrographs of the dimeric MmMyoVa motor 
are shown for comparison (n=804). Scale bar: 50 nm. 
As XlMyoVa is expressed in small quantities and object to protein degradation, it was not 
possible to employ size exclusion chromatography to confirm homodimerization of 
XlMyoVa. Therefore, negative-staining transmission electron microscopy in cooperation 
with Evi Meier and Hendrik Dietz (Technische Universität München, Munich, Germany) was 
chosen to examine whether MyoVa from Xenopus laevis assembles into a dimeric motor. 
Figure 19 B clearly demonstrates the formation of XlMyoVa homodimers that closely 
resemble the appearance of the well characterized homodimeric motor protein MmMyoVa 
(Figure 19 C). 
5.3.5 XtMlph binds to XlRab27a in a GTP-dependent manner 
The adaptor protein Mlph that links MyoVa to Rab27a was the last member of the MyoVa 
receptor complex to be discovered in the mouse system 2002 (40-44, 49, 115). To date, the 
Mlph sequence is only known for Xenopus tropicalis (NCBI Reference Sequence: 
NP_001120194.1), a close relative to Xenopus laevis. As sequence information on XlMlph 
is not yet available, I worked with Mlph from Xenopus tropicalis. 
The first step toward building the tripartite complex was to establish the binding between 
Rab27a and Mlph. After successful single expressions of both proteins (Figure 17 A and C), 
the Rab27a/Mlph protein complex could be obtained by simply coexpressing FLAG-tagged 
wild type Rab27a and untagged Mlph in Sf9 cells and subsequent FLAG-tag affinity 
purification (Figure 20, lane I). Coimmunoprecipitations with GTP- and GDP-mimicking 
point mutants of XlRab27a (XlRab27a-Q78LF and XlRab27a-T23NF) and untagged XtMlph 
revealed the GTP-dependence of this interaction (Figure 20, lane II and III). 
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Figure 20: GTP-dependent binding of XtMlph to XlRab27a. Untagged, wild type XtMlph 
coprecipitates with FLAG-tagged wild type XlRab27aF (I) and with a constitutively active Rab27a 
mutant (XlRab27a-Q78LF; III), but not with the mutant mimicking the GDP-bound state (XlRab27a-
T23NF; II). Lanes IV and V show FLAG-tag purified XlRab27aF and XtMlphF proteins, respectively, for 
comparison. To control for unspecific binding to the FLAG affinity resin, untagged XtMlph was 
expressed and subjected to FLAG-tag affinity purification as above (VI). M: molecular weight 
marker. 
XlRab27a and XtMlph are able to interact in vitro and this interaction is exclusively GTP-
dependent, similar to results obtained in Mus musculus (11, 42, 45, 121). Thus XlRab27a 
and XtMlph can be used for building the tripartite complex in vitro. 
5.3.6 Reconstitution of the tripartite MyoVa receptor complex in vitro 
Until today, no direct biochemical data (i.e. SDS-PAGE) has been published showing the 
reconstituted tripartite complex, consisting of Rab27a, Mlph, and MyoVa subunits. 
As the most straightforward way of assembling the entire tripartite MyoVa receptor 
complex, I coexpressed the three subunits Rab27a, Mlph, and MyoVa that were differently 
tagged or untagged, respectively. Subsequent FLAG-tag affinity purification only yielded in 
Rab27a and Mlph for the Xenopus proteins and Mlph and MyoVa for the proteins from 
mouse. 
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Figure 21: Coexpression of all three members of the tripartite complex from Xenopus and mouse 
only yields in expression of two subunits. (A) Coexpression of XlRab27aF, XtMlphF, and XlMyoVaF 
that were all equipped with a FLAG-tag and subsequent FLAG-affinity purification resulted in the 
purification of only XlRab27a and XtMlph. (B) SNAP- and 6XHis-tagged MmRab27aS-H was 
coexpressed with FLAG-tagged MmMlphF and MmMyoVaF and FLAG-affinity purified. Only 
MmMlph and MmMyoVa were present in the elution. 
Even coexpression of all three subunits with a FLAG-tag underscored the result that 
XlMyoVa was not coexpressed together with XlRab27a and XtMlph (Figure 21 A). 
MmRab27a is not expressed when it was coexpressed with MmMyoVa (Figure 21 B). Next, 
I attempted to purify the Rab27a/Mlph complex and subsequently add separately purified 
MyoVa like Wu et al. who successfully formed the tripartite complex in vitro (115) by mixing 
preassembled Rab27a/Mlph complex with separately purified MyoVa. They observed 
movement of the fluorescently labeled Rab27a subunit on actin filaments indicating the 
presence of both Mlph and MyoVa. It turned out to work best when 6XHis-tagged Rab27a 
and FLAG-tagged Mlph were coexpressed and tandem purified via Ni-NTA-affinity 
purification followed by FLAG-tag affinity purification (Figure 22, lane I). This preformed 
complex was reattached to Ni-NTA beads and separately FLAG-tag affinity purified MyoVa 
(Figure 22, lane II) was incubated with Rab27a/Mlph-covered beads. This way it was 
possible to elute the entire MyoVa receptor complex and analyze it with SDS-PAGE (Figure 
22, lane III). Mlph and MyoVa are present in substoichiometric amounts compared to 
Rab27a. 
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Figure 22: Reconstitution of the tripartite complex from recombinantly expressed full length 
XlRab27a, XtMlph, and XlMyoVa proteins. (I) Tandem purification of SNAP-6XHis-tagged 
XlRab27aS-H and FLAG-tagged XtMlphF complex via Ni-NTA and FLAG affinity resin. (II) FLAG affinity 
purified full length XlMyoVaF. A lower molecular weight band (arrow) corresponds to an N-terminal 
degradation product of XlMyoVa as assessed by LC-MS/MS. (III) A tripartite complex, reconstituted 
from a preformed XlRab27aS-H/XtMlphF complex and XlMyoVaF, could be purified by Ni-NTA affinity 
purification. Note that the N-terminal degradation product of XlMyoVaF seen in lane II (arrow) did 
not corporate into the complex. 
To my knowledge, this is the first direct evidence that a tripartite MyoVa transport complex 
is also formed in amphibians and that MyoVa attachment to pigment granules is 
evolutionary conserved between amphibians and mammals. 
5.3.7 Exon F is essential for the interaction between XtMlph and XlMyoVa 
Extensive investigations on the connection between Mlph and the motor protein MyoVa 
have been carried out in mouse. In mouse, MyoVa binds with its globular tail domain and 
exon F to the middle domain of Mlph. For this interaction, exon F is absolutely required in 
vivo in mouse melanocytes (33, 122, 123). Sequence alignment between MmMyoVa and 
XlMyoVa revealed that XlMyoVa presumably contains exon F as the mouse protein does. 
The highly conserved region of exon F between XlMyoVa and MmMyoVa is shown in yellow 
(Figure 23 A). To test the potential exon F-dependence of the Mlph-MyoVa interaction in 
Xenopus, I used the purified Rab27a/Mlph complex and incubated it with either the purified 
XlMyoVa C-tail (residues 1110-1852) that includes exon F or the purified XlMyoVa GTD 
(residues 1445-1852) that excludes exon F, respectively. 
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Figure 23: Sequence alignment of XlMyoVa, MmMyoVa, and MmMyoVb proteins. Exon F in the 
MmMyoVa and in the XlMyoVa is highlighted in yellow. MmMyoVb has a deletion of large parts of 
this region. Asterisks, colons and dots indicate positions that are fully, partially or weakly conserved, 
respectively. (B) XlMyoVa binds to the XlRab27a/XtMlph complex in an exon F-dependent 
manner. Lane I shows the tandem purified XlRab27a/XtMlph complex. Lane II contains FLAG-
purified XlMyoVa C-tail possessing the exon F sequence. Lane III demonstrates that XlMyoVa C-tail 
is able to bind to the preformed XlRab27a/XtMlph complex. Lane IV shows the purification of the 
FLAG-tagged XlMyoVa C-tail via Ni-NTA resin as a control. Lane V shows the purified XlMyoVa GTD 
via FLAG-tag. Lane VI demonstrates that the GTD that is devoid of exon F can no longer interact 
with XlRab27a/XtMlph complex. Lane VII contains a purification of the FLAG-tagged XlMyoVa GTD 
via Ni-NTA resin as a control. 
The XlMyoVa C-tail construct containing exon F was capable of binding to the preformed 
Rab27a/Mlph complex (Figure 23, lane III), whereas XlMyoVa GTD that lacks exon F did not 
interact with Mlph (Figure 23, lane VI). 
Taken together, the interaction between Mlph and MyoVa in the amphibian Xenopus laevis 
takes place in the same way as shown for the mammalian system mouse, where exon F is 
essential for binding of MyoVa to Mlph. 
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5.4 The adaptor protein Mlph is the target of PKA 
It is well established that PKA plays an important role in signal transduction governing 
intracellular melanosome transport in amphibian melanophores. Additionally, proteomic 
analyses of mouse melanoma cells identified numerous phosphorylated residues in all 
three subunits of the tripartite complex (124, 125). In particular, several conserved 
serine/threonine residues within Mlph’s ABD that also represent potential cAMP-
dependent protein kinase consensus sites were found to be phosphorylated in vivo (Figure 
24) (126). 
 
Figure 24: Alignment of Mlph ABDs from mouse (Mm), human (Hs), Fukomys (Fd), dog (Cl), sheep 
(Oa), and Xenopus (Xt). Sequence alignment of selected Mlph ABDs revealed numerous conserved 
serine/threonine residues that represent potential PKA targets. Serine and threonine residues that 
were found to be phosphorylated in vivo are in bold. Boxes indicate conserved phosphorylatable 
serine residues. Numbers represent the residue numbers according to MmMlph. Asterisks, colons 
and dots indicate positions that are fully, partially, or weakly conserved, respectively. 
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5.4.1 The ABD of Mlph is negligible for the interaction between Mlph and MyoVa 
To investigate the functional importance of Mlph’s ABD in vitro, I generated C-terminally 
truncated Mlph constructs that either lacked the entire or partial ABD. Both Xenopus and 
mouse wild type and truncated Mlph proteins were capable of reconstituting the tripartite 
complex in vitro (Figure 25) (127). 
 
Figure 25: The ABD of Mlph is not involved in formation of the MyoVa receptor complex in vitro. 
(A) Tripartite complexes reconstituted with Xenopus proteins. SNAP-6XHis-tagged XlRab27aS-H, 
FLAG-tagged XlMyoVaF and FLAG-tagged full length (lane I) or C-terminally truncated XtMlphF (lanes 
II, III) purified by Ni-NTA affinity purification as in Figure 22. As a control for non-specific binding, 
FLAG-tagged XlMyoVaF was also subjected to Ni-NTA affinity purification (lane IV). (B) 
Reconstitution of the tripartite complex from mouse as in (A) using the full length SNAP-6XHis-
tagged MmRab27aS-H, FLAG-tagged MmMyoVaF, and FLAG-tagged full length (I) or truncated (II-III) 
MmMlphF subunits. As a control for non-specific binding, FLAG-tagged MmMyoVaF was subjected 
to Ni-NTA affinity purification (lane IV). 
Taken together, removal of the ABD does not interfere with Mlph’s protein structure and 
truncated Mlph proteins are still able to link MyoVa to Rab27a to fulfill their function as 
adaptor protein. Furthermore, the in vitro reconstitution of the tripartite complexes from 
Xenopus and mouse demonstrates that Rab27a, Mlph, and MyoVa are sufficient to form 
the MyoVa receptor complex in two distantly related species, arguing for a conserved 
mechanism of MyoVa recruitment to the melanosome. 
5.4.2 In vitro phosphorylation assays with MyoVa receptor complex subunits 
To test whether Mlph’s ABD along with the other members of the tripartite complex are 
phosphorylated by PKA, a number of truncation constructs were used in addition to the 
wild type proteins. The two Mlph C-terminal truncation constructs that were still capable 
of recruiting MyoVa (Figure 25) were included to assess phosphorylation of the ABD. 
MyoVa is known to adapt an autoinhibited and folded conformation that might prevent 
effective phosphorylation (128-131). Therefore, I generated C-terminal (XlMyoVa HMM, 
Results   80 
 
 
residues 1-1237, and MmMyoVa HMM, residues 1-1109) and N-terminal truncations of 
MyoVa (XlMyoVa C-tail, residues 1110-1852) to exclude potential effects on 
phosphorylation. 
 
Figure 26: The Mlph subunit of the tripartite complex from Xenopus and mouse is specifically 
phosphorylated by PKA. (A) The subunits of the tripartite complex were treated with PKA and 
radiolabeled ATP. Autoradiography showed specific phosphorylation of XtMlph. Deletion of the C-
terminus of Mlph decreased phosphorylation levels significantly. (B) Phosphorylation of the 
respective mouse subunits yielded in equivalent results. 
In vitro phosphorylation assays with all individually expressed proteins described above, 
revealed that Mlph and its truncation constructs were the sole target of PKA (Figure 26) 
(127). In addition, I have assayed the MyoVa transport complex from mouse because there 
was no C-terminal portion (i.e. C-tail) available. Cargo (here: Mlph) binding was previously 
shown to release MyoVa from its folded inhibited conformation (120, 132). 
 
Figure 27: Mlph is the sole 
phosphorylation target of the 
reconstituted tripartite complex. (A) 
Coomassie-stained SDS-PAGE image of 
the reconstituted Rab27a/Mlph/MyoVa 
transport complex that was subjected to 
in vitro phosphorylation. (B) PKA 
specifically phosphorylated Mlph in the 
presence of Rab27a and MyoVa 
(autoradiograph). 
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Again, Mlph was phosphorylated by PKA, whereas Rab27a and MyoVa remained 
untargeted (127). 
Importantly, the adaptor protein Mlph is the only target of PKA in both Xenopus and mouse, 
strongly indicating that this mechanism is evolutionary conserved. Furthermore, 
phosphorylation levels significantly dropped when the ABD was removed (Figure 26). 
Collectively, kinase assays with all subunits of the tripartite complex and PKA demonstrate 
that Mlph is specifically and directly targeted by PKA, especially its C-terminal ABD. 
5.4.3 Mlph is an effective substrate of PKA 
Time course experiments of PKA-dependent phosphorylation of Mlph demonstrated that 
Mlph, from both Xenopus and mouse, is an effective substrate for PKA and phosphorylation 
occurs fast (Figure 28). Saturation is reached within less than five minutes. 
 
Figure 28: Time-dependent phosphorylation of XtMlph and MmMlph by PKA. (A) Phosphorylation 
time course of the recombinantly expressed XtMlph by PKA demonstrates that XtMlph is an 
effective substrate of PKA (k = 2.1 min-1). (B) Phosphorylation time course as in (A) but with 
MmMlph (k = 1.1 min-1). Both proteins show similar phosphorylation kinetics (A: 15.5 a.u. and B: 
16.9 a.u.). Time courses were fitted to a single-exponential function. 
Therefore, phosphorylation of Mlph by PKA takes place in a similar way in distantly related 
organisms. 
5.4.4 In vitro phosphorylation resembles in vivo phosphorylation pattern 
To identify phosphorylated residues and compare in vivo and in vitro phosphorylation 
patterns, I employed quantitative mass spectrometry analysis. The in vitro phosphorylation 
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by PKA resembled the previously known in vivo phosphorylation pattern remarkably well 
(124, 125) (Table VIII). 
Table VIII: Identification of phosphorylated residues and their quantification in the ABD of wild 
type MmMlph in vitro. The residues found to be phosphorylated in proteomic analyses are 
highlighted in bold letters as in Figure 24. The highly conserved residue S498 that also represents 
the most conserved cAMP-dependent protein kinase consensus site was quantitatively 
phosphorylated in vitro. 
Modified 
amino acid 
Localization 
probability 
Phospho (STY) 
probabilities 
Score Occupancy 
400 0.708 ISGSST(0.708)SSEDE 183 18.1% 
401 0.949 SGSSTS(0.949)SEDET 208 37.1% 
416 0.999 TFLGGS(0.999)PKVCT 186 51.1% 
435 1.00 ERNPRS(1.00)PGNPA 128 60.9% 
443 0.386 NPARPT(0.386)KSTDE 51 ND 
445 0.989 ARPTKS(0.989)TDEEL 122 18.9% 
446 0.988 RPTKST(0.988)DEELS 92 8.46% 
451 0.999 TDEELS(0.999)EMEDR 214 26.9% 
491 0.999 LTVKPS(0.999)GKPRR 145 ND 
498 1.00 KPRRKS(1.00)GIPIF 150 99.7% 
517 1.00 DRIPKT(1.00)PPADP 137 22.2% 
537 0.999 TTAVPS(0.999)LLRRK 49 ND 
544 0.999 LRRKYS(0.999)PSSQG 185 49.2% 
546 0.836 RKYSPS(0.836)SQGVD 126 ND 
554 0.994 GVDSGS(0.994)FDRKS 143 ND 
559 0.972 SFDRKS(0.972)VYRGS 100 ND 
564 0.982 SVYRGS(0.982)LTQRN 89 ND 
ND, not detected. 
The conserved and strong PKA-consensus site S498 contributed most to the overall 
phosphorylation within the ABD (Figure 24, Table VIII) (127). The close resemblance of the 
phosphorylation patterns in vitro and in vivo enabled me to test the functional 
consequences of Mlph phosphorylation in vitro. The following experiments were carried 
out employing the proteins from Mus musculus, because there is no in vivo phosphorylation 
pattern available for XtMlph or XlMlph. 
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5.5 PKA-dependent phosphorylation of Mlph does not interfere with MyoVa activity, 
actin binding or complex assembly 
What function does Mlph phosphorylation serve? The following five scenarios are 
conceivable: (I) the phosphorylation alters MyoVa’s activity and thereby regulates 
melanosome transport on F-actin, (II) the interaction between Mlph’s ABD and actin is 
modulated by phosphorylation to bias transport direction, (III) motor protein (here: 
MyoVa) recruitment is changed in response to Mlph phosphorylation or in other words: 
phosphorylation of Mlph influences the stability of the tripartite transport complex, (IV) a 
yet unknown element is involved in regulation or (V) a combination of the possible 
scenarios described above accounts for the observed transport regulation. 
The different motor proteins are indeed regulated as MyoVa was previously shown to be 
downregulated by ca. 50% and dynein is upregulated during aggregation in amphibian 
melanophores (73). How this is achieved is only partially known to date. The here 
performed in vitro motility assays with purified melanosomes (see section 5.1.3 PKA 
directly regulates MyoVa-driven melanosome transport in vitro) point to a mechanism 
different from motor activity regulation, because all biophysical transport parameters from 
active, inactive, and reactivated transport are similar. 
5.5.1 Mlph phosphorylation does not affect MyoVa-based transport on F-actin in vitro 
The first scenario posits that Mlph phosphorylation might alter the activity of the actin-
based motor MyoVa. Single-molecule TIRF assays on surface-attached actin filaments were 
employed to test this hypothesis. For this purpose, the tripartite complex was assembled 
with Mlph lacking its ABD (Mlph ΔABD), phosphorylated (Mlph Phos) and 
dephosphorylated Mlph (Mlph Dephos) and fluorescently labeled on the Rab27a subunit. 
Velocities and run lengths of all three assembled complexes were determined on 
fluorescently labeled actin filaments in a TIRF microscope. 
The velocities and run lengths of the respective MyoVa transport complex were 
independent of the presence or absence of the ABD (Figure 29 A-C) (127). Likewise, the 
transport parameters of the complexes assembled with phosphorylated or 
dephosphorylated Mlph were indistinguishable (Figure 29 B and C). 
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To conclude, phosphorylation of Mlph does not impact MyoVa-driven transport 
parameters like velocity and run length on actin filaments in vitro. 
 
Figure 29: Transport parameters of the tripartite complex on surface-attached actin filaments in 
single-molecule TIRF assays. The tripartite complex assembled with Mlph that lacked its ABD (A) 
and the complexes assembled with phosphorylated (B) and dephosphorylated (C) Mlph, 
respectively, all moved at consistent velocities. The absence of ABD (A) or the phosphorylation state 
of the Mlph (B vs. C) did not interfere with the velocities and run lengths of the respective 
complexes. The majority of the complexes displayed a single-step photobleaching of the SNAP-
tagged Rab27a subunit as shown in the right panels of A to C, demonstrating that the transport 
parameters are derived from single molecules of Rab27a. 
5.5.2 Mlph phosphorylation does not impact actin binding 
In 2002, it was first reported that Mlph is capable of binding to actin via its C-terminal ABD 
(49). Further studies supported this result and broadened the knowledge by demonstrating 
that a cluster of positively charged amino acids (K493, R495, R496, K497) is responsible for 
this interaction (37, 48). It was suggested that the positively charged residues in the ABD 
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interact with the negatively charged N-terminus of actin through electrostatic interactions 
(37). The here presented finding that Mlph is phosphorylated – in particular Mlph’s ABD 
(Figure 26) – might suggest a phosphorylation-dependent regulation of this electrostatic 
interaction by reducing the net positive charge on Mlph’s C-terminus. To test this 
hypothesis, fluorescently labeled MmRab27a-Q78LS-H in complex with either 
dephosphorylated or phosphorylated MmMlphF was subjected to in vitro filament 
decoration assays. Briefly, MmRab27aS-H was coexpressed with MmMlphF and tandem 
purified. Fluorescent labeling of the Rab27a subunit was performed while the complex was 
bound to Ni-NTA-beads, whereas dephosphorylation or phosphorylation was performed 
while protein complex was FLAG-resin bound. Phosphatase- or PKA-treated and 
fluorescently labeled Rab27a/Mlph complex (Alexa 647) was flushed into a flow chamber 
with surface-immobilized and fluorescently labeled actin filaments (Atto488) and 
decoration was imaged by TIRF microscopy. 
Intriguingly, dephosphorylated as well as phosphorylated Mlph in complex with Rab27a 
decorated F-actin to an equivalent extent (Figure 30 A) (127). Mlph that lacked its ABD 
(MmMlph ΔABD) was no longer capable of interacting with actin filaments, regardless of 
its phosphorylation state (Figure 30 B). 
 
Figure 30: Mlph interacts with F-actin, but not in a phosphorylation-dependent manner. (A, B) 
Actin decoration experiments in which surface-immobilized fluorescently labeled F-actin (red 
channel) was incubated with a complex formed between Mlph and fluorescently labeled Rab27a 
(green channel). (A) Both the phosphorylated (Phos) and dephosphorylated (Dephos) Mlph 
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decorated F-actin similarly well. (B) Removal of the C-terminal ABD of Mlph inhibited this 
interaction regardless of the phosphorylation state. Scale bar: 10 µm. 
To further verify that phosphorylation of Mlph did not impact its association with actin 
filaments, I performed decoration assays to quantify the intensities of the 
dephosphorylated and phosphorylated Rab27a/Mlph complexes associated with actin 
filaments in one flow chamber. For this purpose, the dephosphorylated Rab27a/Mlph 
complex was labeled with Alexa Fluor 488 and the phosphorylated complex was labeled 
with Alexa Fluor 647. Equal amounts of the differentially labeled, dephosphorylated and 
phosphorylated complexes were flowed into a single flow chamber with surface-adhered 
Atto565-labeled actin filaments and three-color TIRF microscopy was employed (Figure 31 
A). Quantification of the actin-associated fluorescent intensities of the dephosphorylated 
and phosphorylated complex, respectively, demonstrated that both complexes bound to 
very similar extents to actin (Figure 31 A, right panel) (127). To exclude any effects of 
protein labeling, I swapped the colors of the complexes (i.e. dephosphorylated complex 
was labeled with Alexa Fluor 647 and the phosphorylated complex was labeled with Alexa 
Fluor 488, respectively) and the quantification yielded similar results (Figure 31 B). 
Collectively, the phosphorylation state of Mlph does not influence its association with actin 
filaments in vitro. 
 
Figure 31: Quantification of Mlph’s interaction with actin filaments in vitro. (A) Dephosphorylated, 
Alexa Fluor 488-labeled Rab27a/Mlph complex was mixed in equal amounts with phosphorylated, 
Alexa Fluor 647-labeled Rab27a/Mlph complex and incubated with surface-attached, Atto565-
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labeled actin filaments. The quantification of the actin-associated fluorescence signals from the 
respective PKA- and phosphatase-treated Rab27a/Mlph complexes showed that the 
phosphorylation state of Mlph did not substantially interfere with actin actin binding (right panel). 
(B) Same experiment as in panel A for which the fluorescent labels on the Rab27a/Mlph complexes 
were swapped. Error bars represent SD. Scale bar: 10 µm. 
5.5.3 Phosphorylation of Mlph does not alter complex assembly 
Is MyoVa specifically recruited to the pigment granule at the onset of dispersion? In vitro 
reconstituting the tripartite complex with Rab27a, MyoVa and dephosphorylated Mlph or 
phosphorylated Mlph, respectively, demonstrated that both, dephosphorylated and 
phosphorylated, Mlph proteins assemble the complex with comparable amounts of Rab27a 
and MyoVa proteins (Figure 32). Additionally, single-molecule data could be collected with 
both the dephosphorylated and the phosphorylated MyoVa transport complexes indicating 
that both complexes assemble similarly well. 
 
Figure 32: The tripartite complex from mouse can be assembled from full length subunits with both 
phosphatase-treated (left lane) and PKA-treated Mlph (right lane). 
5.6 Phosphorylation regulates Mlph’s binding to MTs 
Not only actin filaments serve as tracks for melanosome transport in vivo, but 
melanosomes are transported on MTs as well. However, no information on a possible 
interaction between the MyoVa adaptor protein Mlph and MTs has yet been reported. 
Nevertheless, employing microtubule filaments in the filament decoration assay, as 
performed with actin filaments described above, was a fairly easy way of testing this 
possibility. Surprisingly, Mlph in its dephosphorylated state exhibited strong decoration of 
surface-attached MTs (Figure 33 A, upper panel) (127). In addition, phosphorylated Mlph 
barely showed an interaction with MTs (Figure 33 A, lower panel). This novel interaction 
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between Mlph and MTs was again dependent on the C-terminal ABD of Mlph (Figure 33 B) 
(127). 
 
Figure 33: Mlph interacts with MTs via its ABD in phosphorylation-dependent manner. 
Microtubule decoration experiments in which fluorescently labeled MTs (red) were incubated with 
the labeled complex (green) as described in Figure 30. (A) Decoration of MTs was strictly dependent 
on the phosphorylation state of Mlph. The fluorescent background from the phosphorylated and 
dephosphorylated Rab27a/Mlph complex seen in the green channel was comparable indicating 
similar protein amounts. (B) Removal of the ABD inhibited the interaction of Mlph with MTs. Scale 
bar: 10 µm. 
To conclude, Mlph associates with MTs in a strictly phosphorylation-dependent manner – 
namely only in the dephosphorylated state – and this interaction is mediated by the 
previously described C-terminal ABD of Mlph. 
5.6.1 Point mutations in the ABD rescue MT binding 
If association of Mlph with MTs is indeed phosphorylation-dependent, mutation of the 
involved residues into alanines, mimicking the dephosphorylated state, will lead to 
microtubule decoration even in the presence of PKA. Alignment of several ABD domains of 
Mlph from distinct species (Figure 24) revealed three conserved serine residues that also 
contained the known PKA consensus site R-R-X-S/T (126). To test whether one or more of 
these residues are involved in microtubule association, I generated the following 
unphosphorylatable alanine mutations of the conserved residues and additional 
neighboring serine or threonine residues: T443/S445/T446, S491/S498, and 
S544/S546/S547 (Figure 34) (127). 
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Figure 34: Mutated serine and threonine residues in conserved regions within the ABD of Mlph. 
Serine and threonine residues in three conserved regions (see Figure 24) were mutated to alanines 
to mimic the dephosphorylated state. Mutated residues are shown in bold letters. A serine- and 
threonine-rich stretch outside the ABD was mutated as a negative control (MmMlph Dephos 
control mutant).  
S498 is the most conserved residue and possesses a strong PKA recognition site, making it 
the most promising candidate. The other regions (T443/S445/T446, S544/S546/S547) are 
only partially conserved and possess weak PKA consensus sites, respectively. Additionally, 
an exceptionally serine- and threonine-rich stretch at the very N-terminus of the ABD that 
is conserved, but contains no PKA recognition motif, was mutated as a negative control 
(T392A/S393/396/398/399A/T400A/S401A, Figure 34) and is termed MmMlph Dephos 
control mutant. 
Wild type and mutated MmMlphF constructs in complex with MmRab27a-Q78LS-H were 
tandem purified side-by-side, fluorescently labeled with Alexa Fluor 647, and 
dephosphorylated with antarctic phosphatase (wild type MmMlph) and phosphorylated 
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with PKA (wild type and mutant MmMlphs, Figure 35). Fluorescent labeling with SNAP-
Surface 
 
Alexa 647 specifically occurred on the SNAP-tagged Rab27a subunit (Figure 35 B).These 
proteins were employed in MT decoration assays as performed for dephosphorylated and 
phosphorylated wild type Mlph (Figure 33). Mutant MmMlph T443A/S445A/T446A, 
S491/498A, and S544/546/547A associated with MTs even in the presence of PKA (Figure 
36 A-C) (127). In contrast, the MmMlph Dephos control mutant failed to decorate MTs 
(Figure 36 D). In parallel, wild type MmMlph treated with phosphatase or PKA decorated 
MTs or was not capable of interacting with MTs, respectively (Figure 36 E-F). 
Figure 35: Purified MmRab27a 
in complex with wild type and 
mutant MmMlph 
(T443A/S445A/T446A, 
S491/498A, S544/546/647A, 
and Dephos control mutant) 
analyzed with SDS-PAGE and 
Coomassie-staining (A) and 
fluorescence scanning (B). 
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Figure 36: Mutations in candidate phosphorylation sites of Mlph prevent PKA-induced 
dissociation of Mlph from MTs. MT decoration experiments were performed as in Figure 33. (A-C) 
PKA-treated Mlph mutants T443A/S445A/T446A, S491/498A, and S544/546/547A all decorated 
MTs, but not the Dephos control mutant (D). The wild type Mlph decorated MTs in its 
dephosphorylated state (E), but not in its phosphorylated state (F) as in Figure 33 A. Scale bar: 10 
µm. 
Collectively, all three mutated regions rescued MT binding even though the proteins were 
fully phosphorylated. The fact that the MmMlph Dephos control mutant with mutations 
outside the ABD is not capable of interacting with MTs additionally demonstrates that the 
interaction specifically occurs via the ABD. These results strongly support the 
phosphorylation-dependence of the interaction between Mlph’s ABD and MTs. 
To verify that the actin association of Mlph is not affected by the introduced mutations, 
actin decoration assays with F-actin and wild type and mutant MmMlph constructs were 
performed. In line with the results obtained with dephosphorylated and phosphorylated 
wild type MmMlph in actin decoration assays (Figure 30), all mutant MmMlph constructs 
as well as phosphorylated wild type MmMlph decorated F-actin to a comparable extent 
(Figure 37) (127). 
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Figure 37: Mutations in candidate phosphorylation sites of Mlph do not interfere with F-actin 
binding. (A-E) Decoration of fluorescently labeled F-actin (red channel) with the wild type and 
mutant MmMlph constructs (green channel) as in Figure 36. All mutant complexes interacted with 
F-actin as efficiently as the wild type. Scale bar: 10 µm. 
5.6.2 S491/498 is the main contributor to MT association 
The here performed filament decoration assays only allowed a qualitative statement about 
the involvement of individual mutated regions in MT association. To obtain more 
quantitative results different experimental approaches were used. On the one hand, in 
vitro phosphorylation assays are suitable to gather information on how each mutated 
region influences overall phosphorylation levels. Wild type Mlph and its three rescue 
mutants were therefore phosphorylated by PKA using radiolabeled ATP and the resulting 
signals corresponded to the different phosphorylation levels for wild type and mutant 
Mlphs. On the other hand, quantitatively comparable results on the extent of interaction 
between different mutated regions and MTs might indicate the importance of one/more 
site(s) over the others. For this purpose, MT cosedimentation assays were performed. In 
this experiment, MTs are incubated with the protein of interest followed by 
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ultracentrifugation through a sucrose cushion. Thereby, MT-bound proteins pellet with 
MTs and are separated from unbound proteins that remain in the supernatant. 
In vitro phosphorylation assays with wild type and mutant MmMlph demonstrated that the 
MmMlph S491/498A mutant could not be phosphorylated efficiently anymore (Figure 38) 
(127). The phosphorylation level reached 26% compared to wild type MmMlph, whose 
phosphorylation level was set to 100%. The phosphorylation of T443A/S445A/T446A was 
only modestly reduced to 76% and S544/546/547A reached a phosphorylation level of 57% 
compared to wild type MmMlph. 
 
For quantifying the Mlph-MT interaction, wild type and mutant MmMlph proteins were 
treated with PKA for phosphorylation. In parallel, MmMlph lacking its ABD (ΔABD) and 
phosphatase-treated wild type MmMlph were prepared. MT cosedimentation assays were 
performed side-by-side with identical concentrations of all proteins described above. Equal 
volumes of the total reaction, supernatant, and pellet were analyzed with Coomassie-
stained SDS-PAGE. MmMlph lacking its ABD did not interact with MTs (Figure 39, I) and only 
4% of the applied phosphorylated wild type MmMlph interacted with MTs (Figure 39, II). In 
contrast, 27% of the applied dephosphorylated wild type MmMlph bound to MTs (Figure 
39, III), further supporting the results from decoration assays that demonstrated that 
dephosphorylated Mlph associates with MTs and phosphorylated Mlph does no longer 
interact with MTs. All mutant Mlph constructs displayed a significantly higher extent of 
interaction with MTs than phosphorylated wild type Mlph (Figure 39, IV-VI), with 
S491/498A showing the most pronounced rescue of interaction (127). 
Figure 38: Non-phosphorylatable alanine mutations in the 
three predicted phosphorylation sites reduce PKA-
dependent phosphorylation. In vitro phosphorylation 
assays (lower panel: autoradiograph, upper panel: 
corresponding Coomassie-stained SDS-PAGE as loading 
control) with wild type MmMlph and its mutants showed 
that the S491/498A mutant suppressed the PKA-dependent 
phosphorylation of Mlph most efficiently (26%) when 
compared to wild type (100%), T443A/S445A/T446A (76%), 
and S544/546/547A mutants (57%), where weaker and less 
conserved PKA recognition sites were mutated. Percentages 
are mean values obtained from two independent assays ± 
SD. 
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Figure 39: S491/498A is the main contributor to the phosphorylation-dependent release of Mlph 
from MTs. MT cosedimentation assays were performed side-by-side with the truncated Mlph that 
lacked its ABD (I, ∆ABD), phosphorylated wild type Mlph (II, wild type Phos), dephosphorylated wild 
type Mlph (III, wild type Dephos), and along with phosphorylated Mlph that carried the respective 
nonphosphorylatable alanine mutations (IV-VI). The total reaction (T), supernatant (SN), and pellet 
(P) were analyzed with Coomassie-stained SDS-PAGE. As expected from results shown in Figure 33, 
Mlph that lacked its ABD and the phosphorylated wild type Mlph failed to display a pronounced 
interaction with MTs (N/D and 4%, I-II). In line with results from Figure 36, the dephosphorylated 
wild type Mlph and all rescue mutants displayed significant pelleting with MTs (8%-27%, III-VI). The 
S491/498A mutant containing the strong and most conserved PKA consensus site S498 also 
demonstrated the most pronounced effect of rescue (17%, IV). Percentages are mean values 
obtained from two independent assays ± SD. N/D, not determinable. 
To summarize, the quantitative characterization of the MmMlph rescue mutants using in 
vitro phosphorylation assays and MT cosedimentation assays revealed that the most 
conserved serine residue 498, which possesses the strong PKA consensus site, suppressed 
phosphorylation most efficiently and rescued MT binding best. Taken together, these 
results implicate that S498 is the key site in regulating MT association of Mlph through PKA-
dependent phosphorylation. 
5.7 Dephosphorylated Mlph predominantly associates with MTs in the presence of both 
filaments 
What is the in vivo implication of the results presented so far? I demonstrated that the 
MyoVa adaptor protein Mlph is not only capable of binding to actin filaments, but is also 
able to interact with MTs in vitro. Importantly, the association of Mlph to MTs is strictly 
dependent on Mlph’s phosphorylation status. Dephosphorylated Mlph bound to MTs, 
whereas phosphorylated Mlph did not. To approach the cellular scenario for melanosome 
transport further with in vitro tools at hands, I built so-called mixed networks, containing 
both actin filaments and MTs. With this experimental setup, I wanted to test which 
interaction was stronger under competitive conditions with both filaments present. 
Results   95 
 
 
 
To build the actin/MT networks in vitro, Atto488-labeled MTs and Atto565-labeled actin 
filaments, both biotinylated, were attached to the biotin-streptavidin-coated flow chamber 
surface. Dephosphorylated or phosphorylated Rab27a/Mlph complex labeled with Alexa 
Fluor 647 was subsequently added and the chamber was imaged using three-color TIRF 
microscopy. The actin and MT area was determined using a custom MATLAB tool. The 
fluorescence intensity associated with each filament type was quantified and the 
percentage of Mlph bound to each filament type was calculated for each image. 
Figure 40: Dephosphorylation sufficiently 
relocates Mlph from actin filaments to MTs in 
vitro. (A) Surface-immobilized and Atto488-
labeled MTs and Atto565-labeled actin filaments 
were incubated with phosphorylated complex 
formed between Mlph and Alexa Fluor 647-
labeled Rab27a. Under these competitive 
conditions, the binding of the phosphorylated 
Rab27a/Mlph complex to actin dominated (83 ± 
4%) over MT binding (17 ± 4%). (B) Upon 
dephosphorylation, the behavior of the 
Rab27a/Mlph complex was reversed and the MT 
binding clearly dominated (76 ± 4%) over actin 
binding (24 ± 4%). Error bars represent SD. Scale 
bar: 10 µm. 
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Intriguingly, phosphorylated Rab27a/Mlph complex preferentially associated with actin 
filaments (Figure 40 A) in the presence of both filament types (127). In stark contrast, MT 
binding clearly dominated in the case of dephosphorylated Rab27a/Mlph complex (Figure 
40 B). This experiment suggests that the interaction between MTs and Mlph might to be 
stronger than Mlph’s association with actin filaments. 
In conclusion, MTs efficiently compete for Mlph binding in the presence of actin filaments 
in vitro. Phosphorylation is sufficient to relocalize Mlph from MTs onto the actin network. 
5.8 The ABD of Mlph enforces track selection on the MT and actin networks in vitro 
I showed that MyoVa’s adaptor protein Mlph in complex with Rab27a interacts with both 
actin filaments and MTs in vitro. On cytoskeletal networks composed of MTs and actin 
filaments, Mlph’s phosphorylation state dictated to which filament Mlph primarily binds. 
Dephosphorylated MmRab27/Mlph complex predominantly associated with MTs, whereas 
phosphorylated MmRab27a/Mlph complex preferred to bind to actin filaments. What are 
the functional consequences of Mlph phosphorylation on the physiologically relevant 
MyoVa transport complex Rab27a/Mlph/MyoVa? To answer this question in vitro, single-
molecule TIRF assays with the tripartite complex assembled with dephosphorylated or 
phosphorylated Mlph on networks built with actin filaments and MTs were performed. As 
expected from an actin-based motor protein, the MyoVa transport complex with 
phosphorylated Mlph incorporated mainly exhibited directional movement on actin 
filaments (Video 4) (127). In stark contrast, the MyoVa transport complex built with 
dephosphorylated Mlph showed diffusional movement on MTs to a significant extent 
besides directional transport on actin filaments (Video 5) (127). 
Remarkably, Mlph was able to dictate filament association of the tripartite complex even 
in the presence of the actin-based motor protein MyoVa. The tripartite complex switched 
between actin filaments and MTs at inter-filament intersections (Figure 41, Video 6, Video 
7) (127). 
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Figure 41: Examples of switching events at actin-MT intersections. (A) Example of a tripartite 
complex (green) that diffused on MTs (red) and switched to an intersecting actin filament (blue) 
(Movie S3) and (B) of a tripartite complex that moved directionally on the actin filament and 
switched to an intersecting MT (Movie S4). Scale bar: 3 µm. 
To assess the influence of the phosphorylation state of Mlph’s ABD on the switching 
behavior of the tripartite complex, only complexes that were in close proximity to an actin-
MT intersection and either passed the intersection without changing filament type or 
switched filament type at the intersection were taken into account. The percentages of 
passing and switching complexes were calculated for each switching direction (from actin 
to MTs and vice versa). One third of the complexes assembled with dephosphorylated Mlph 
switched from actin onto MTs (Figure 42 A) (127). Complexes exhibited directional 
movement on actin filaments that was interrupted by diffusion on MTs. Opposed to this, 
the propensity to switch from actin to MTs was completely abolished when the tripartite 
complex was reconstituted with phosphorylated Mlph (Figure 42 B). In fact, complexes with 
phosphorylated Mlph rarely interacted with MTs (reflected in the low N number of 
switching events from MTs to actin filaments for the complex with phosphorylated Mlph) 
and mostly displayed uninterrupted directional movement on actin filaments (Video 4). 
MyoVa was previously shown to interact with MTs on its own. Specifically, MyoVa diffuses 
on MTs (84, 85). What is MyoVa’s contribution to the interaction between MTs and the 
tripartite complex? Tripartite complexes with dephosphorylated or phosphorylated Mlph 
lacking the ABD (Mlph ΔABD) were reconstituted and tested on actin and MT networks in 
vitro. Independent of the phosphorylation state, tripartite complexes assembled with Mlph 
ΔABD exhibited a probability of around 7% to switch from actin to MTs and around 65% to 
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switch from MTs to actin filaments (Figure 42 C and D). Importantly, phosphorylation of 
Mlph outside the ABD did not influence the switching behavior of the assembled 
complexes. 
 
Figure 42: Phosphorylation state of Mlph’s ABD dictates the directionality of switching at the 
actin-MT intersections. Movement of the tripartite complex on actin and MTs is represented by 
single- and double-headed black arrows, respectively. Cyan arrows depict switching from actin to 
MTs, red arrows indicate switching from MTs to actin. (A) The tripartite complex reconstituted with 
dephosphorylated Mlph displayed a significantly higher probability to switch from actin to MTs at 
the inter-filament intersections. Whereas 32.3% of complexes switched from actin to MTs (67.7% 
continued directional movement on actin, A), (B) the propensity of switching from actin to MTs was 
abolished when the tripartite complex was assembled with phosphorylated Mlph. The 
phosphorylated complex completely ignored the inter-filament intersections (0% switching) and 
continued its directional movement on the actin (100%, B). Conversely, dephosphorylated Mlph 
significantly suppressed the switching probability of the complex from MTs to actin (26.1%, A) when 
compared to the complex built with phosphorylated of Mlph (100%, B). Indeed, the phosphorylated 
complex rarely interacted with the MTs substantially decreasing the probability of switching events 
from MTs to actin (Video 4). (C, D) In contrast, tripartite complexes assembled with 
dephosphorylated Mlph ΔABD (C) and phosphorylated Mlph ΔABD (D) displayed similar 
probabilities to switch between the two filament types confirming that phosphorylation outside of 
Mlph’s ABD did not interfere with the switching behavior of the tripartite complex. N indicates the 
number of events for each switching direction. 
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Taken together, the phosphorylation state of Mlph’s ABD dictates the track selection of the 
MyoVa transport complex on actin filaments and MTs. Phosphorylation of Mlph’s ABD is 
sufficient to locate the MyoVa transport complex onto actin filaments. Dephosphorylation 
of Mlph’s ABD, on the other hand, enhances the interaction of the complex with MTs. 
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6. Discussion 
For intracellular transport, eukaryotes often employ a set of distinct motor types that unite 
their efforts to achieve proper cargo delivery within the cell. This motor ensemble 
commonly consists of two MT-based molecular motors with opposing transport direction 
and an actin-based motor protein. As these motor proteins work together, a tight 
regulation of motor activity is needed to ensure an effective overall transport of cargo. 
Despite the prevalence of this concept to join efforts of different types of motors to 
transport one single cargo, only very limited insights have been obtained about 
mechanisms that functionally link the two cytoskeletal systems. 
Using melanosomes from the amphibian Xenopus laevis, a well-studied model system for 
intracellular transport, I set out to shed light onto the molecular mechanisms governing 
coordination of MT- and actin-based motor proteins. MT-based and actin-based motility of 
melanosomes was reconstituted previously in vitro (12, 15). For MT-based motility, it was 
shown that the regulated cell states (i.e. dispersed and aggregated cell state) were retained 
after the purification procedure (12), enabling the investigation of motor regulation during 
melanosome transport in vitro. In contrast, it remained to be shown that the regulated 
states for the actin-based transport that were observed in vivo (50% downregulation of 
MyoVa during aggregation (73)) are also preserved in vitro. Therefore, I reconstituted 
melanosome motility on actin filaments in vitro and compared the motility of melanosomes 
from the dispersed and aggregated cell states regarding the number of transport events, 
but also the kinetic transport parameters (e.g. velocity and run length). The here obtained 
velocity and run lengths values were well in line with published parameters from actin 
motility of melanosomes isolated from mouse melanocytes, in vivo tracking (110, 133), or 
recombinantly expressed full length XlMyoVa (90), supporting that the purification 
procedure and assay conditions did not interfere with melanosome motility. However, the 
first published reconstitution of melanosome motility on actin cables from Nitella reported 
a significantly slower average velocity of 36 nm s-1 (15). Since there are several reports of a 
MyoVa velocity of approximately 100-200 nm s-1 in vitro, including the velocity displayed 
by recombinantly purified XlMyoVa, it seemed that the slow velocity might be caused by 
the Nitella actin cables or other assay conditions and did not reproduce the actual MyoVa-
driven melanosome velocity. 
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I observed a higher frequency of runs on F-actin for melanosomes purified from dispersed 
cells than from aggregated cells, though melanosomes from both cell states exhibited 
similar biophysical transport parameters. Thus, actin-based transport is regulated during 
the two cell states and the regulation seems to occur on the melanosome surface alike the 
MT-based melanosome motility. Motor protein activity did not seem to be primarily 
modulated, because the biophysical transport parameters did not differ between 
dispersion and aggregation. Moreover, cytoplasmic extract from the dispersed cell state 
was sufficient to reactivate ‘dormant’ melanosomes from aggregated melanophores, 
indicating that the activating factor for actin-dependent transport of melanosomes was 
present in the cytoplasm of dispersed melanophores. Is it possible to identify the 
cytoplasmic factor responsible for this regulation? Intracellular cAMP levels were 
demonstrated to influence the switching from MT to actin filaments in fish melanophores 
(81) and it is long known that PKA activity plays a key role in the signaling cascade for 
dispersion (57, 58). However, so far signaling cascades have not been linked to the motor 
proteins that conduct the transport of melanosomes. Applying constitutively active PKA on 
purified melanosomes revealed that the frequency of actin-based melanosome transport 
events was directly regulated by PKA and this regulation directly occurred on the 
melanosome surface. For the first time, the downstream target(s) of PKA were pinpointed 
to be present directly on the melanosome surface. Furthermore, the reconstituted actin-
based melanosome motility assays suggested that PKA was involved in the coordination 
between both transport systems by upregulating the actin-based motility during 
dispersion. Molecular details of this coordination mechanism by PKA or the identity of PKA 
target protein(s), however, remain elusive. In contrast, it was suggested earlier that MyoVa 
is mainly regulated via detachment (aggregation) and recruitment (dispersion) to the 
melanosome (73). The here presented result that addition of PKA is sufficient to reactivate 
aggregated melanosomes in the absence of any cytosolic MyoVa strongly contradicts a 
regulation mechanism solely by motor recruitment. 
The most obvious target of PKA is the motor protein MyoVa itself, followed by one of the 
two adaptor proteins linking MyoVa to the melanosome surface (i.e. Rab27a or Mlph). To 
directly test this hypothesis, I opted for recombinantly expressing the three proteins from 
Xenopus laevis and Mus musculus. Both, XtMlph and MmMlph, proved to be difficult in 
handling (e.g. abnormal running behavior in SDS-PAGE and tendency to aggregate) and 
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could not be objected to size-exclusion chromatography as the protein was absorbed to 
the column material to a high extent. Elution profiles of the Mlph fraction that did not bind 
to the column suggested that the Mlph protein by itself was not homogenous. Mlph ran 
higher on SDS gels than its calculated molecular mass from the amino acid sequence as 
reported earlier (117, 118, 120). This might be caused by posttranslational modifications or 
a unique amino acid sequence (Mlph possesses a high number of serine and threonine 
residues). In complex with Rab27a, Mlph seemed to be more homogenous, because no 
aggregates were observed when fluorescently labeled Rab27a/Mlph complex was 
visualized via TIRF microscopy. By coexpressing Rab27a and Mlph proteins and subsequent 
incubation of the dimeric complex with MyoVa it was possible to reconstitute the tripartite 
complex from both organisms in vitro. This has been achieved with mouse proteins before 
(117), however the tripartite complex was reconstituted by mixing Rab27a/Mlph complex 
with MyoVa and the assembled tripartite complex was never directly shown by SDS-PAGE. 
For amphibians, it is the first evidence that MyoVa attachment occurs in the same way as 
in the distantly related species mouse. In particular, it has not been demonstrated that 
Mlph binds Rab27a in a GTP-dependent manner and that exon F is absolutely essential for 
the Mlph-MyoVa interaction in the amphibian Xenopus laevis. This is homologous to the 
mouse tripartite complex (44-47), implying that the anchorage of MyoVa to the 
melanosome is evolutionary conserved. 
In vitro phosphorylation assays with radiolabeled ATP and various constructs of the MyoVa 
transport complex revealed that Mlph was the specific and sole target of PKA. Especially, 
Mlph’s ABD is target of phosphorylation. Moreover, the PKA target is conserved from 
amphibians to mammals, as XtMlph and MmMlph are both specifically phosphorylated in 
vitro. This is the first identification of a substrate for PKA and expands the knowledge on 
signal transduction in melanosome transport to an element downstream of PKA, in 
particular in mouse where signaling pathways are not well explored and involvement of 
PKA has not been demonstrated. Importantly, these results collectively demonstrate that 
PKA directly acts on the melanosome surface by phosphorylating Mlph. Remarkably, the in 
vitro phosphorylation pattern of MmMlph ABD closely resembled the previously published 
in vivo phosphorylation pattern (124, 125), validating this candidate approach with the 
kinase PKA to investigate the function of this phosphorylation with mouse proteins in vitro. 
Three conserved regions for phosphorylation in the ABD were identified. Mass 
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spectrometry analysis of recombinantly expressed and purified Rab27a/Mlph complex 
confirmed the phosphorylation of all conserved regions in the in vitro phosphorylation 
assays performed during this study. 
Surprisingly enough, PKA’s target is the adaptor protein Mlph of the actin-based motor 
MyoVa and not the motor itself. How is actin-based transport regulated by phosphorylation 
of Mlph and, further, how is transport coordination achieved by Mlph phosphorylation in 
the cell? Mlph has previously been implicated by different studies to play a role in 
coordinating the two different transport systems (37, 45, 46, 50, 83). How can 
phosphorylation of the adaptor protein Mlph govern coordination of both transport 
systems? Motor activity was not altered between dispersion and aggregation as implied by 
similar kinetic transport parameters obtained from in vitro motility assays with 
melanosomes from the distinct cell states (see section 5.1.1, page 59). In addition, 
transport parameters of tripartite complexes assembled with dephosphorylated or 
phosphorylated Mlph, respectively, were indistinguishable (5.5.1). 
Does the phosphorylation modulate the previously discovered interaction between Mlph 
and actin and thereby bias transport direction? To investigate a potential role for ABD 
phosphorylation in modulating Mlph’s affinity for actin filaments, I performed in vitro 
decoration experiments with the dephosphorylated and phosphorylated Rab27a/Mlph 
complex on actin filaments. Unexpectedly, the phosphorylation state of Mlph did not alter 
the interaction between Mlph and actin filaments in decoration assays in vitro (see section 
5.5.2, page 84). Regardless of the phosphorylation state, both dephosphorylated and 
phosphorylated Mlph decorated actin filaments similarly well, which was supported by 
quantification of the actin-associated fluorescence intensities for dephosphorylated and 
phosphorylated Mlph. Furthermore, the stability of the tripartite complex is not affected 
by the phosphorylation of Mlph (see section 5.5.3, page 87). 
The findings that Mlph suppressed dynein activity during dispersion in zebrafish 
melanophores (83) and Mlph tracked MT plus-ends via the +TIP EB1 (50) imply a potential 
connecting function of Mlph between both cytoskeletal transport systems. In vitro 
decoration assays with MTs could easily reveal whether Mlph was additionally capable of 
directly interacting with MTs. Indeed, Mlph interacted with MTs strictly dependent on its 
phosphorylation state. Only dephosphorylated Mlph bound to surface-attached MTs via 
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the ABD, whereas phosphorylated Mlph barely interacted with MTs in vitro (see section 
5.6, page 87). Alanine mutations of the serine or threonine residues in the three conserved 
regions that mimic the dephosphorylated state rescued binding to MTs even in the 
presence of active PKA (see section 5.6.1, page 88). Quantitative phosphorylation assays 
and MT cosedimentation assays demonstrated that the most conserved serine 498, which 
possesses a strong PKA recognition site, was the main contributor to Mlph’s association 
with MTs. Nevertheless, the other two regions were able to rescue MT binding to a 
significant extent as well, pointing to bulk electrostatics that collectively contribute to the 
phosphorylation-dependent release of Mlph from MTs. This is the first report of a direct 
interaction between Mlph and MTs via Mlph’s C-terminal ABD. Importantly, the interaction 
between Mlph and MTs is strictly phosphorylation-dependent. 
To further resemble the situation in the cell in vitro, I built mixed networks with actin 
filaments and MTs in flow chambers to test Mlph localization in the presence of both 
filaments. Using the fluorescently labeled dephosphorylated or phosphorylated 
Rab27a/Mlph complex, I could demonstrate that dephosphorylation of Mlph was sufficient 
to relocate Mlph from actin filaments onto MTs. In other words, localization of Mlph on 
actin filaments and MTs was regulated via phosphorylation of Mlph’s ABD. Specifically, 
phosphorylation released Mlph from MTs and led to Mlph association to actin filaments. 
Vice versa, dephosphorylation of Mlph localized Mlph mainly to MTs. 
How might phosphorylation of Mlph be involved in biasing melanosome transport direction 
in the cell? Foremost, transport direction is determined by the activity of the motor 
proteins. As previously demonstrated, dynein is upregulated during melanosome 
aggregation and downregulated during dispersion, whereas MyoVa activity is higher during 
dispersion and decreased during melanosome aggregation (73). Additionally, switching 
between MTs and actin filaments is essential to achieve correct intracellular melanosome 
distribution. Slepchenko et al. discovered that the switching of melanosomes is determined 
by the regulation of the MT-based transport in fish melanophores (82). Specifically, they 
found that the switching rate from actin filaments onto MTs was significantly increased 
during melanosome aggregation, while the switching rate from MTs to actin filaments 
remained unchanged. Therefore, they postulated that, in addition to motor protein activity, 
another layer of regulation might be involved in determining the transport direction of 
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melanosomes. The here presented finding of the phosphorylation-dependent binding of 
Mlph to MTs could reasonably explain the regulated switching rate from actin filaments to 
MTs, assuming that melanosome transport in mouse melanocytes follows similar 
mechanisms. The prerequisite would certainly be that association of Mlph to actin 
filaments or MTs was dominant over MyoVa binding to either actin or MTs. Single-molecule 
TIRF assays with the tripartite complex Rab27a/Mlph/MyoVa on networks of actin and MTs 
in vitro demonstrated that the phosphorylation state of Mlph’s ABD enforced track 
selection on actin and MT networks in vitro. To my knowledge, this is the first direct 
demonstration of the regulatory dominance of an adaptor protein over its associated 
motor protein. Furthermore, these results highlight the function of an adaptor protein in 
crosstalk between the actin- and MT-based transport systems besides linking motor 
proteins to cargo. 
How can phosphorylation of Mlph’s ABD bias intracellular melanosome transport on actin 
and MTs in vivo? To disperse melanosomes in amphibian melanophores, both 
phosphorylation by PKA and switching of melanosomes from MTs onto actin filaments are 
required. During dispersion, MyoVa activity is increased to favor switching onto actin 
filaments and thereby actin-based transport is promoted (73). In mouse melanocytes, 
signal transduction governing intracellular melanosome transport remains largely elusive. 
Nevertheless, it has been shown that the MyoVa transport complex is essential for 
delivering melanosomes to the cell periphery. As presented in this work, Mlph, in particular 
its ABD, is phosphorylated by PKA (127). Thereby, the affinity of the melanosome is lowered 
for MTs (Figure 43 A), supporting the transfer of melanosomes from MTs onto actin 
filaments and favoring MyoVa-driven transport on actin filaments. 
Oppositely, aggregation is characterized by increased dynein activity, lowered MyoVa 
activity and increased phosphatase activity. Consequently, Mlph is mainly present in its 
dephosphorylated state that favors binding to MTs (127) and aids dynein-dependent 
switching from actin filaments to MTs (Figure 43 B). 
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Figure 43: Tuning the affinity of melanosomes to the MT network through specific targeting of 
Mlph. (A) During dispersion, kinase activity is increased and phosphorylation events occur (e.g. in 
amphibian melanophores, cAMP levels increase that activate PKA). The resulting phosphorylation 
of Mlph within its ABD decreases the affinity of Mlph for MTs. Release from MTs in turn supports 
the transfer of the organelles to actin filaments by an increased activity of MyoVa. (B) At the onset 
of aggregation, kinase activity declines, phosphatase activity is increased (e.g. PP2A in Xenopus 
melanophores) and Mlph loses its phosphorylation. The affinity of Mlph toward MTs thereby 
increases, promoting the transfer of the organelles onto the MT network for aggregation (arrow 
diagrams are adapted from (82)) as an additional mechanism to assist dynein-mediated transport 
that is upregulated during the aggregation process. 
The phosphorylation state of Mlph’s ABD dictates the track selection on actin and MTs of 
the entire tripartite complex, even when the actin-based motor protein MyoVa is present. 
Specifically, phosphorylation of Mlph’s ABD favors uninterrupted directional movement on 
actin filaments and the complex largely ignores MTs (Figure 44 A) (127). In stark contrast, 
dephosphorylation of Mlph’s ABD is sufficient to interrupt directional movement on actin 
filaments and significantly increase the interaction of the complex with MTs (Figure 44 B). 
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Figure 44: Proposed model for regulating the affinities of the moving organelles on the MT and 
actin networks in vivo. The mechanistic dissection unmasked the regulatory dominance of the 
adaptor protein Mlph over its associated motor. Even though MyoVa is an actin-associated motor, 
the dephosphorylation of Mlph’s ABD was sufficient to redirect the MyoVa from directional 
movement on the actin network to MTs for diffusive movement. Consequently, the 
phosphorylation state of Mlph’s ABD regulated the probability of directional switching of MyoVa 
between the MT and actin networks. Based on these findings, I propose that Mlph serves to bias 
the transport of organelles on the MT or actin networks in vivo. (A) Specifically, phosphorylation of 
Mlph’s ABD promotes MyoVa-dependent motility on the actin network by suppressing the affinity 
of the tripartite complex towards MTs. (B) To reverse this process, Mlph is dephosphorylated to 
increase the affinity of the tripartite complex for the MT network (B). 
Taken together, the in vitro dissection of the actin-based MyoVa transport complex 
revealed the regulatory dominance of the adaptor protein Mlph over its motor protein 
MyoVa that biases the transport complex towards either actin or MTs via phospho-
targeting of Mlph’s ABD. 
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7. Outlook 
The novel findings presented in this thesis open up several exciting research directions to 
gather a more detailed knowledge on the mechanisms governing intracellular melanosome 
transport. As the understanding of principles underlying intracellular transport advances, 
it becomes clear that the concept of using a team of distinct motor proteins for the 
transport of a single cargo (e.g. vesicle or organelle) is widely employed. How melanosome 
transport is regulated might therefore also be applicable to other intracellular transport 
processes and consequently be of general interest. 
The reconstitution of actin-based motility of melanosomes from Xenopus laevis on actin 
filaments in vitro provides an experimental setup to test the effects of further kinases or 
inhibitors on MyoVa-driven transport of pigment granules. Other kinases (e.g. PKC or MAPK 
kinase) are implied to also regulate dispersion in amphibian melanophores and can be 
tested with the in vitro motility assays. The question how crosstalk and coordination 
between the actin- and MT-system is achieved in cells can be addressed by application of 
inhibitory substances specific for one motor protein. Observation of possible effects on the 
other motor proteins might point to a coordinated action or rather a tug-of-war between 
the motors. 
Secondly, the recombinant expression and in vitro reconstitution of the tripartite complex 
paves the way for a detailed in vitro dissection of MyoVa in complex with both adaptor 
proteins. So far, only few studies investigated MyoVa in the presence of one or both 
adaptor proteins. The drawback of these studies was, however, that proteins were mixed 
without removing excess subunits from the assays. The optimized strategy to assemble the 
MyoVa transport complex in vitro presented in this thesis now allows a detailed 
mechanistic investigation of the functional and physiologically relevant complex. Further 
conceivable experiments involve building an ‘artificial’ melanosome in vitro by linking the 
tripartite complex to silica beads and investigate its behavior on 2D or even 3D built 
networks of actin filaments and MTs. Binding kinesin-2 and/or dynein to the MyoVa-
covered artificial melanosome would lend the setup a further layer of complexity and make 
it ideal to study motor coordination in vitro. This in vitro reconstituted melanosome would 
allow to test potential regulators and their impact on overall transport under defined and 
precisely controllable conditions. Precise manipulation of distinct motor proteins or 
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specific protein domains would expand our understanding of the mechanisms coordinating 
MyoVa, kinesin, and dynein that join forces to correctly deliver melanosomes within the 
cell. 
Most importantly, further data will be needed to provide evidence that Mlph 
phosphorylation modulates Mlph’s affinity for MTs and thereby biases melanosome 
transport direction in cells. Specifically, in vivo experiments are of fundamental importance 
to support this hypothesis. Several residues involved in the MT-Mlph interaction were 
identified during the course of this study. Different combinations of these residues should 
be point-mutated to mimic the dephosphorylated (mutation of serine/threonine residues 
to alanines) or phosphorylated state (mutation of serine/threonine residues to aspartic or 
glutamic acids) of Mlph’s ABD. These mutants should be transfected into the mouse 
melanocyte cell line lacking endogenous Mlph that are called leaden melanocytes (134). 
These melanocytes exhibit defects in melanosome transport to the dendritic tips and 
melanosomes are clustered in the perinuclear region. According to the model, 
dephosphorylation of Mlph’s increases the affinity of melanosomes for MTs. Therefore, 
dephos-mimetic versions of Mlph are predicted to at least partially inhibit melanosome 
transport to the dendritic tips, because melanosomes prefer to stay on MTs. As switching 
from MT onto actin is a prerequisite for melanosome dispersion, the dephos-mimetic Mlph 
mutants are expected to impair dispersion. On the other hand, transfection of the phos-
mimetic versions of Mlph is expected not to interfere with the dispersion of pigment 
granules (switching from MT to actin filaments), but switching melanosomes from actin 
filaments onto MTs should be affected. 
Collectively, this study offers novel and unexpected mechanistic insights into how cells 
might bias the direction of a moving organelle that deserve further attention in the future. 
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8. Supporting information 
 
Video 1: Examples of MyoVa-dependent melanosome transport derived from the dispersed cell 
state on F-actin in vitro. Movie is displayed at 4X speed. 
 
 
Video 2: MyoVa-dependent melanosome transport derived from the aggregated cell state and 
reactivated with cytoplasmic extract from the dispersed cell state. Movie is displayed at 4X speed. 
 
 
Video 3: MyoVa-dependent melanosome transport derived from the aggregated cell state and 
reactivated with exogenous, purified PKA. Movie is displayed at 4X speed. 
 
 
 
 
 
 
 
Video 4: Tripartite complex assembled with phosphorylated Mlph 
(green) assayed on a surface-attached network of MTs (red) and actin 
filaments (blue) in vitro. The transport complex largely ignores the 
MTs and displays directional movement on the actin network. Scale 
bar: 10 µm. Movie is displayed at 7.4X speed. 
Video 5: Tripartite complex reconstituted with dephosphorylated 
Mlph assayed on a surface-attached network of MTs and actin 
filaments in vitro. Colors are the same as in Video 4. 
Dephosphorylation of Mlph is sufficient to redirect the MyoVa-
dependent transport complex from the actin to the MT network. 
Scale bar: 10 µm. Movie is displayed at 7.4X speed. 
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Video 6: MyoVa transport complex switching from a MT onto a crossing actin 
filament in vitro. MTs are shown in red, actin filaments in blue, and the 
protein complex in green color. Scale bar: 3 µm. Movie is displayed at 2.2X 
speed. 
Video 7: Tripartite complex switching from an actin filament onto a crossing 
MT in vitro. Colors are the same as in Video 6. Scale bar: 3 µm. Movie is 
displayed at 2.2X speed. 
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10. Abbreviations 
 
ABD  actin-binding domain 
BD  binding domain 
cAMP  cyclic adenosine monophosphate 
C-terminus carboxy terminus 
DIC  differential interference contrast 
F-actin  filamentous actin 
G-actin globular actin 
GTD  globular tail domain 
GTPase guanosine triphosphatase 
Mlph  melanophilin 
MmMlph melanophilin from Mus musculus 
XlMlph melanophilin from Xenopus laevis 
XtMlph melanophilin from Xenopus tropicalis 
MT  microtubule 
MyoVa myosin Va 
MmMyoVa myosin Va from Mus musculus 
XlMyoVa myosin Va from Xenopus laevis 
N-terminus amino terminus 
MmRab27a Rab27a from Mus musculus 
XlRab27a Rab27a from Xenopus laevis 
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PAGE  polyacryl amide gel electrophoresis 
PCR  polymerase chain reaction 
PKA  protein kinase A 
SD  standard deviation 
Slp  synaptotagmin-like protein 
SEM  standard error of the mean 
SDS  sodium dodecyl sulfate 
S.O.C.  Super optimal catabolite 
TIRF  total internal reflection fluorescence 
α-MSH  α-melanocyte-stimulating hormone 
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